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Abbreviations 
aa    amino acid 
ABI    Abelson-interacting protein 
ABD    actin-binding domain 
ABP    actin-binding protein 
ADF    actin-depolymerizing factor 
ADMIDAS   adjacent to metal-ion-dependent adhesion site 
Ala    alanine 
Alk    activin-receptor-like kinase 
α-NAC   nascent-polypeptide-associated complex and co-activator-α 
ANK    ankyrin 
Arg    arginine 
Arp2/3 complex  actin-related protein 2/3 complex 
Asp    asparagine 
ATP    adenosine triphosphate 
ATPase   adenosine triphosphatase 
bFGF    basic firbroblast growth factor 
BM    basement membrane 
BMP    bone morphogenetic protein 
Ca2+    calcium-ion 
Cdc42    cell division cycle 42 
CH    calponin homology domain 
CH-ILKBP   CH domain-containing ILK-binding protein 
Col    collagen 
CPI-17    protein-kinase-C-dependent phosphatase inhibitor of 17 kDa 
CR16    corticosteroids and regional expression-16 
Crk    v-crk sarcoma virus CT10 oncogene homolog 
Dbl    diffuse B-cell-lymphoma 
DEJ    dermal-epidermal junction 
DLL4    Delta-like-4 
DNA    deoxyribonucleic acid 
Dock180   180-kDa protein downstream of CRK 
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DRF    diaphanous-related formin 
E    embryonic day 
EB    embryoid bodies 
EC    endothelial cell 
ECM    extracellular matrix 
ELMO1   engulfment and motility 1 
Ena/Vasp   enabled/vasodilator-stimulated phosphoprotein 
Eng    endoglin 
EPC    endothelial precursor cell 
EPU    epidermal proliferative unit 
EST    expressed sequence tag 
FA    focal adhesion 
F-actin    filamentous actin 
FAK    focal adhesion kinase 
FC    focal complexes 
FERM    4.1, ezrin, radixin, moesin 
FGF    fibroblast growth factor 
FN    fibronectin 
G-actin   globular actin 
GAP    GTPase activating protein 
GEF    guanine nucleotide exchange factor 
GDI    guanine nucleotide dissociation inhibitor 
GDP    guanosine diphosphate 
GIT    G-protein-coupled receptor kinase interacting protein 
GRAF    GTPase regulator associated with FAK 
GSK3β   glycogen-synthase kinase-3β 
GTP    guanosine triphosphate 
GTPase   guanosine triphosphatase 
HeLa    Henrietta Lacks 
HF    hair follicle 
HM    hair matrix 
HS    hair shaft 
HSPC300   haematopoietic stem-cell progenitor 
ICAM-1   intercellular adhesion molecule-1 
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I-EGF    integrin epidermal growth factor–like 
IFE    interfollicular epidermis 
Ig    immunoglobulin 
IL    interleukin 
ILK    integrin linked kinase 
ILKAP   ILK-associated phosphatase 
IMC    inner membrane clasp 
IPP complex   ILK-PINCH-Parvin complex 
IRS    inner root sheath 
JNK    c-Jun N-terminal kinase 
K    keratin 
kAE1    kidney anion exchanger 
kDa    kilodalton 
LAD-III   leukocyte-adhesion deficiency type III 
LAP    latency associated peptide 
LDV    leucine-aspartic acid-valine 
LLC    Lewis lung carcinoma 
LIM    Lin11, Isl1, Mec3 
LIMBS   ligand-induced metal ion binding site 
LIMK    LIM kinase 
Ln    laminin 
LTBP    latent TGFβ-binding protein 
MAdCAM-1   mucosal addressin cell adhesion molecule-1 
Mg2+    magnesium-ion 
MHC    myosin heavy chain 
MIDAS   metal-ion-dependent adhesion site 
MLC    myosin regulatory light chain 
MLCK    MLC kinase 
MLCP    MLC phosphatase 
MLP    muscle LIM protein 
MM    metanephric mesenchyme 
µm    micrometer 
Mn2+    manganese-ion 
mRNA    messenger RNA 
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MSQ    main squeeze 
MYPT1   myosin phosphatase-targeting subunit 1 
Nap125   Nck-associated protein 
NLS    nuclear localization signals 
NPF    nucleation promoting factor 
OMC    outer membrane clasp 
ORS    outer root sheath 
P    postnatal day 
PAK    p21-activated kinase 
PAT    paralyzed and arrested at the twofold stage 
PDGF    platelet-derived growth factor 
PDGFB   PDGF B 
PDGFRβ   PDGF receptor β 
PHI-1    phosphatase-holoenzyme inhibitor-1 
PINCH   particularly interesting Cys-His-rich protein 
PIR121   p53-inducible mRNA 
PIX    PAK-interacting exchange factor 
PKB    protein kinase B/Akt 
PKL    paxillin-kinase linker 
PLGF    placental growth factor 
PSGAP   PH- and SH3-domain-containing RhoGAP 
PSI    plexin-semaphorin-integrin 
PTB    phospho-tyrosine binding 
PtdIns(3,4,5)P3  phosphatidylinositol-3,4,5-trisphosphate 
Rac1    Ras-related C3 botulinum toxin substrate 1 
Ras    rat sarcoma 
RGD     arginine-glycine-aspartic acid 
RhoA    Ras homologous 
RIAM    Rap1-GTP-interacting adaptor molecule 
Rif    Rho in filopodia/RhoF 
RNA    ribonucleic acid 
RNAi    RNA interference 
ROCK    Rho-associated kinase 
s    second 
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S1P    sphingosine-1-phosphate 
SC    sebaceous gland 
Ser    serine 
SFK    Src family of tyrosine kinases 
SH2    Src-homology 2 
SRF    serum response factor 
TA    transit amplifying cells 
TESK1   testicular protein kinase 1 
TGFβ    transforming growth factor β 
THD    talin head domain 
Thr    Threonine 
Tiam    T-cell lymphoma invasion and metastasis 
TNFα    tumor necrosis factor α 
TOCA-1   transducer of Cdc42-dependent actin assembly 1 
UB    ureteric bud 
UNC    uncoordinated 
VCAM-1    vascular cell adhesion molecule 1 
VN    vitronectin 
vSMC    vascular smooth muscle cell 
vWFA    von Willebrand factor A 
WASP    Wiskott-Aldrich syndrome protein 
WAVE   WASP-family verprolin-homologous protein 
WICH    WIP- and CR16-homologous protein 
WIP    WASP-interacting protein 
Y2H    yeast two hybrid 
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Summary 
The development and homeostasis of multicellular organisms critically depends on the ability 
of cells to migrate on and to adhere to glycoproteins of the extracellular matrix (ECM), which 
is secreted and organized by cells. Key receptors for components of the ECM are the 
members of the integrin protein family, which not only mediate adhesion to the ECM but also 
sense and transmit ECM-derived mechano-chemical cues to facilitate the appropriate cellular 
responses. This signaling function of integrins depends on the recruitment of various signaling 
and adaptor molecules to the cytoplasmic tails of integrins. Among the recruited adaptor 
molecules is the actin-binding protein α-Parvin. Although in vitro studies indicate that α-
Parvin is essential for integrin signaling by providing a linkage to the actin cytoskeleton, its 
functions in vivo have not been analyzed. 
In this study, we analyzed the in vivo functions of α-Parvin, which forms a ternary complex 
with the integrin linked kinase (ILK) and particularly interesting Cysteine-Histidin-rich 
protein (PINCH). Constitutive deletion of the α-Parvin-gene in mice resulted in embryonic 
lethality due to severe cardiovascular defects. The vascular defects were due to poor blood 
vessel-coverage by mural cells, compromised angiogenic remodeling, formation of 
aneurysms, blood vessel dilations and rupture of blood vessels leading to hemorrhages and 
edemas. Mechanistically, the vascular smooth muscle cell (vSMC) dysfunction resulted from 
increased contractility, which in turn was due to elevated RhoA-activity. 
To investigate the in vivo functions of α-Parvin specifically in keratinocytes, we conditionally 
deleted α-Parvin-gene using the Cre/loxP system. The consequences ranged from severely 
compromised epidermal homeostasis to hair follicle morphogenesis in vivo and impaired 
adhesion and migration of α-Parvin -deficient keratinocytes in vitro. Impaired adhesion of α-
Parvin-deficient keratinocytes resulted in locally confined detachments of the epidermis and 
displacement of integrin expressing cells into suprabasal layers of the epidermis and was 
accompanied by delayed differentiation and ectopic proliferation of suprabasal keratinocytes. 
In conclusion, our data define a crucial function of α-Parvin in vascular development, 
epidermal homeostasis and hair follicle morphogenesis in vivo. 
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Introduction 
1) The integrin family of adhesion receptors 
 
Integrins are a family of glycosylated, heterodimeric, type I transmembrane adhesion 
receptors. Each integrin heterodimer is composed of one α- and one β-subunit that are non-
covalently associated to form a shared ligand binding interface at their extracellular globular 
head domains (Arnaout et al., 2005; Luo et al., 2007). Therefore, both subunits contribute to 
the binding specificity of a given integrin heterodimer for its extracellular ligand(s). Their 
main ligands are components of the ECM but also a considerable number of soluble ligands 
and cell-surface molecules can be recognized by certain members of the integrin family 
(Humphries et al., 2006). The name “integrin” refers to their ability to integrate cues from the 
extracellular environment with the cells’ interior organization (Tamkun et al., 1986). This 
property together with the ability to modulate growth factor receptor signaling makes 
integrins important regulators of a broad range of cellular processes including adhesion, 
migration, proliferation, survival and differentiation, which are crucial for the development 
and homeostasis of multicellular organisms (Humphries et al., 2006; Hynes, 2002; Legate et 
al., 2009; Sheppard, 2000). In line with their essential function in multicellular organisms, 
integrins are evolutionary conserved but restricted to metazoans (Whittaker and Hynes, 2002), 
where the number of subunits increases with the complexity of the organism. While the 
integrin repertoire of the nematode Caenorhabditis elegans comprises only two integrins, 
formed by two α- and one β-subunits, in the fruit fly Drosophila melanogaster, a set of five 
integrins is assembled by the combination of five α-subunits with one β-subunit. In mammals, 
18 α- and 8 β-subunits are known to form 24 distinct integrin heterodimers that have 
overlapping substrate specificity and cell-type-specific expression patterns (Humphries et al., 
2006; Hynes, 2002). 
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Figure 1: The integrin family of adhesion receptors 
Depicted are the 24 mammalian integrin heterodimers arranged according to their main ligand binding 
specificity and leukocyte-specific expression. The nine α-subunits containing an αA/I-domain are indicated (*). 
See text for details. Figure modified from (Hynes, 2002). 
 
According to their main ligand binding specificity and leukocyte-specific expression, 
integrins can be classified into four major groups (Figure 1) (Hynes, 2002): 
1) Integrins that preferentially bind to ligands containing the tripeptide sequence RGD 
(arginine-glycine-aspartic acid); they consist of the αV heterodimers αvβ1, αvβ3, αvβ5, αvβ6 
and αvβ8 as well as α5β1, α8β1, the platelet integrin αIIbβ3. Ligands for this group include 
fibronectin (FN), vitronectin (VN), thrombospondin, osteopontin and tenascin. 
2) Collagen (Col) binding integrins are the β1 heterodimers α1β1, α2β1, α10β1 and α11β1. 
3) The β1 heterodimers α3β1, α6β1, α7β1 and the α6β4 integrin are the main receptors for 
laminin (Ln). However, the collagen-receptors α1β1, α2β1 and α10β1 can also bind laminin 
(Humphries et al., 2006). 
4) Leukocyte specific integrins are the α4β7 and αEβ7 heterodimers and the β2 heterodimers 
αLβ2, αMβ2, αXβ2, αDβ2. They recognize the tripeptide motif LDV (leucine-aspartic acid-
valine) or structurally related motifs, and thereby mediate binding to ligands such as VCAM-1 
(vascular cell adhesion molecule-1), mucosal addressin cell adhesion molecule-1 (MAdCAM-
1) and intercellular adhesion molecule-1 (ICAM-1). 
The two related integrins α9β1 and α4β1 also bind to the LDV motif in FN and additionally 
recognize Ig-superfamily counter receptors such as VCAM-1. 
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2) Integrin structure and ligand binding 
 
Both integrin subunits are type I transmembrane proteins, containing a short C-terminal 
cytoplasmic segment of about 20-50 amino acids (aa), a  helical transmembrane segment of 
25-29 aa and a long extracellular segment of up to 1104 aa for α- and 778 aa for β-subunits. 
The only exception is the β4 subunit, with a long cytoplasmic segment of about 1000 aa that 
links the α6β4 integrin to intermediate filaments. 
 
 
Figure 2: Integrin structure and conformational changes 
Schematic representation of the integrin structure and conformational changes that switch integrins between 
states of low and high ligand-binding affinities. See text for details. Figure modified from (Luo et al., 2007) 
 
At their extracellular N-termini, a seven-bladed β-propeller domain of the α-subunit non-
covalently associates with the βA/I domain of the β-subunit to form the globular ligand-
binding “head” of the integrin heterodimer. A long (~170 Å) stalk or leg region separates the 
globular head from the membrane. The β-subunits-stalk consists of a Hybrid, a PSI (plexin-
semaphorin-integrin), four I-EGF (integrin epidermal growth factor–like) and a β-tail domain, 
whereas the α-subunit stalk is formed by Thigh (Immunoglobulin (Ig)-like), Genu, Calf-1 and 
Calf-2 (β-sandwich) segments. Importantly, the ectodomain of integrins can switch between 
an extended “active” and a bent “inactive” conformation, which is referred to as the 
“switchblade” model and involves separation of the cytoplasmic tails and the transmembrane 
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segments. Bending occurs at the Genu domain of the α-subunit and between I-EGF domains 1 
and 2 of the β-subunit. Additionally, a “swing-out” of the Hybrid domain in the extended 
conformation results in a shift from a closed (low affinity) to an open (high affinity) 
conformation of the βA/I domain (Figure 2). The collagen-binding and the leukocyte specific 
α-subunits additionally contain an N-terminal von Willebrand factor A (vWFA) domain 
inserted into their β-propeller which is known as the αA/I domain. Structurally, this αA/I 
domain is highly similar to the βA/I domain, and likewise can adopt a closed (low affinity) or 
open (high affinity) conformation. Both domains contain a conserved metal-ion-dependent 
adhesion site (MIDAS), which physiologically is occupied by Mg2+ and is important for 
ligand binding. Substitution of Mg2+ by Mn2+ results in conformational alterations and 
induces the open (high affinity) conformation. Two additional metal-ion-binding sites, 
LIMBS (ligand-induced metal ion binding site) and ADMIDAS (adjacent to metal-ion-
dependent adhesion site), that physiologically bind Ca2+, are present in βA/I but not in αA/I 
and contribute to the regulation of the affinity state. Ligand binding is mainly mediated by the 
βA/I domain in integrins lacking an αA/I domain. However, in the nine integrins containing 
an αA/I domain, it is the αA/I domain that predominantly contributes to ligand binding (see 
Figure 1) (Arnaout et al., 2005; Hynes, 2002; Luo et al., 2007). 
 
3) Bidirectional signaling of integrins 
 
One important feature of integrins is their ability to transmit signals across the membrane in a 
bidirectional manner. Their ability to elicit intracellular responses upon ligand binding is 
referred to as “outside-in signaling”, which in turn depends on the reversible activation of 
integrins by intracellular signals, referred to as “inside-out signaling”. 
 
3.1) Inside-out signaling 
 
The affinity of integrins for their ligand(s) is tightly regulated. Without activating signals, 
integrins are believed to adopt a bent, inactive conformation. Upon the appropriate stimuli 
long range conformational changes take place in the transmembrane- and extracellular-
domains, resulting in extended integrins with high affinity for their ligands (Figure 2). 
Physiologically, this is particularly important in platelets that must aggregate only upon 
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activation. While inappropriate activation of the platelet integrin αIIbβ3 and subsequent 
binding to its major ligand fibrinogen results in thrombosis, defective integrin αIIbβ3 
signaling results in bleeding disorders such as Glanzmann thrombasthenia (Bennett, 2005; 
George et al., 1990; Lefkovits et al., 1995). Integrin activation is achieved by the binding of 
cytoplasmic proteins to the β integrin tails to enable separation of α- and β-transmembrane 
and cytoplasmic segments (Shattil et al., 2010; Wegener and Campbell, 2008; Wegener et al., 
2007). An electrostatic salt bridge between Asp723 and Arg995 in the β3 and αIIb 
cytoplasmic tails, respectively, is implicated in preventing integrin activation by mediating a 
super weak interaction between integrin cytoplasmic tails (Hughes et al., 1996) and mutations 
of the corresponding residues in the conserved GFFKR motif in α4 and αL that disrupted this 
interaction resulted in integrin activation (Imai et al., 2008; Lu and Springer, 1997). However, 
no obvious phenotype was observed in mice upon replacement of the corresponding Asp by 
an Ala residue in the β1 integrin tail, questioning the importance of the putative salt bridge, at 
least for β1 integrins in vivo (Czuchra et al., 2006). Several studies also indicate an important 
regulatory function of transmembrane domain interactions for integrin activation, which are 
primarily mediated by an inner (IMC) and an outer (OMC) membrane clasp (Lau et al., 2009), 
although the αIIbβ3 salt bridge might contribute to the association of the transmembrane 
domains (Kim et al., 2009). While artificially preventing the separation of the transmembrane 
domains inhibited integrin activation (Lu et al., 2001; Luo et al., 2004; Zhu et al., 2008), 
mutations that interfere with the transmembrane association resulted in constitutive integrin 
activation (Gottschalk, 2005; Hughes et al., 1996; Li et al., 2005b; Luo et al., 2005; Luo et al., 
2004; Partridge et al., 2005). 
 
3.1.1) Cytoplasmic regulators of integrin inside-out signaling 
 
In vitro and in vivo studies identified talin as key-regulator of integrin activation. Talin is a 
large (~270kDa) cytoplasmic protein composed of a globular head domain and a flexible rod 
domain. The 47-kDa talin head domain (THD) is comprised of a FERM (4.1, ezrin, radixin, 
moesin) domain, consisting of subdomains F1, F2 and F3, and a F0 subdomain (Calderwood 
et al., 2002; Garcia-Alvarez et al., 2003; Rees et al., 1990). Talin binds to lipids of the plasma 
membrane and to a conserved membrane proximal NPxY-motif and additional membrane 
proximal residues in the cytoplasmic tail of integrin β-subunits, leading to the separation of 
integrin cytoplasmic tails and transmembrane domains; this is thought to be the final common 
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step required for integrin activation (Lim et al., 2007; Nieswandt et al., 2007; Petrich et al., 
2007; Simonson et al., 2006; Tadokoro et al., 2003). Binding to β-integrin tails mainly occurs 
via the phospho-tyrosine binding (PTB)-like F3 subdomain (Garcia-Alvarez et al., 2003), 
which is sufficient for β3 integrin activation (Calderwood et al., 2002). However, additional 
regions of the THD are required for β1 integrin activation (Bouaouina et al., 2008). 
Other PTB-domain containing proteins can also bind to the NPxY-motif, but in contrast to 
talin they are not able to activate integrins (Calderwood et al., 2003), suggesting that pure 
binding to the NPxY is not sufficient for integrin activation. Indeed, additional interactions 
between talin and membrane proximal regions of the β3 integrin cytoplasmic tail and plasma 
membrane lipids are required for integrin activation, and mutations that disrupt these 
interactions prevent integrin activation (Knezevic et al., 1996; Ulmer et al., 2003; 
Vinogradova et al., 2002; Wegener et al., 2007). Although the THD is sufficient for integrin 
activation (in the presence of kindlin), formation of multimolecular adhesion structures, such 
as focal adhesions (FA), additionally requires the talin rod domain (Zhang et al., 2008a). The 
rod domain primarily mediates the linkage to vinculin and the actin cytoskeleton, and it 
consists of 62 amphipathic α-helices that are assembled into helical bundles. In addition, the 
rod domain contains a second integrin binding site and a homodimerization motif, which 
might facilitate integrin clustering and FA formation (Critchley and Gingras, 2008). 
Regulation of talin function can take several forms. An autoinhibitory interaction between the 
talin rod and head domains represents an important regulatory mechanism in integrin inside-
out signaling. Phosphatidylinositol-4,5-bisphosphate disrupts this interaction and thereby 
contributes to talin activation (Goksoy et al., 2008; Martel et al., 2001). In hematopoietic 
cells, talin recruitment to the plasma membrane is controlled by the small guanosine 
triphosphatase (GTPase) Rap1 and its effector Rap1-GTP-interacting adaptor molecule 
(RIAM) (Lee et al., 2009), representing another example of how integrin activation by talin 
can be regulated. Additionally, tyrosine phosphorylation at the membrane proximal NPxY 
motif of β-integrin tails is thought to serve as a regulatory switch that negatively influences 
talin binding while at the same time promoting binding of proteins such as Dok1, that 
compete with talin for the NPxY motif (Legate and Fassler, 2009; Oxley et al., 2008). 
However, in vivo, no obvious phenotype was observed upon the replacement of the 
corresponding tyrosine by non-phosphorylateable phenylalanine in the β1 integrin tail (Chen 
et al., 2006; Czuchra et al., 2006), whereas the respective mutation in β3 integrins resulted in 
a mild bleeding phenotype due to defects in outside-in signaling (Law et al., 1999), and 
impaired pathological angiogenesis (Mahabeleshwar et al., 2006). 
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Although talin is essential for integrin activation, recent studies revealed that integrin 
activation additionally requires the presence of kindlins (Ma et al., 2008; Montanez et al., 
2008; Moser et al., 2008; Ussar et al., 2008). In mammals, kindlin-1, -2, and -3 comprise the 
kindlin family (Siegel et al., 2003). Kindlin-1 expression is mainly restricted to epithelial cells 
of tissues such as skin, intestine, and kidneys. While kindlin-2 is widely expressed, most 
prominently in skeletal and smooth muscle cells, expression of kindlin-3 is confined to the 
hematopoietic system (Jobard et al., 2003; Siegel et al., 2003; Ussar et al., 2006). Structurally, 
kindlins closely resemble the THD. However, a pleckstrin homology (PH) domain is inserted 
into the F2 subdomain of the kindlin FERM domain (Goult et al., 2009; Kloeker et al., 2004). 
Like in talin, kindlin binding to the β integrin tails is primarily mediated by the PTB-like F3 
subdomain (Moser et al., 2008; Shi et al., 2007; Ussar et al., 2008). However, in contrast to 
talin, kindlin binding to the β integrin tails does not occur at the membrane proximal NPxY 
motif but at the membrane distal NxxY motif, and additionally depends on Thr/Thr or Ser/Thr 
residues, located between these two motifs (Ma et al., 2008; Montanez et al., 2008; Moser et 
al., 2009a; Moser et al., 2008; Shi et al., 2007; Ussar et al., 2008). 
Although it is widely accepted that talin and kindlin synergistically activate integrins and thus 
are both required for efficient integrin activation, mechanistic details about how this 
synergistic effect is achieved remain largely elusive. The non-overlapping binding sites could 
allow simultaneous binding of talin and kindlin to one integrin tail. However, sequential 
binding or binding to different integrin-tails and transactivation are also possibilities (Moser 
et al., 2009b). 
The importance of kindlins for integrin activation and outside-in signaling is demonstrated by 
the severe consequences of kindlin loss-of-function in vivo. 
Loss-of-function mutations in human Kindlin-1 were identified as cause of a rare 
genodermatosis known as Kindler syndrome, characterized by defects in epithelial cell-
adhesion subsequently resulting in poikiloderma, cutaneous atrophy and susceptibility to skin 
cancer (Jobard et al., 2003; Siegel et al., 2003). Deletion of kindlin-1 in mice resulted in a 
similar skin phenotype, although intestinal defects were more pronounced and finally led to 
perinatal lethality due to severe ulcerative colitis (Ussar et al., 2008). In the meantime 
gastrointestinal abnormalities have also been reported in man. 
Kindlin-2 deletion in mice resulted in early embryonic lethality at the peri-implantation stage 
due to severe endoderm and epiblast detachment from the basement membrane (Montanez et 
al., 2008). 
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Finally, the deletion of kindlin-3 in mice resulted in defective platelet aggregation and severe 
bleedings due to impaired integrin activation, although talin expression was unaltered (Moser 
et al., 2008). Furthermore, kindlin-3 was found to be required for leukocyte adhesion and 
extravasation (Moser et al., 2009a). In humans, kindlin-3 mutation leads to a rare disease 
known as leukocyte-adhesion deficiency type III (LAD-III) characterized by severe bleedings 
and leukocyte adhesion and extravasation defects (Kuijpers et al., 2009; Malinin et al., 2009; 
Mory et al., 2008; Svensson et al., 2009). 
 
3.2) Integrin avidity and clustering 
 
Affinity modulation is essential to control the binding of an integrin to its ligand. As 
individual integrin-ligand interactions are relatively weak, firm adhesion of a cell to the ECM 
requires the collective binding of multiple integrins. The synergistic effect of multiple weak 
interactions is known as avidity. Integrin avidity occurs by clustering integrins into adhesive 
units. In cultured cells, several types of adhesive units can be distinguished based on size, 
morphology, localization and protein composition. These include nascent adhesions (Choi et 
al., 2008), which can subsequently mature into focal complexes (FCs), FAs and fibrillar 
adhesions (Geiger et al., 2001). Podosomes and invadopodia are related but structurally 
distinct adhesive structures characteristic for monocytic and tumor cells, respectively (Linder, 
2009). 
A vast number of cytoplasmic adaptor and signaling molecules are recruited to and organized 
within these adhesive units, which not only mediate the linkage to the F (filamentous)-actin 
cytoskeleton but also function as a signaling platform, orchestrating complex intracellular 
responses and signaling crosstalks upon integrin ligand engagement. Collectively, these 
processes are referred to as outside-in signaling. 
 
3.3) Outside-in signaling 
 
Integrins regulate a vast number of cellular processes such as adhesion, migration, 
proliferation, survival and differentiation. However, their short cytoplasmic tails lack 
enzymatic activity. Instead, integrin signaling relies on the recruitment of signaling and 
adaptor molecules. 
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To date, the “integrin adhesome” comprises far over 180 molecules, which are found to be 
associated with integrin adhesions (Schiller et al., 2011; Zaidel-Bar and Geiger, 2010; Zaidel-
Bar et al., 2007). Among them, more than 40 proteins can bind directly, although not 
simultaneously, to β integrin cytoplasmic tails, while so far, only a few are known to directly 
interact with the cytoplasmic tails of α subunits (Legate and Fassler, 2009). 
Recruitment and direct binding of adaptor and signaling molecules to the cytoplasmic tails 
creates a platform for the assembly of additional adaptor and signaling molecules and finally 
results in the formation of a highly complex and dynamic multimolecular adhesion and 
signaling machinery. Spatiotemporal control of assembly/disassembly and molecular 
composition as well as cell-type and developmental specific expression of its constituents 
additionally contribute to the complexity of this machinery. 
 
3.3.1) Linkage to the actin cytoskeleton 
 
One key function of the integrin adhesome is the linkage to and regulation of the actin 
cytoskeleton. The physical linkage to the actin cytoskeleton depends on and is mediated by 
the actin-binding capability of several members of the adhesome. Talin, α-actinin, filamin and 
tensin can directly link integrins to the actin cytoskeleton by binding to both the β integrin 
cytoplasmic tail and F-actin. However, firm linkage to the actin cytoskeleton additionally 
depends on actin-binding proteins indirectly associated with integrins via adaptor molecules. 
For instance, although talin can provide the initial connection to the actin cytoskeleton, 
vinculin recruitment to talin reinforces the linkage (Humphries et al., 2007; Legate et al., 
2009). Vinculin is additionally connected to integrins by its association with paxillin, which in 
turn binds to the ILK-PINCH-Parvin (IPP) complex through a direct interaction with ILK and 
Parvin. ILK can also directly bind to β integrin cytoplasmic tails and through Parvin provides 
another crucial link to the actin cytoskeleton. Furthermore, ILK can bind to kindlin, which, by 
its association with migfilin, indirectly connects ILK to filamin and thus to the actin 
cytoskeleton. Taken together this exemplifies, that multiple proteins synergize to firmly link 
the actin cytoskeleton to integrins and that the individual components of the adhesome are 
highly interconnected. The IPP complex and especially α-Parvin are the main focus of this 
thesis and therefore will be discussed in more detail in a separate chapter. 
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4) Rho GTPases regulate actin cytoskeleton dynamics 
 
The adhesome facilitates not only the physical anchorage of the actin cytoskeleton, but also 
regulates its dynamics. Key regulators of the actin cytoskeleton and its dynamics are members 
of the Rho family of small (~21kDa) GTPases (Rho GTPases). The Rho family is a subfamily 
of the Ras (rat sarcoma) superfamily and comprises more than 22 members in humans. The 
most prominent and best studied representatives are RhoA (Ras homologous), Rac1 (Ras-
related C3 botulinum toxin substrate 1) and Cdc42 (cell division cycle 42). Like other small 
GTPases, most Rho GTPases cycle between an inactive (GDP-bound) and an active (GTP-
bound) state and thereby function as molecular switches (Figure 3) (Bustelo et al., 2007). In 
the GTP-bound state, Rho GTPases specifically interact with diverse effector proteins to 
control not only cytoskeletal dynamics, but also many other essential cellular processes such 
as gene expression, membrane trafficking, microtubule dynamics, proliferation and 
cytokinesis (Heasman and Ridley, 2008; Jaffe and Hall, 2005). 
Tight regulation of these processes requires the spatiotemporal control of Rho GTPases, 
which is mainly mediated by three classes of regulatory proteins: GEFs (guanine nucleotide 
exchange factors), GAPs (GTPase activating proteins), and GDIs (guanine nucleotide 
dissociation inhibitors) (Figure 3). 
 
 
Figure 3: Cycling of Rho GTPases is controlled by GAPs, GEFs and GDIs 
Cycling of Rho GTPases between an inactive GDP-bound and an active GTP-bound state is controlled by GEFs 
and GAPs. GDIs sequester Rho GTPase in an inactive state and negatively regulate their membrane association 
by masking a lipid moiety at the C-terminus of Rho GTPases. Figure taken from (Etienne-Manneville and Hall, 
2002). 
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In humans, over 70 distinct GEFs are known, most of which belong to the Dbl (diffuse B-cell-
lymphoma) family. GEFs facilitate the exchange of GDP for GTP and thus are required for 
the activation of Rho GTPases (Garcia-Mata and Burridge, 2007). 
Similar to the large number of GEFs, around 80 GAPs are encoded in the human genome. 
GAPs inactivate Rho GTPases by enhancing their intrinsically inefficient GTPase activity 
(Garcia-Mata and Burridge, 2007; Moon and Zheng, 2003; Tcherkezian and Lamarche-Vane, 
2007). 
In contrast to GEFs and GAPs, only three GDIs have been identified in humans. GDIs inhibit 
the guanine nucleotide exchange and sequester Rho GTPases in an inactive state in the 
cytosol. Upon dissociation from the inhibitory GDIs, Rho GTPases can translocate to 
membranes and interact with GEFs, GAPs, and effector proteins. Membrane anchorage is 
facilitated by the post-translational isoprenylation at the C-terminus of most Rho GTPases. 
Binding of GDIs masks this hydrophobic lipid moiety and thus prevents membrane 
association of Rho GTPases (DerMardirossian and Bokoch, 2005; Wennerberg and Der, 
2004). 
Although Rho GTPases are primarily controlled by GEFs, GAPs and GDIs, accurate Rho 
signaling additionally requires tight regulation of the expression, stability, activity, 
localization and scaffolding of Rho GTPases, GEFs, GAPs, GDIs, effector proteins and 
upstream regulatory components in a spatiotemporal and cell context-dependent manner 
(Bustelo et al., 2007). Many GEFs and GAPs are controlled by a wide variety of regulatory 
mechanisms (Bos et al., 2007; Rossman et al., 2005; Schmidt and Hall, 2002; Tcherkezian 
and Lamarche-Vane, 2007). Both activity and subcellular localization of GEFs and GAPs are 
frequently determined by phosphorylation, binding of phospholipids, and/or interaction with 
regulatory and adaptor proteins. Additionally, GEFs and GAPs can function as scaffolding 
proteins and thereby couple the activity of Rho GTPases to specific effectors and downstream 
signaling pathways. Furthermore, a particular Rho GTPase often can be controlled by a 
number of different GEFs and GAPs, and although some GEFs and GAPs are specific for a 
certain Rho GTPase, others are more promiscuous. Cell type-specific expression of some 
GEFs and GAPs adds another layer of complexity to Rho GTPase signaling. The highly 
complex regulation of Rho GTPase signaling provides cells with the flexibility to coordinate 
and integrate actin cytoskeleton dynamics and other Rho-mediated processes with a variety of 
different stimuli and signaling pathways. Particularly for dynamic processes such as cell 
migration, Rho GTPase-mediated integration of actin cytoskeleton dynamics with integrin 
signaling and other signaling pathways is of utmost importance. 
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5) Actin cytoskeleton dynamics 
 
The actin cytoskeleton is not a static entity, but is highly dynamic and flexible. Tight 
spatiotemporal control of its dynamics is essential for processes such as cell morphology, cell 
polarity, directional migration, cytokinesis, tissue homeostasis, wound healing, and 
embryonic development. Although Rho GTPases are key regulators of actin cytoskeleton 
dynamics, numerous additional proteins, collectively referred to as actin-binding proteins 
(ABPs), are required to facilitate the dynamic assembly and disassembly of actin fibers, their 
organization into higher order structures such as bundles or dendritic networks and the 
controlled rearrangement or breakdown of these structures. 
Assembly of actin filaments requires the polymerization of globular actin monomers (G-actin) 
into F-actin, which generates the protrusive force required for cell migration. However, 
spontaneous de novo formation of actin filaments is kinetically hampered, due to the 
instability of short dimeric and trimeric actin intermediates. Instead, initiation of new actin 
filaments depends on and is regulated by ABPs, which can catalyze the rate limiting 
nucleation step and therefore are known as “nucleators”. The best characterized nucleators are 
the heptameric actin-related protein 2/3 (Arp2/3) complex, formins and spire (Firat-Karalar 
and Welch, 2011; Goley and Welch, 2006). Unlike formins and spire, which nucleate the 
linear actin filaments characteristic of protrusive finger-like structures known as filopodia, the 
Arp2/3 complex is thought to promote branched actin filaments by nucleating new daughter 
filaments at the side of existing mother filaments. Accordingly, the Arp2/3 complex is 
essential for the formation of lamellipodia, which are thin, sheet-like cellular protrusions at 
the leading edge of migrating cells, characterized by a branched network of actin-fibers. 
However, the existence of branched actin filaments in the lamellipodium was recently 
challenged and is debated (Insall, 2011; Koestler et al., 2008; Small, 2010; Urban et al., 
2010). Alternatively, the lamellipodium might be comprised of cross-linked linear actin 
filaments. Once nucleated, the growth of actin filaments is kinetically favorable and 
eventually must be restricted. ABPs known as “capping proteins” can bind to the fast growing 
“barbed-ends” of actin filaments and thereby prevent further actin filament elongation. 
Conversely, proteins preventing the binding of capping proteins such as the diaphanous-
related formin (DRF) mDia or Ena/Vasp (enabled/vasodilator-stimulated phosphoprotein), 
promote filament elongation (Ridley, 2006; Ridley et al., 2003). Other ABPs, including actin-
depolymerizing factor (ADF)/cofilin, are critically involved in the disassembly and 
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reorganization of actin filaments. On the one hand, these proteins can sever and/or 
depolymerize actin fibers and thus facilitate actin fiber disassembly. On the other hand, they 
can also promote the assembly of new filaments by increasing the number of free barbed ends 
and the G-actin pool in the cell. Several ABPs also bind to G-actin and either inhibit actin 
polymerization by sequestering G-actin (e.g. thymosin β4), or promote F-actin formation by 
increasing the local availability of polymerization competent actin monomers (e.g. profilin). 
Finally, various ABPs, including α-actinin, filamin, fascin, and the molecular motor protein 
myosin II, can cross-link individual actin fibers and thereby facilitate the formation of more 
complex structures such as actin bundles and dendritic networks. Myosin II not only cross-
links actin filaments, but also provides tension and contractility to the actin cytoskeleton. 
Myosin II is essential for the maturation of nascent adhesions and the formation of stress 
fibers, which are contractile bundles consisting of actin fibers cross-linked by bipolar myosin 
filaments and α-actinin (Vicente-Manzanares et al., 2009). Interestingly, although tension is 
known to promote the maturation of FA, the contractile properties of myosin II were found to 
be dispensable for initial adhesion maturation. Instead, the actin bundling activity of a motor-
deficient myosin II mutant was sufficient to rescue the initial adhesion maturation in cells 
where myosin II or α-actinin had been depleted by RNA interference (RNAi) (Choi et al., 
2008). Integrins play a major role in the complex organization and orchestration of actin 
cytoskeleton dynamics by establishing the physical linkage to the ECM and by controlling 
key signaling pathways, which frequently culminate in the activation or inhibition of Rho 
GTPases. 
 
6) Regulation of actin cytoskeleton dynamics by Rho 
GTPases 
 
Spatiotemporal control of actin cytoskeleton dynamics critically depends on and is mediated 
by Rho GTPases. Through their interaction with specific effector proteins, Rho GTPases not 
only control actin cytoskeleton dynamics and contractility but also regulate the formation and 
maturation of adhesion complexes. Although the constantly advancing knowledge about other 
Rho family members frequently reveals their important functions for actin cytoskeleton 
dynamics, RhoA, Rac1, and Cdc42 remain the best studied. Therefore, the discussion will be 
limited to these three prototypic members, which when activated, promote and regulate the 
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formation of prominent and morphologically distinct actin-based structures, namely 
lamellipodia (Rac1), filopodia (Cdc42) and stress fibers (RhoA). 
 
6.1) RhoA promotes stress fiber formation and adhesion 
maturation 
 
RhoA primarily promotes the maturation of nascent adhesions and the formation of stress 
fibers through its effectors Rho-associated serine/threonine kinase (ROCK) and the DRF 
mDia (Burridge and Wennerberg, 2004). ROCK is essential for the formation of stress fibers 
and FCs, and pharmacological inhibition of ROCK or expression of dominant-negative 
ROCK inhibits their formation (Riento and Ridley, 2003). Through the formin mDia, RhoA 
promotes polymerization, elongation, and bundling of linear actin filaments, whereas RhoA-
mediated activation of ROCK results in increased phosphorylation of the regulatory light 
chain of myosin II (MLC) at Thr18 and Ser19, which activates the contractile and cross-
linking functions of myosin II (Amano et al., 2010; Burridge and Wennerberg, 2004; Jaffe 
and Hall, 2005; Legate et al., 2009). ROCK primarily promotes MLC phosphorylation 
through the inhibition of MLC phosphatase (MLCP) by phosphorylating Thr696 and Thr853 
of the regulatory myosin phosphatase-targeting subunit 1 (MYPT1). Although ROCK can 
directly phosphorylate MLC at Ser19 in vitro, the Ca2+-dependent myosin light chain kinase 
(MLCK) might be the physiologically more relevant kinase in vivo (Amano et al., 2010; Jaffe 
and Hall, 2005). Additionally, the RhoA effector citron kinase also phosphorylates MLC at 
Thr18 and Ser19, although this may only play a role during cytokinesis (Burridge and 
Wennerberg, 2004). 
ROCK not only controls MLC phosphorylation, but it also activates LIM (Lin11, Isl1, Mec3) 
kinase (LIMK). LIMK in turn phosphorylates cofilin at Ser3, resulting in the inactivation of 
cofilin and thus contributing to the stability of stress fibers (Jaffe and Hall, 2005). 
However, RhoA controls stress fiber formation and adhesion maturation primarily through the 
regulation of myosin II activity. While assembly of nascent adhesions in the lamellipodium is 
myosin II-independent and instead depends on actin polymerization, adhesion maturation into 
FCs and FAs at the lamellipodium-lamellum interface is myosin II-dependent and depletion 
of myosin II by RNAi or pharmacological inhibition with blebbistatin prevents adhesion 
maturation and promotes the formation of nascent adhesions (Choi et al., 2008). Although the 
cross-linking activity of myosin II is sufficient for the initial maturation of nascent adhesions, 
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ATPase activity of myosin II contributes to adhesion maturation at later stages and is required 
for the formation of stress fibers and trailing edge retraction at the rear of migrating cells 
(Burridge and Wennerberg, 2004; Choi et al., 2008; Legate et al., 2009; Ridley et al., 2003; 
Riento and Ridley, 2003). 
 
6.2) Rac1 and Cdc42 promote membrane protrusions at the 
leading edge of migrating cells 
 
The formation of sheet-like membrane protrusions at the leading edge of migrating cells, 
known as lamellipodia, largely depends on, and is driven by, Arp2/3 complex-mediated actin 
polymerization. The Arp2/3 complex needs to be activated by nucleation promoting factors 
(NPFs) to enable efficient actin polymerization (Goley and Welch, 2006). Both Rac1 and 
Cdc42 can activate the Arp2/3 complex through members of the WASP/WAVE (Wiskott-
Aldrich syndrome protein)/(WASP-family verprolin-homologous protein) protein families, 
which are class I NPFs (Goley and Welch, 2006). WAVE proteins together with ABI 
(Abelson-interacting protein), HSPC300 (haematopoietic stem-cell progenitor), Nap125 (Nck-
associated protein), and PIR121 (p53-inducible mRNA) form a pentameric heterocomplex, 
referred to as the WAVE complex (Goley and Welch, 2006; Takenawa and Suetsugu, 2007). 
In the active state, Rac1 interacts with Nap125 and PIR121 and thereby activates the WAVE 
complex to stimulate Arp2/3 complex-mediated actin polymerization. Activation of the 
WAVE complex also involves IRSp53 (insulin-receptor substrate), which binds to both 
WAVE and Rac1, and additionally promotes the activity of the WAVE complex. 
Interestingly, IRSp53 binding to Cdc42 reduces the affinity of IRSp53 for WAVE (Goley and 
Welch, 2006; Jaffe and Hall, 2005; Takenawa and Suetsugu, 2007). 
While Rac1 promotes Arp2/3 activity through the WAVE complex, WASP family members 
mediate the Cdc42-induced activation of the Arp2/3 complex. WASP proteins adopt an auto-
inhibited conformation and direct binding of active Cdc42 is required for the activation of 
WASPs. Additionally, WASP proteins are thought to be inhibited by members of the WIP 
(WASP-interacting protein) family, including WIP, CR16 (corticosteroids and regional 
expression-16) and WICH (WIP- and CR16-homologous protein) (Takenawa and Suetsugu, 
2007). Activation of the WASP-WIP complex is facilitated by the Cdc42 effector TOCA-1 
(transducer of Cdc42-dependent actin assembly 1) and can be enhanced by phosphorylation of 
WASP through members of the Src family of tyrosine kinases. 
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Both Rac1 and Cdc42 also activate Ser/Thr kinases of the PAK (p21-activated kinase) family. 
PAKs phosphorylate and thereby activate LIMKs (Edwards et al., 1999), which results in the 
inhibition of cofilin. Additionally, PAKs are implicated in regulating myosin II activity. On 
the one hand, PAK-mediated phosphorylation of both MLCK and myosin heavy chain (MHC) 
decreases myosin II activity (Sanders et al., 1999; van Leeuwen et al., 1999). On the other 
hand, PAK can directly phosphorylate MLC, which increases myosin II activity (Chew et al., 
1998). 
Although Rac1 and Cdc42 use similar downstream signaling pathways to regulate the actin 
cytoskeleton, they promote morphologically distinct actin-based protrusive structures. While 
Rac1 promotes dendritic actin organization in lamellipodia, Cdc42 is thought to be the main 
mediator of the parallel linear actin filaments constituting filopodia. However, filopodia can 
also form in the absence of Cdc42, indicating that other Rho GTPases such as Rif (Rho in 
filopodia)/RhoF can compensate for Cdc42 function (Czuchra et al., 2005; Ridley, 2006). 
Furthermore, filopodia also form in the absence of either WASP (Snapper et al., 2001), the 
Arp2/3 complex or WAVE (Steffen et al., 2006), indicating that actin polymerization in 
filopodia neither depends on the formation of lamellipodia nor is mediated by the Arp2/3 
complex but instead might be facilitated by other actin nucleators, such as formins, which in 
contrast to the Arp2/3 complex promote linear actin filaments (Schirenbeck et al., 2005). 
Indeed, Cdc42 and Rif bind to and activate the DRF mDia2, which also localizes to filopodia 
(Pellegrin and Mellor, 2005; Peng et al., 2003). RhoA also promotes actin polymerization 
through the DRF mDia1. Interestingly, although RhoA activity was thought to be restricted 
mainly to the cell body and the retracting rear, recent studies revealed that RhoA is also active 
at the leading edge and that its activity directly coincides with leading edge protrusion, 
whereas Cdc42 and Rac1 are activated 2µm behind the leading edge with a delay of 
approximately 40s (Machacek et al., 2009). Thus RhoA-mediated actin polymerization might 
initiate leading edge protrusion, whereas Rac1 and Cdc42 are required to sustain the 
protrusion (Spiering and Hodgson, 2011). This exemplifies, that tight spatiotemporal control 
of Rho GTPases and their effectors is essential for the complex orchestration of actin 
dynamics. 
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7) Integrin signaling contributes to the spatiotemporal 
control of Rho GTPases 
 
Spatiotemporal control of Rho GTPases largely depends on the activity and localization of 
GEFs and GAPs. By controlling both the recruitment and activity of multiple GEFs and 
GAPs, integrins are critically involved in the regulation of Rho GTPases. Upon ligand 
engagement, integrins recruit non-receptor tyrosine kinases such as FAK (focal adhesion 
kinase) and members of the Src family of tyrosine kinases (SFK), which elicit multiple 
signaling pathways and critically contribute to the regulation of GEFs and GAPs (Huveneers 
and Danen, 2009). FAK recruitment to integrins and autophosphorylation at tyrosine 397 
creates a high affinity binding site for the SH2 (Src-homology 2) domain of Src. Upon 
binding to FAK, Src subsequently trans-phosphorylates FAK on additional tyrosine residues, 
which fully activates the kinase activity of FAK and creates new binding sites for additional 
proteins (Huveneers and Danen, 2009; Mitra and Schlaepfer, 2006). This active FAK-Src 
complex facilitates the recruitment and phosphorylation of p130Cas, which in turn binds to 
Crk (v-crk sarcoma virus CT10 oncogene homolog) and thereby recruits a complex of 
Dock180 (180-kDa protein downstream of CRK) and ELMO1 (engulfment and motility 1), 
which serves as a GEF for Rac1. Additionally, the active FAK-Src complex promotes the 
phosphorylation of the adaptor protein paxillin, leading to the recruitment of a complex 
consisting of PAK, the ArfGAP PKL(paxillin-kinase linker)/GIT (G-protein-coupled receptor 
kinase interacting protein) and β-PIX (PAK-interacting exchange factor-beta), which is a GEF 
for Rac1 and Cdc42 (Huveneers and Danen, 2009). Interestingly, several studies also 
demonstrate an important function for β-Parvin in the regulation of α- and β-PIX (Filipenko et 
al., 2005; Matsuda et al., 2008; Mishima et al., 2004; Rosenberger et al., 2003). Finally, other 
Rac GEFs such as Vav and Tiam (T-cell lymphoma invasion and metastasis) are also 
regulated by SFK (Huveneers and Danen, 2009). Thus, integrin-mediated activation of the 
FAK-Src complex and recruitment of adaptor proteins such as β-Parvin, promote membrane 
protrusion by activating Rac1 and Cdc42 at sites of adhesion. 
However, for efficient cell spreading and migration, protrusive and contractile activities need 
to be tightly balanced. This balance in part is facilitated by an extensive cross-talk between 
Rho GTPases. For instance, Rac1-mediated production of reactive oxygen species leads to the 
inactivation of phosphatases which otherwise inhibit p190RhoGAP-mediated RhoA 
inactivation. Conversely, through its effector ROCK, which phosphorylates and activates the 
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Rac1 GAP FilGAP, RhoA negatively influences Rac1 activity (Huveneers and Danen, 2009). 
The balance between contractility and protrusion also depends on FAK, which recruits and 
regulates not only multiple GAPs for RhoA, including p190RhoGAP, GRAF (GTPase 
regulator associated with FAK) and PSGAP (PH- and SH3-domain-containing RhoGAP) but 
also several Rho GEFs, such as PDZRhoGEF and p190RhoGEF (Schaller, 2010). Thus FAK 
essentially contributes to the balance between RhoA-mediated contractility and Rac1 
facilitated protrusion by controlling both Rac1/Cdc42 and RhoA activities. In summary, 
integrin signaling profoundly affects the spatiotemporal coordination of actin cytoskeleton 
dynamics through Rho GTPases and thus integrates ECM derived mechano-chemical cues 
with the dynamic organization of the actin cytoskeleton. Although many more details than 
presented here already have been unraveled, precise understanding of how these complex 
processes are regulated in space and time, and how they are integrated with growth factor 
signaling and other signaling pathways still requires further extensive research. 
 
8) The IPP complex 
 
8.1) Formation of the IPP complex: identification, structure 
and expression of ILK, PINCH and Parvin 
 
Integrin-mediated outside-in signaling depends on the recruitment of cytoplasmic adaptor and 
signaling molecules and is essential for the dynamic organization of the actin cytoskeleton 
and its linkage to integrin adhesions. Key components of the cytoplasmic integrin machinery 
are ILK, PINCH and Parvin, which together form the ternary IPP complex (Tu et al., 2001; 
Wu, 2001), whose assembly precedes its recruitment to integrin adhesions in mammalian cells 
(Zhang et al., 2002b) (Figure 4). 
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Figure 4: The IPP complex and its binding partners 
Schematic representation of the IPP complex and some of its binding partners. Through Parvins, the IPP 
complex links integrins to the actin cytoskeleton. See text for details. Figure taken from (Legate et al., 2006) 
 
ILK was identified in 1996 in a yeast two hybrid (Y2H) screen for β1 integrin-binding 
proteins (Hannigan et al., 1996), and was found to be ubiquitously expressed throughout 
development and adulthood (Li et al., 1997; Nikolopoulos and Turner, 2001; Sakai et al., 
2003). ILK, which is conserved throughout the metazoan lineage (Bendig et al., 2006; 
Mackinnon et al., 2002; Yasunaga et al., 2005; Zervas et al., 2001), is composed of five 
ankyrin (ANK) repeats at its N-terminus (Chiswell et al., 2008) and a C-terminal Ser/Thr 
kinase-like domain (Hannigan et al., 1996). Additionally, a PH domain, which is believed to 
bind phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3), is interspersed between the 
N-terminal ANK repeats and the C-terminal kinase-like domain (Delcommenne et al., 1998; 
Pasquali et al., 2007). 
In 1999, PINCH was identified as direct binding partner of ILK in an Y2H screen for proteins 
that bind to the ANK repeats of ILK (Tu et al., 1999; Wu, 1999). PINCH is a LIM-only 
protein, composed of five LIM domains (Rearden, 1994). PINCH is conserved among 
metazoans (Hobert et al., 1999) and in mammals, two highly homologous isoforms (82% 
identical at the amino acid sequence level in humans), have been identified (Rearden, 1994; 
Zhang et al., 2002a), referred to as PINCH-1 (also known as LIMS1) and PINCH-2 (LIMS2). 
In contrast to PINCH-1, which is ubiquitously expressed at embryonic and adult stages, 
PINCH-2 expression is slightly more restricted and absent in early embryonic development 
(Braun et al., 2003; Wickstrom et al., 2010b). Direct binding to ILK is facilitated by the first 
LIM domain of both PINCH-1 and PINCH-2 and the second ANK repeat of ILK (Li et al., 
1999; Tu et al., 1999; Velyvis et al., 2001). However, recent structural data revealed that the 
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first LIM domain of both PINCH-1 and PINCH-2 binds in a highly similar and competitive 
manner not only to ANK 2 of ILK but also to ANK 3-5 and that ANK 4 provides the strongest 
contribution to the binding interface (Chiswell et al., 2010; Chiswell et al., 2008). 
Parvin, the third member of the IPP complex, was identified in 2000 in a screen for paxillin 
LD1 (leucine-rich sequence) domain binding proteins and at that time was termed actopaxin 
due to its ability to bind to both paxillin and actin (Nikolopoulos and Turner, 2000). 
Subsequently, Y2H screening for novel ILK-binding partners and expressed sequence tag 
(EST)-database mining for proteins with homology to the actin-binding domain of α-actinin, 
revealed that Parvins form an evolutionary conserved family of ILK-binding proteins, with 
three members in mammals and a single isoform in the invertebrates Caenorhabditis and 
Drosophila, whereas the unicellular organisms Dictyostelium and Saccharomyces lack 
recognizable Parvin isoforms (Olski et al., 2001; Tu et al., 2001; Yamaji et al., 2001). The 
three mammalian isoforms are referred to as α-Parvin (also known as actopaxin or CH-ILKBP 
(CH domain-containing ILK-binding protein)), β-Parvin (also known as affixin) and γ-Parvin. 
While α-Parvin and β-Parvin are closely related (74% identity and 85% similarity), γ-Parvin is 
more divergent and only shares 42% identity and 67% similarity with α-Parvin. Structurally, 
Parvins are characterized by the presence of two calponin homology domains (CH1 and CH2) 
in the C-terminal region, which are separated by a linker-sequence of about 60 aa. Particularly 
the CH2 domain, which facilitates the direct binding of all three isoforms to the kinase-like 
domain of ILK (Fukuda et al., 2009; Tu et al., 2001; Yamaji et al., 2001; Yoshimi et al., 
2006), is highly homologous, with 84% identity and 94% similarity between α-Parvin and β-
Parvin, and 50% identity and 71% similarity between α-Parvin and γ-Parvin. The CH1-
domain is preceded by an N-terminal region with little homology between the three isoforms. 
Two putative nuclear localization signals (NLS) and three potential SH3 (Src homology 3)-
binding sites are situated in this region in both α-Parvin and β-Parvin but not in γ-Parvin 
(Olski et al., 2001). While α-Parvin is ubiquitously expressed, β-Parvin expression is enriched 
in heart and skeletal muscle, and γ-Parvin expression is restricted to the haematopoietic 
system (Chu et al., 2006; Olski et al., 2001; Tu et al., 2001; Yamaji et al., 2001). 
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8.1.1) Distinct IPP complexes assemble in mammalian cells 
 
The binding of the different Parvin and PINCH isoforms to ILK is mutually exclusive and 
their partially overlapping expression patterns potentially permits the assembly of up to six 
molecularly and functionally distinct IPP complexes (Fukuda et al., 2003a; Montanez et al., 
2009; Zhang et al., 2002a). Thus the ternary IPP complex in mammalian cells can consist of 
ILK, connected via its N-terminal ANK-repeats to the first LIM-domain of either PINCH-1 or 
PINCH-2, and via its C-terminal kinase-like domain to the second CH-domain either of α-, β-, 
or γ-Parvin. However, it is not clear if all combinations are physiologically relevant, or if 
there is a preference for certain IPP complex combinations. 
It has been shown that the stability of IPP constituents critically depends on the assembly of a 
complete complex; depletion of either ILK, PINCH or Parvin results in proteasome-dependent 
degradation of the two remaining constituents, which complicates functional analyses of 
individual IPP members (Fukuda et al., 2003a; Li et al., 2005a). However, proteasomal 
degradation is not complete and the presence of residual amounts of IPP constituents suggests 
potential IPP-independent functions for the individual IPP members. 
Although overexpression or up-regulation of the alternative PINCH or Parvin isoforms 
generally restores the protein levels of the IPP complex and is sufficient for its recruitment 
into adhesion complexes, this does not always functionally compensate for the loss of a 
particular Parvin or PINCH isoform (Wickstrom et al., 2010b). 
For instance, whereas depletion of β-Parvin in vSMCs can be fully compensated by α-Parvin, 
β-Parvin is unable to functionally compensate for the loss of α-Parvin in these cells, even 
though expression of β-Parvin is elevated upon α-Parvin deletion and is sufficient to rescue 
protein-levels and recruitment of ILK and PINCH to FAs. However, β-Parvin is sufficient to 
functionally compensate for the loss of α-Parvin in fibroblasts (Montanez et al., 2009). 
Similarly, whereas depletion of PINCH-2 can be fully compensated by PINCH-1, 
overexpression of PINCH-2 in HeLa (Henrietta Lacks) cells is unable to functionally 
compensate for the loss of PINCH-1, despite stabilizing the protein levels of ILK and Parvin 
(Fukuda et al., 2003a). In contrast, PINCH-2 compensates for the loss of PINCH-1 in 
cardiomyocytes (Liang et al., 2009; Liang et al., 2005), and artificial expression of PINCH-2 
functionally compensates for the depletion of PINCH-1 in mouse embryonic fibroblasts 
(MEFs) (Stanchi et al., 2005). Taken together, this indicates overlapping as well as cell-type- 
and isoform-specific functions of distinct IPP complexes, which likely depend on the 
recruitment and interaction with shared and isoform and/or cell-type specific binding partners. 
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8.2) IPP interaction partners 
 
8.2.1) ILK-associated proteins 
 
Apart from binding to Parvins and PINCHs, ILK either directly or indirectly associates with a 
variety of additional proteins. Since there are no alternative isoforms of ILK, direct ILK-
binding partners may be shared by all the distinct IPP complexes. However, direct interaction 
with ILK was not confirmed for all ILK-associated molecules and thus might depend on the 
presence of specific PINCH and/or Parvin isoforms. Additionally, direct interactions might be 
stabilized by the simultaneous binding to both ILK and specific PINCH or Parvin isoforms, 
and thus might be favored by certain IPP complexes. Paxillin, for instance, has been shown to 
bind to ILK as well as to α- and γ-Parvin, but not to β-Parvin (Nikolopoulos and Turner, 
2000; Nikolopoulos and Turner, 2001; Yoshimi et al., 2006). Similarly, thymosin-β4 binds to 
both ILK and PINCH-1, whereas its interaction with PINCH-2 has not been reported (Bock-
Marquette et al., 2004; Fan et al., 2009). 
Direct ILK binding partners, either shown by Y2H experiments, interaction of recombinant 
proteins or co-crystallization studies, include β1 and β3 integrins (Hannigan et al., 1996; 
Pasquet et al., 2002; Yamaji et al., 2002), paxillin (Nikolopoulos and Turner, 2001; 
Nikolopoulos and Turner, 2002), thymosin β4 (Bock-Marquette et al., 2004; Fan et al., 2009), 
ELMO-2 (Ho et al., 2009), EphA1 (Yamazaki et al., 2009), kAE1 (kidney anion exchanger) 
(Keskanokwong et al., 2007), the serine/threonine phosphatase ILKAP (ILK-associated 
phosphatase) (Leung-Hagesteijn et al., 2001), PKB (protein kinase B)/Akt (McDonald et al., 
2008; Persad et al., 2001), Rictor (McDonald et al., 2008), Src (Kim et al., 2008) and the 
muscle LIM protein (MLP/CRP3) (Postel et al., 2008). 
Additionally, Caenorhabditis UNC-112/kindlin-2 directly binds to ILK, suggesting that the 
ILK-kindlin-2 interaction in mammalian cells, observed by co-immunoprecipition of kindlin-
2 and ILK, also might be direct (Mackinnon et al., 2002; Montanez et al., 2008). 
α- and β-tubulin as well as the tubulin binding proteins ch-TOG, RUVBL1, (Dobreva et al., 
2008; Fielding et al., 2008) and IQGAP (Wickstrom et al., 2010a) also have been shown to be 
associated with ILK. However, evidence for their direct interaction with ILK has not been 
reported. 
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Thus, the IPP complex, through the plethora of ILK interactions, can connect integrins not 
only to regulators of the actin and microtubule cytoskeleton but also to essential signaling 
pathways downstream of Src, PKB/Akt and Ephrins. 
 
8.2.2) PINCH-associated proteins 
 
PINCH-1 or PINCH-2 specific interactions could provide signaling specificity to distinct IPP 
complexes. Although several binding partners of PINCH-1 have been described, no PINCH-2 
interactors have been reported so far. Among the identified PINCH-1 binding partners is the 
SH2- and SH3-containing adaptor protein Nck-2, which directly binds via its third SH3-
domain to the LIM4 domain of PINCH-1. Mutations that interfere with the PINCH-1-Nck-2 
interaction negatively affect both the recruitment of PINCH-1 into FAs and the organization 
of the actin cytoskeleton (Vaynberg et al., 2005; Velyvis et al., 2003). Through its SH3 
domains, Nck-2 also associates with IRS-1, whereas its SH2 domain facilitates the interaction 
with growth factor receptors such as PDGFRβ (platelet derived growth factor receptor β). 
Interestingly, Nck-2 also associates with PAK, WASP and DOCK180. Thus, Nck-2 connects 
the IPP complex to both growth factor receptor signaling and mediators of actin cytoskeleton 
dynamics. Another PINCH-1-specific interaction partner, which binds to the LIM5 domain of 
PINCH-1, is the Ras-suppressor protein RSU-1, which negatively regulates Rac1 and JNK (c-
Jun N-terminal kinase) signaling (Dougherty et al., 2005; Kadrmas et al., 2004; Legate et al., 
2006). 
Additionally, the G-actin binding and sequestering protein thymosin-β4 binds to LIM4 and 
LIM5 of PINCH-1, promoting cardiomyocyte migration and survival (Bock-Marquette et al., 
2004). PINCH-2 can functionally compensate for the loss of PINCH-1 in ventricular 
cardiomyocytes (Liang et al., 2005), indicating that PINCH-2 might also be able to bind to 
thymosin-β4, although this needs to be experimentally verified. 
Finally, PINCH-1 associates and negatively regulates the phosphatase PP1α, and thus 
indirectly promotes phosphorylation and activation of PKB/Akt. Association of PP1α and 
PINCH-1 depends on a KFVEF-motif in the LIM5-domain of PINCH-1 (Eke et al., 2010), 
which is conserved in PINCH-2, raising the possibility that PINCH-2 might also be able to 
associate with PP1α (Braun et al., 2003). 
Since most studies focused on PINCH-1 and did not explicitly exclude a possible binding of 
the identified PINCH-1 interactors to PINCH-2, a direct comparison of the PINCH-1 and 
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PINCH-2 interactomes is required to determine whether binding partners are specific or 
shared between PINCH isoforms. 
 
8.2.3) Parvin-associated proteins 
 
The most prominent structural feature of Parvins is the presence of two tandemly arranged 
CH domains in the C-terminal region. Through the second CH domain, Parvins bind to the 
kinase-like domain of ILK, which is the only binding partner known to be shared by all three 
mammalian isoforms. 
The tandem arrangement of two CH domains serves as the actin-binding domain (ABD) in a 
variety of actin binding proteins, including α-actinin, spectrin, filamin, plectin, dystonin, 
dystrophin, and utrophin (Gimona et al., 2002). Although Parvin CH domains diverge 
considerably from the typical type-1 and type-2 CH domains and are therefore classified as 
type-4 and type-5 CH domains (Gimona et al., 2002), they also can facilitate actin binding 
(Olski et al., 2001). However, direct binding to actin was verified only for α-Parvin (Olski et 
al., 2001) and could not be confirmed for β-Parvin and γ-Parvin (Yamaji et al., 2004; Yamaji 
et al., 2001; Yoshimi et al., 2006). Instead, β- and γ-Parvin might indirectly link the IPP 
complex to the actin cytoskeleton by binding directly to α-actinin (Yamaji et al., 2004; 
Yoshimi et al., 2006), which α-Parvin does not bind (Nikolopoulos and Turner, 2002). 
Binding of β-Parvin to α-actinin depends on the CH2 domain and the linker sequence between 
the two CH-domains (Yamaji et al., 2004). In contrast to β-Parvin, both α-Parvin and γ-
Parvin, via their CH2-domains also bind to paxillin, which through its interaction with 
vinculin provides an additional link to the actin cytoskeleton, and profoundly affects actin 
cytoskeletal dynamics by recruiting important actin-regulators such as the GIT-Pix-PAK 
complex (Nayal et al., 2006; Nikolopoulos and Turner, 2000; Yamaji et al., 2004; Yoshimi et 
al., 2006). Additionally, α-Parvin also binds to the paxillin family member Hic-5 (Lorenz et 
al., 2008; Nikolopoulos and Turner, 2000). In contrast to α-Parvin, both β- and γ-Parvin 
directly bind to α-Pix through their CH1 domains (Mishima et al., 2004; Rosenberger et al., 
2003; Yoshimi et al., 2006), and β-Parvin additionally can bind to β-PIX (Matsuda et al., 
2008). Furthermore, through its CH1 domain, β-Parvin binds to dysferlin and both proteins 
co-localize at the sarcolemma of skeletal muscles, suggesting a potential function of β-Parvin 
in membrane repair (Matsuda et al., 2005). Based on luciferase-complementation assays, β-
Parvin was recently suggested to interact with PKB/Akt, and thereby interfering with the 
Introduction 
40 
interaction between ILK and PKB/Akt (Kimura et al., 2010). Two additional binding partners 
for α-Parvin have been identified. However, it is not known, whether they also can bind to β- 
and/or γ-Parvin. The first one is CdGAP, a Cdc42- and Rac-specific GAP that concentrates at 
the ends of actin stress fibers. Binding to CdGAP is mediated by the N-terminus of α-Parvin 
and critically depends on residues 21-25 of α-Parvin (LaLonde et al., 2006). 
The second one is the Ser/Thr kinase TESK1 (testicular protein kinase 1). Through its C-
terminus α-Parvin directly binds to and thereby inhibits TESK1, which, when active, 
phosphorylates and inhibits cofilin. Interestingly, the binding of ILK and TESK1 to α-Parvin 
seems to be mutually exclusive and might be regulated through N-terminal phosphorylation of 
α-Parvin at Ser4 and Ser 8. Adhesion to FN promotes the phosphorylation of α-Parvin at these 
residues and negatively affects its association with TESK1, which finally results in 
inactivation of cofilin and stabilization of actin fibers (LaLonde et al., 2005). 
 
8.3) Functions of the IPP complex 
 
Many of the IPP interactors are involved in the linkage and/or regulation of the actin 
cytoskeleton. Accordingly it is not surprising that the IPP complex plays a fundamental role in 
the organization and regulation of the actin cytoskeleton and its dynamics, with profound 
effects on cell-adhesion, spreading and migration. Furthermore, several studies indicate an 
important function of the IPP complex for cell survival. 
 
8.3.1) In vitro functions 
 
In vitro studies in HeLa cells identified distinct functions of α- and β-Parvin in the regulation 
of the actin cytoskeleton, cell spreading, migration and survival. RNAi-mediated depletion of 
α-Parvin in HeLa cells stimulates Rac activation and cell spreading, whereas cell spreading is 
reduced upon knockdown of β-Parvin (Zhang et al., 2004). This antagonistic effect might be 
explained by the distinct binding partners of α- and β-Parvin. While α-Parvin binds to the 
Rac/Cdc42 GAP CdGAP, which negatively regulates cell spreading by inactivating Rac 
(LaLonde et al., 2006), β-Parvin stimulates Rac activity by binding to the Rac/Cdc42 GEF α-
Pix (Mishima et al., 2004). However, Erk (extracellular signal-regulated protein kinase) 
dependent phosphorylation of α-Parvin or expression of a phosphomimetic mutant form of α-
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Parvin (Ser4/8Asp), promote cell spreading and migration (Clarke et al., 2004). Interestingly, 
the phosphomimetic α-Parvin mutant exhibits impaired binding to TESK1, resulting in 
activation of TESK1, cofilin inhibition and stabilization of actin fibers (LaLonde et al., 2005). 
Additionally, α-Parvin is required to facilitate membrane translocation of PKB/Akt, and thus 
promotes cell survival by protecting cells from apoptosis (Fukuda et al., 2003b), whereas 
overexpression of β-Parvin promotes apoptosis (Zhang et al., 2004). Interestingly it has been 
reported, that β-Parvin negatively regulates the ILK-PKB/Akt interaction, which might 
explain the pro-apoptotic effect of β-Parvin in HeLa cells (Kimura et al., 2010). Although 
studies in HeLa cells have revealed distinct functions for α- and β-Parvin, it appears that the 
specific functions of the Parvin-isoforms critically depend on the cell context. 
Overexpression of PINCH-2 in HeLa cells interferes with the PINCH-1-ILK interaction and 
results in reduced cell spreading and migration (Zhang et al., 2002a). Additionally, similar to 
α-Parvin, PINCH-1 is crucial for cell survival. Phosphorylation of PKB/Akt at both Ser473 
and Thr308 is required for the activation of PKB/Akt and depletion of PINCH-1 results in 
reduced phosphorylation of both residues in HeLa cells. PINCH-1 might regulate the 
phosphorylation and activation of PKB/Akt indirectly by binding and inhibiting PP1α (Eke et 
al., 2010). Additionally, PINCH-1 has been shown to prevent activation of the intrinsic 
apoptosis pathway by negatively regulating Bim through Erk (Chen et al., 2008). Although 
increased expression of PINCH-2 is sufficient for stabilization and recruitment of ILK and α-
Parvin to FAs, PINCH-2 fails to compensate for the defects in PKB/Akt phosphorylation, 
survival, spreading and migration in PINCH-1-depleted HeLa cells (Fukuda et al., 2003a). 
However, PINCH-2 can functionally compensate for the loss of PINCH-1 in cardiomyocytes 
(Liang et al., 2009; Liang et al., 2005) and in MEFs (Stanchi et al., 2005), indicating that the 
downstream signaling pathways of PINCH isoforms are also cell context dependent. 
Similar to the depletion of PINCH-1, depletion of ILK in HeLa cells also impairs cell 
spreading, migration and survival. In contrast to the depletion of PINCH-1, depletion of ILK 
in these cells only reduced phosphorylation of PKB/Akt on Ser473, without affecting Thr308 
phosphorylation (Fukuda et al., 2003a). Similarly in fibroblasts, deletion of ILK results in 
defects in cell adhesion, spreading and migration. Additionally, formation of stress fibers and 
maturation of FAs into fibrillar adhesions are impaired in ILK-deficient fibroblasts. Fibrillar 
adhesions are essential for the assembly and organization of the FN matrix. Accordingly, FN 
matrix assembly is hampered in ILK-deficient fibroblasts. Unlike in HeLa cells, deletion of 
ILK in fibroblasts diminishes their proliferation rate but does not result in altered 
phosphorylation of PKB/Akt and apoptosis (Sakai et al., 2003; Stanchi et al., 2009). 
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8.3.2) ILK is a pseudokinase 
 
Although the C-terminal kinase-like domain of ILK has significant sequence homology to 
Ser/Thr protein kinases, essential residues required for kinase activity are not conserved in 
ILK (Hanks et al., 1988). Nevertheless, several studies showed Ser/Thr kinase activity 
towards several substrates including the cytoplasmic tail of β1 integrin (Hannigan et al., 
1996), PKB/Akt, GSK3β (glycogen-synthase kinase-3β), MLC, MYPT1, α-NAC (nascent-
polypeptide-associated complex and co-activator-α), Myelin basic protein, CPI-17 (protein 
kinase C-dependent phosphatase inhibitor of 17 kDa), PHI-1 (phosphatase holoenzyme 
inhibitor-1), and β-Parvin (Legate et al., 2006). However, the putative kinase activity of ILK 
has been a matter of controversy and there are striking arguments against ILK being a 
functional kinase under physiological conditions (Boudeau et al., 2006). First, in Drosophila 
and Caenorhabditis, the absence of ILK results in muscle detachment and embryonic 
lethality, but expression of kinase-dead versions of ILK are sufficient to completely restore 
the wild-type phenotype. This indicates that the putative kinase activity, at least in 
invertebrates, is dispensable in vivo. Furthermore, the phenotypes of PKB/Akt or GSK3β (or 
downstream signaling molecule β-catenin) deficient mutants, both suggested to be important 
downstream targets of ILK, differ strikingly from the phenotype of ILK deficient mutants 
(Mackinnon et al., 2002; Zervas et al., 2001). Second, although Ser473 phosphorylation of 
PKB/Akt is impaired in heart, skeletal muscle, Schwann cells, and macrophages in the 
absence of ILK (Pereira et al., 2009; Troussard et al., 2003; Wang et al., 2008; White et al., 
2006), phosphorylation of PKB/Akt and/or GSK3β is not altered when ILK is deleted in 
fibroblasts, chondrocytes, or keratinocytes (Grashoff et al., 2003; Lorenz et al., 2007; Sakai et 
al., 2003). This indicates that the putative kinase activity of ILK is only required in certain 
cell-types, if at all. Third, mice carrying different point-mutations (R211A, S343A or S343D) 
in the ILK-gene, which have been reported to result in kinase-dead or hyperactive versions of 
ILK, are phenotypically normal and without obvious alterations in PKB/Akt or GSK-3β 
phosphorylation. This clearly excludes an essential function of the putative ILK-kinase 
activity in vivo (Lange et al., 2009). Only when the presumptive ATP-binding site is mutated 
(K220A/M) mice develop kidney agenesis/dysgenesis and die shortly after birth. However, 
neither phosphorylation of PKB/Akt or GSK-3β in vivo nor phosphorylation of MBP in vitro 
was impaired by these mutations. Thus, loss of the putative ILK-kinase activity cannot 
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explain the observed phenotype. Instead, the K220A/M mutations strikingly and specifically 
interfere with the binding of α-Parvin to ILK, suggesting that this interaction is crucial for 
kidney development. Indeed, loss of α-Parvin results in similar kidney defects (Lange et al., 
2009; Montanez et al., 2009). Finally, the high-resolution crystal structure of the ILK kinase-
like domain clearly demonstrates, that ILK is a pseudokinase unable to hydrolyze ATP, and 
that the pseudoactive site is essential for the ILK-α-Parvin interaction (Fukuda et al., 2009). 
Collectively, these data identify ILK as a pseudokinase. ILK-associated changes in PKB/Akt 
phosphorylation and other potential substrates are likely indirect and depend on ILK’s 
function as an essential scaffolding protein to locally orchestrate signaling networks 
downstream of integrins. 
 
8.3.3) In vivo functions 
 
8.3.3.1) Invertebrates 
 
Studies in invertebrates, which only possess a limited number of integrins and IPP 
components, clearly demonstrate that the IPP complex is essential for the linkage of integrins 
to the actin cytoskeleton. 
In Caenorhabditis, orthologues of β-integrin (PAT-3), ILK (PAT-4), PINCH (UNC-97), and 
Parvin (PAT-6) co-localize in FA-like structures known as dense bodies and M-lines. Dense 
bodies and M-lines are sites of muscle attachment, where actin- and myosin-filaments are 
connected to the basal sarcolemma and the underlying basement membrane (BM). Genetic 
deletion of β integrin or any of the IPP constituents impairs dense body and M-line assembly 
and results in a PAT (paralyzed and arrested at the twofold stage) phenotype, which is defined 
by muscle detachment from the body wall and embryonic lethality (Lin et al., 2003; 
Mackinnon et al., 2002; Norman et al., 2007). 
The Drosophila orthologues of β integrin (βPS), ILK and PINCH, also co-localize at muscle 
attachment sites and at basal junctions of the wing epithelium. Loss-of-function mutations or 
deletion of either β integrin, ILK or PINCH, results in embryonic lethal muscle detachment 
from the body wall and blister formation in the wings of adult chimeras due to defective cell-
adhesion (Brown, 1994; Clark et al., 2003; Zervas et al., 2001). However, the cell adhesion 
defects differ between β integrin and the ILK or PINCH mutants. Loss of β integrin impairs 
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the linkage between the cell membrane and the ECM, whereas loss of ILK or PINCH leads to 
the detachment of actin filaments from the plasma-membrane (Clark et al., 2003; Zervas et 
al., 2001). In contrast to ILK mutants, β integrin and PINCH mutants additionally exhibit 
defects in midgut morphogenesis and dorsal closure, which indicates that cell migration is 
compromised in these mutants, but not in ILK mutants (Brown, 1994; Kadrmas et al., 2004; 
Zervas et al., 2001). Interestingly, PINCH negatively regulates JNK activity by binding to 
RSU-1 and thereby integrates integrin and JNK signaling, which is essential for dorsal closure 
(Kadrmas et al., 2004). Thus in Drosophila, ILK might be dispensable for cell migration, 
whereas β integrin and PINCH are critically required, suggesting that β integrin and PINCH 
also can function in an ILK-independent manner. Indeed, in contrast to mammalian IPP 
complexes, individual IPP constituents can be recruited to adhesion complexes independently 
both in Drosophila and Caenorhabditis (Clark et al., 2003; Lin et al., 2003; Zhang et al., 
2002b), suggesting IPP complex-independent functions in these organisms. 
 
8.3.3.2) Vertebrates 
 
8.3.3.2.1) Zebrafish 
 
The essential function of the IPP complex in vivo has also been demonstrated in zebrafish 
(Danio rerio). In the zebrafish heart and skeletal muscle, ILK, PINCH and β-Parvin co-
localize at sarcomeric Z-disks and costameres and are part of the cardiac mechanical stretch 
sensor. Antisense-mediated depletion either of ILK, PINCH-1, PINCH-2, or β-Parvin, 
phenocopies the embryonic lethal ILK-(L308P)-mutant main squeeze (MSQ), which is 
characterized by a progressive reduction of cardiac contractility. Although binding of β-
Parvin to ILK is impaired in MSQ mutants, β-Parvin still localizes to costameres of 
cardiomyocytes and skeletal muscle, whereas depletion either of β-Parvin, PINCH-1, or 
PINCH-2 results in severe reduction of ILK protein levels. Loss of β-Parvin is accompanied 
by reduced phosphorylation of PKB/Akt at Ser 473 and the concomitant decrease of stretch-
responsive atrial natriuretic factor (ANF) and vascular endothelial growth factor (VEGF) 
expression. Overexpression of VEGF or constitutively active PKB/Akt, reconstitutes the 
cardiac function, indicating that the β-Parvin- IPP complex-dependent regulation of PKB/Akt 
signaling plays an essential role in the zebrafish heart. Although it was reported in these 
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studies, that the cardiac and skeletal muscle ultrastructure was unaffected by the loss of ILK, 
PINCH-1/2 or β-Parvin (Bendig et al., 2006; Meder et al., 2011), a different study provided 
evidence for the detachment of the sarcolemma from the ECM following increased 
mechanical force in skeletal muscles of ILK- or β-Parvin-depleted zebrafish (Postel et al., 
2008). Thus, the IPP complex not only regulates PKB/Akt-signaling but also is required to 
reinforce the integrin-actin linkage in this organism. 
 
8.3.3.2.2) Mammals 
 
In mice, genetic deletion either of β1 integrin (Fassler and Meyer, 1995; Stephens et al., 
1995), ILK (Sakai et al., 2003), PINCH-1 (Li et al., 2005a; Liang et al., 2005), or α-Parvin 
(Montanez et al., 2009), results in embryonic lethality, whereas mice lacking PINCH-2, β-
Parvin, γ-Parvin or both β- and γ-Parvin are phenotypically normal, likely due to 
compensation by PINCH-1 or α-Parvin, respectively (Chu et al., 2006; Montanez et al., 2009; 
Stanchi et al., 2005). 
Embryos lacking β1 integrin and ILK die between day 5.5 and 6.5 of embryonic (E5.5-E6.5) 
development, whereas PINCH-1 deleted embryos survive slightly longer, until E6.5-E7.5. 
PINCH-2 is not expressed at this early developmental stage and thus cannot compensate for 
the loss of PINCH-1 (Braun et al., 2003).  
The early lethality at the peri-implantation stage resulting from deletion of β1 integrin, ILK, 
or PINCH-1, complicates functional analyses. Embryoid bodies (EB) can recapitulate most 
aspects of early embryonic development and therefore have been employed to study the 
consequences of β1 integrin, ILK and PINCH-1 deletion. These studies revealed that β1 
integrin is required for Ln secretion and assembly of the BM (Aumailley et al., 2000; Li et al., 
2002), whereas secretion of Ln was unaffected in EBs lacking ILK or PINCH-1. However, in 
the absence of ILK or PINCH-1, EBs failed to form an amniotic cavity, displayed a distorted 
epiblast polarization, abnormal localization of F-actin, and impaired adhesion of primitive 
endoderm and epiblast to the BM (Li et al., 2005a; Sakai et al., 2003). These defects were 
more pronounced in EBs lacking ILK compared to PINCH-1, which may explain the slightly 
longer survival of PINCH-1 deficient embryos. Additionally, cell-cell adhesion and endoderm 
survival was impaired in EBs lacking PINCH-1 but not in EBs lacking ILK, suggesting an 
IPP-independent function of PINCH-1 in these processes (Li et al., 2005a). 
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While deletion of β1 integrin, ILK, or PINCH-1 results in death at the peri-implantation stage, 
embryos lacking α-Parvin develop normally until E9.5, but die between E11.5 and E14.5 from 
severe cardiovascular defects (Montanez et al., 2009). Additionally, these embryos show 
severe kidney agenesis/dysgenesis due to impaired ureteric bud (UB) invasion into the 
metanephric mesenchyme (MM) (Lange et al., 2009). This suggests that β-Parvin can 
compensate for the loss of α-Parvin during early mouse development, but fails to substitute 
for α-Parvin-specific functions at later stages. 
Although β-Parvin is expressed in vSMCs and is sufficient to rescue protein-levels and 
adhesion recruitment of ILK and PINCH, β-Parvin cannot functionally compensate for the 
loss of α-Parvin in these cells. Without α-Parvin, vSMCs are hypercontractile and fail to 
establish a persistent leading edge due to elevated RhoA-ROCK signaling and enhanced 
phosphorylation of MLC. Although the random motility of these cells is increased, their 
directional migration is severely impaired, resulting in the inefficient recruitment of vSMCs to 
endothelial tubes and insufficient coverage of blood-vessels. Accordingly, remodeling of 
blood-vessels is rudimentary in the absence of α-Parvin, and is accompanied by the formation 
of micro-aneurysms, dilations and rupture of vessels, hemorrhages and edemas (Montanez et 
al., 2009). 
Although constitutive deletion of β1 integrin, ILK, PINCH-1 and α-Parvin demonstrate that 
they are essential for mammalian development, analysis of their functions in adult animals 
and/or in specific organs is precluded due to embryonic lethality. Tissue-specific deletion and 
knock-in strategies to introduce specific point-mutations have been employed to overcome 
this limitation. 
Similar to the constitutive ablation of α-Parvin, vSMC-specific deletion of ILK also results in 
increased RhoA activity and ROCK/MLC-dependent hypercontractility of vSMCs. Embryos 
lacking ILK specifically in vSMCs die around E18.5 due to severe vascular defects, including 
micro-aneurysms, inefficient recruitment of vSMCs to the vessel-wall, insufficient coverage 
and stabilization of blood-vessels, dilation and rupture of vessels as well as hemorrhages and 
edemas (Kogata et al., 2009). 
Tissue-specific ablation of ILK in Schwann cells also leads to Rho-mediated 
hypercontractility in these cells, leading to defective myelination of axons (Pereira et al., 
2009). Additionally, mice harboring a point mutation in the potential ATP-binding site of 
ILK, which specifically abrogates the ILK-α-Parvin interaction, develop kidney defects 
similar to mice lacking α-Parvin and die shortly after birth. Collecting duct epithelial cells 
from these mice display enhanced contractile properties and increased random migration but 
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are impaired in their directional migration, indicating that the ILK-α-Parvin interaction is 
required for persistent migration in these cells, possibly by negatively regulating RhoA 
activity (Lange et al., 2009). Collectively, these studies indicate that the α-Parvin plays an 
essential role in the regulation of RhoA activity in certain cell-types. Although vSMC-specific 
deletion of β1 integrin, similar to the loss of ILK and α-Parvin, also leads to vascular leakage 
and instability, these defects result from impaired differentiation and abnormal proliferation 
of vSMCs but are not due to increased MLC phosphorylation and hypercontractility of 
vSMCs (Abraham et al., 2008). This is consistent with a loss of the RhoA/ROCK-promoting 
function of α5β1 integrins upon deletion of β1 integrin. Thus, β1 integrin signaling promotes 
RhoA/ROCK signaling, whereas the α-Parvin is required to prevent excessive RhoA activity 
in certain cell types. 
One possibility is that the α-Parvin directly counteracts the RhoA/ROCK promoting function 
of α5β1 integrins by recruiting or activating Rho GAPs and/or by displacing or inhibiting Rho 
GEFs. Alternatively, the α-Parvin-IPP complex could be required for αvβ3 integrin mediated 
signaling, which promotes Rac activation and negatively regulates β1 integrin recycling to the 
membrane (Danen et al., 2002; Danen et al., 2005). 
Constitutive and conditional deletion of integrins and members of the IPP complex have 
identified important functions in a broad variety of tissues and cell-types, including 
skeleton/chondrocytes (Aszodi et al., 2003; Grashoff et al., 2003; Terpstra et al., 2003), 
heart/cardiomyocytes (Liang et al., 2009; Liang et al., 2005; Shai et al., 2002; White et al., 
2006), vasculature/endothelial cells (Friedrich et al., 2004) and vSMCs (Abraham et al., 2008; 
Kogata et al., 2009; Montanez et al., 2009), skeletal muscle/myocytes (Gheyara et al., 2007; 
Wang et al., 2008), skin/keratinocytes (Brakebusch et al., 2000; Lorenz et al., 2007; Nakrieko 
et al., 2008; Raghavan et al., 2000), nervous system/neurons, Schwann cells and neural crest 
cells (Breau et al., 2006; Niewmierzycka et al., 2005; Pereira et al., 2009), kidney/podocytes 
and UB epithelial cells (Dai et al., 2006; El-Aouni et al., 2006; Kanasaki et al., 2008; Pozzi et 
al., 2008; Smeeton et al., 2010) and many more. A detailed discussion of integrin and IPP 
function in these numerous tissues and cell-types would exceed the scope of this introduction. 
Therefore, the focus will be on their function in the vascular system and in the skin. 
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9) Development of the vascular system 
 
The first functional organ to form in vertebrate development is the cardiovascular system. It 
comprises the heart, blood vessels and lymphatic vessels. Blood vessels and lymphatic vessels 
are branched tubular networks, lined by endothelial cells (ECs). They facilitate the transport 
of gases, liquids, nutrients, signaling molecules and circulating cells. Insufficient blood supply 
results in ischaemia and severe pathological deficiencies, which are often fatal. In tumors, on 
the other hand, increased angiogenesis can promote tumor growth, and extravasation of tumor 
cells into lymphatic or blood vessels facilitates their metastatic spread, primarily into lymph 
nodes and the lung (Armulik et al., 2005). 
 
9.1.1) Vasculogenesis 
 
Early during embryogenesis, cells of mesodermal origin differentiate into endothelial 
precursor cells (EPCs), also referred to as angioblasts. EPCs then cluster into so-called blood 
islands, which coalesce to form a capillary network, known as primary capillary plexus. This 
process, which leads to the de novo formation of blood vessels, is referred to as 
vasculogenesis. The dorsal aorta, the cardinal vein and the yolk-sac vasculature are directly 
generated by vasculogenesis (Adams and Alitalo, 2007) (Figure 5). 
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Figure 5: Vasculogenesis, angiogenesis and lymphangiogenesis 
Vasculogenic fusion of blood islands results in the formation of a primary capillary plexus, which is extensively 
remodeled during angiogenesis. Pericytes associate with capillaries and immature blood vessels, whereas large 
and mature vessels are supported by vSMCs. Lymphangiogenesis is initiated by the sprouting of lymphatic ECs 
(LEC) from embryonic veins. For details see text. Figure taken from (Adams and Alitalo, 2007). 
 
9.1.2) Angiogenesis 
 
In a process known as angiogenesis, the primary vascular plexus extends and is extensively 
remodeled, which eventually results in the formation of a hierarchical system consisting of 
major arteries and veins, smaller (pre-capillary) arterioles and (post-capillary) venules, and a 
branched network of fine capillaries (Figure 5). During angiogenesis, new vessels can sprout 
from existing vessels (sprouting angiogenesis) or can be generated by splitting 
(intussusception) of vessels through the insertion of tissue pillars (Djonov and Makanya, 
2005) (non-sprouting angiogenesis). While some vessels regress and become eliminated 
(pruned), others branch, fuse and/or mature. Maturation of vessels requires the recruitment of 
pericytes and vSMCs, collectively referred to as mural cells, to newly formed endothelial 
tubes. While capillaries and immature blood vessels are covered by pericytes, which are 
embedded in the BM and establish direct connections with ECs through focal cell-cell 
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contacts, larger vessels are ensheathed by vSMCs, which are separated from the endothelium 
by the vascular BM (Adams and Alitalo, 2007). 
Mural cells not only mechanically stabilize vessels, but also prevent excessive proliferation 
and sprouting of EC and thus are required to facilitate a quiescent and mature vessel 
phenotype. In addition, vSMCs control the vascular tone through contraction or relaxation of 
their actomyosin cytoskeleton (Armulik et al., 2005; Bergers and Song, 2005). 
 
9.1.3) Regulation of sprouting angiogenesis 
 
Angiogenic sprouting is tightly regulated. ECs have to reverse their polarity and adopt motile 
and invasive features, which includes the activation and/or secretion of proteases to locally 
dissolve the vascular BM. Furthermore, endothelial sprouts have to elongate in a polarized, 
coordinated, and directional way. 
Angiogenic sprouts are guided by ECs located at the front of the tip and referred to as tip 
cells. Similar to axonal growth cones, tip cells extend filopodia to sense attractive and 
repulsive guidance cues in their environment. Notch signaling is essential for the specification 
of tip cells and impaired Notch signaling increases tip cell formation, which leads to excessive 
sprouting, branching and fusion of endothelial tubes (Adams and Alitalo, 2007). 
Expression of the Notch ligand DLL4 (Delta-like-4) in tip cells is induced by VEGFA 
(vascular endothelial growth factor A). This results in activation of Notch signaling in 
adjacent cells which suppresses the expression of VEGFR2 (VEGF receptor) (and VEGFR3 
in zebrafish) in these cells and prevents the formation of additional sprouts. 
Tip cells, in contrast, express high levels of VEGFR2 which help to guide the elongating 
sprout along a spatial concentration gradient of a ECM-anchored isoform of VEGFA 
(VEGF164 in mice, VEGF165 in humans) (Adams and Alitalo, 2007). 
Interestingly, guidance of endothelial sprouts frequently parallels axonal path finding and 
similar guidance cues are used by ECs and neurons. Repulsive cues for ECs include the class 
3 semaphorin SEMA3E and netrin-1, which prevent abnormal vascular patterning by 
interacting with their corresponding endothelial receptors Plexin D1 and UNC5B 
(uncoordinated-5B), respectively. Accurate vascular patterning also depends on the 
expression of ROBO4 (magic roundabout) on ECs, and SLIT proteins might function as 
repulsive cues for ROBO4 expressing ECs. However, it is not clear, if SLIT proteins can 
directly interact with ROBO4 (Adams and Alitalo, 2007). 
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Sprouting ends when elongating endothelial sprouts fuse with existing capillaries or the tips of 
other sprouts, which results in the formation of new vascular connections. Fusion requires the 
establishment of new cell-cell contacts between ECs. Furthermore, ECs have to revert to a 
non-migratory phenotype. However, inappropriate fusion may result in arteriovenous shunts, 
known as anastomoses, and thus fusion needs to be regulated. Repulsive cues are thought to 
prevent the inappropriate fusion of non-matching capillary sprouts (Adams and Alitalo, 2007). 
 
9.1.4) Maturation of vessels 
 
Maturation of vessels is supported by the onset of blood flow, which results in enhanced 
oxygen supply. This in turn lowers the local production of pro-angiogenic VEGFA, which 
results in pruning of immature vessels, whereas maturation prevents vessel regression in the 
absence of VEGFA. Assembly of a vascular BM and suppression of EC-proliferation and 
sprouting further promote the maturation of vessels. Additionally, recruitment of mural cells 
to nascent vessels is essential for vessel maturation. While ECs, in particular tip cells, secrete 
PDGFB (platelet-derived growth factor B), mural cells express the corresponding receptor 
PDGFRβ (PDGF receptor β), which is essential for proliferation and recruitment of mural 
cells to blood-vessels and for their association with the vessel-wall. Similar to VEGFA, 
spatial presentation of PDGFB is essential for the recruitment of mural cells. PDGFB contains 
a retention motif, which by binding to heparin sulfate proteoglycans facilitates the anchorage 
of PDGFB to the ECM. Consequently, mural cell coverage is impaired in mice that express a 
mutant form of PDGFB that lacks the retention motif (Armulik et al., 2005; Lindblom et al., 
2003). 
Interestingly, ECs also secrete sphingosine-1-phosphate (S1P), and PDGFRβ might cooperate 
with S1P-receptors, which belong to the G-protein coupled receptor family (Allende and 
Proia, 2002; Spiegel and Milstien, 2003). S1P1, S1P2 and S1P3 have been shown to be 
involved in vascular development, and deletion of S1P1 results in insufficient investment of 
blood-vessels by mural cells, which might be partially due to impaired Rac activation (Kono 
et al., 2004; Liu et al., 2000). 
TGFβ (transforming growth factor β) signaling also plays an important role in mural cells. 
TGFβ and latency associated peptide (LAP) form a latent complex, which is anchored to the 
ECM through the latent TGFβ-binding protein (LTBP) (ten Dijke and Arthur, 2007). TGFβ 
signaling, together with serum response factor (SRF), myocardin, CRP1 and CRP2, and δEF1, 
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promotes differentiation of progenitor cells into mural cells (Adams and Alitalo, 2007). 
Deletion of TGFβ1, its receptors TGFβ receptor-2 (Tgfbr2) and activin-receptor-like kinase-1 
and -5 (Alk1 and Alk5), the accessory receptor endoglin (Eng), or the downstream effector 
SMAD5, all result in severe cardiovascular defects and embryonic lethality (Armulik et al., 
2005). 
 
9.1.5) Integrins in the vascular system 
 
Integrins play a major role in the development and homeostasis of the vascular system. ECs 
express several integrins, including the β1 integrins α1β1, α2β1, α3β1, α4β1, α5β1, α6β1 and 
α9β1, the αV integrins αvβ3 and αvβ5, as well as α6β4. The integrin repertoire of mural cells 
is less well characterized, although they were shown to express α1β1, α2β1, α3β1, α4β1, 
α5β1, α6β1, α9β1, α6β4 and, in addition, α7β1 and α8β1 (Avraamides et al., 2008; Silva et al., 
2008). Genetic and pharmacological approaches revealed critical functions of several 
integrins in the vasculature. However, as shown for αV integrins, results between 
pharmacological inhibition and genetic ablation can differ significantly. 
While the majority of mice lacking the αV integrin subunit die between E10.5 and E11.5 due 
to vascular defects in placental blood vessels, 20% complete embryonic development but die 
shortly after birth. These mice display enlarged and leaky vessels in the brain and intestine, 
accompanied by severe hemorrhages (Bader et al., 1998). However, deletion of αV 
specifically in ECs does not affect blood vessels in the brain, whereas specific deletion of αV 
in neuronal cells results in vascular defects in the brain that closely resemble those of mice 
completely lacking αV integrins (McCarty et al., 2005). Similar vascular defects in the brain 
are also observed in mice lacking the β8 integrin subunit, which is expressed by neither ECs 
nor mural cells, but instead is expressed by glia cells. This indicates, that the vascular defects 
in brain are due to the loss of αvβ8 in glia cells but not in ECs (McCarty et al., 2002; Zhu et 
al., 2002). 
Studies using antagonists or blocking antibodies specific for the αV integrins αvβ3 and αvβ5 
indicate an essential function for these integrins in pathological angiogenesis. Endothelial 
expression of αvβ3 increases during neovascularization in tumors, wounds and inflamed 
tissue and is promoted by angiogenic growth factors and cytokines, including bFGF (basic 
fibroblast growth factor), TNFα (tumor necrosis factor α) and IL8 (interleukin 8) (Brooks et 
al., 1994a). Furthermore, αvβ3 specific antagonists induce caspase 8-dependent apoptosis in 
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ECs (Stupack et al., 2001) and inhibit angiogenesis, indicating that this integrin is important 
for EC survival and migration (Brooks et al., 1994a; Brooks et al., 1994b; Brooks et al., 1995; 
Friedlander et al., 1995; Friedlander et al., 1996; Fu et al., 2007). However, genetic ablation 
of β3 and/or β5 (and hence αvβ3 and αvβ5) does not impair physiological angiogenesis but 
promotes tumor angiogenesis, possibly due to elevated levels of VEGFR-2 in the absence of 
αvβ3 (Reynolds et al., 2004; Reynolds et al., 2002). Moreover, migration and proliferation of 
αvβ3-deficient ECs is increased in response to VEGF (Reynolds et al., 2004). In contrast, 
tumor angiogenesis is impaired when both Tyrosine 747 and Tyrosine 759 in the β3 
cytoplasmic tail are replaced by Phenylalanine (Mahabeleshwar et al., 2006). Consistently, 
adhesion, spreading, migration and capillary tube formation are compromised in the mutant 
ECs (Mahabeleshwar et al., 2006). 
Genetic ablation of the β1 integrin subunit (and hence all β1 integrin heterodimers) 
demonstrates a key function for β1 integrins in vascular development. In the absence of β1 
integrin, EC proliferation and branching of blood vessels is impaired in EBs and only host 
derived blood vessels form in β1-deficient teratomas (Bloch et al., 1997). Furthermore, 
endothelial-specific deletion of the β1 integrin subunit in mice results in embryonic lethality 
by E10.5 due to severe vascular defects. Although vasculogenesis and formation of larger 
vessels is unaffected, angiogenesis in the embryo and yolk sac is severely compromised in 
mice lacking β1 integrins in ECs (Tanjore et al., 2008). Similarly, endothelial-specific 
deletion of ILK results in severe vascular defects and embryonic lethality around E11.5 
(Friedrich et al., 2004). 
Specific deletion of the β1 integrin subunit in mural cells also results in severe vascular 
defects, which are characterized by insufficient investment of the vessel wall by mural cells. 
Although mural cell specific deletion of ILK and constitutive deletion of α-Parvin both lead to 
similar vascular defects, these defects are due to increased RhoA/ROCK mediated 
contractility, whereas β1 integrin-deficient mural cells are not hypercontractile. Instead, 
proliferation of mural cells is increased and their differentiation is compromised in the 
absence of β1 integrins (Abraham et al., 2008; Kogata et al., 2009; Montanez et al., 2009). 
Constitutive deletion of the integrin α5 subunit results in embryonic lethality between E10 
and E11. The mutant embryos lack posterior somites and have a truncated posterior. 
Furthermore, vascular development is severely impaired, demonstrating an essential role of 
the α5β1 integrin heterodimer in the development of the vasculature (Yang et al., 1993). 
Depletion of α5β1 also results in defects in the formation of the vasculature in EBs and 
Introduction 
54 
teratomas, which are similar to the defects in β1 deficient EBs and teratomas, albeit milder 
(Francis et al., 2002; Taverna and Hynes, 2001). 
Consistent with the essential function of the α5β1 integrin in vascular development, mutation 
or constitutive deletion of its ligand FN in mice results in similar defects, including a severely 
compromised cardiovascular system and lack of somites (Astrof et al., 2007; Gettner et al., 
1995; Takahashi et al., 2007). 
In addition to αvβ3, αvβ5 and α5β1, the integrin heterodimers α4β1 and α9β1 are also FN 
receptors expressed by ECs and mural cells. Although genetic ablation of the integrin α9 
subunit does not result in recognizable abnormalities in blood vessels, mice lacking α9β1 
integrin fail to develop a normal lymphatic system and die between 6 and 12 days after birth 
due to respiratory failure caused by an accumulation of pleural fluid (Huang et al., 2000b). 
This suggests an essential function for α9β1 in the lymphatic vasculature. 
Deletion of the α4 integrin subunit in mice results in embryonic lethality between E10 and 
E12, due to impaired chorio-allantoic fusion during placentation and defects in the 
development of the epicardium and coronary vessels, which lead to cardiac hemorrhages 
(Yang et al., 1995). Although it is not clear if α4 has a relevant function in physiological 
angiogenesis, its expression is increased during tumor angiogenesis and in response to 
angiogenic growth factors and cytokines. Furthermore, α4β1 can promote the association of 
VCAM-1 expressing vSMCs with ECs during neovascularization, whereas α4β1 antagonists 
impair survival of mural cells and ECs and inhibit tumor angiogenesis (Garmy-Susini et al., 
2005). This suggests a pro-angiogenic function for α4β1. 
Vascular development is normal in mice lacking the Col and LN-binding integrins α1β1 or 
α2β1. However, tumor angiogenesis is reduced in mice lacking α1β1 (Pozzi et al., 2000), 
whereas in the absence of α2β1, tumor angiogenesis is increased in melanomas and also in 
Lewis lung carcinomas (LLC), although only upon PLGF (placental growth factor) treatment 
(Zhang et al., 2008b). Thus, these integrins are dispensable for vascular development but 
might have modulatory functions during pathological angiogenesis. 
Genetic ablation of the α6 integrin subunit, which prevents formation of α6β1 and α6β4, does 
not result in obvious vascular defects. Instead, mice lacking either the integrin subunit α6 or 
β4 die immediately after birth due to impaired hemidesmosome formation and severe 
detachment of the epidermis from the underlying dermis (Dowling et al., 1996; Georges-
Labouesse et al., 1996; van der Neut et al., 1996). However, integrin α6β1 is expressed on 
capillary ECs (Lee et al., 2006) and the β4 integrin subunit is present on the endothelium of 
tumors (Nikolopoulos et al., 2004), and blocking antibodies against the α6 integrin subunit 
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impair EC tube formation (Lee et al., 2006). Additionally RNAi-mediated reduction of the α6 
integrin subunit impairs EC migration and tube formation in the brain microvasculature (Lee 
et al., 2006). Although a mutant form of the β4 subunit with a truncated cytoplasmic tail is 
sufficient to prevent the skin defects that result from the complete deletion of β4, tumor 
angiogenesis is reduced in mice expressing this truncated β4 subunit. While EC proliferation 
is normal, adhesion and migration are reduced in ECs expressing the truncated β4 subunit 
(Nikolopoulos et al., 2004). Thus, the α6 heterodimers α6β1 and α6β4 are dispensable for 
physiological angiogenesis but might negatively regulate tumor angiogenesis. 
Integrins expressed in mural cells but not in ECs, are also implicated to play a role in vascular 
development. In mice, deletion of the α7 integrin subunit results in partial embryonic lethality, 
accompanied by cerebrovascular hemorrhages and vSMC hypoplasia as well as defects in the 
development of the placenta. Defects in vSMCs are also present in mice that continue to 
develop in the absence of the α7 integrin subunit. The vSMCs in the surviving mice are 
hyperplastic and hypertrophic (Flintoff-Dye et al., 2005; Welser et al., 2007). This suggests 
that the α7β1 integrin plays a role in mural cells thereby contributing to vascular 
development. 
Finally, the integrin heterodimer α8β1 is also expressed in mural cells but not in ECs. With 
increasing number of passages, cultured vSMC convert from a contractile, low proliferative 
phenotype to a less contractile and more proliferative “synthetic” phenotype. Interestingly, 
while the expression of the integrin subunit α8 is reduced with increasing number of passages, 
overexpression of the integrin α8 subunit in cultured rat-vSMCs promotes the switch from the 
synthetic to the contractile phenotype in a Rho-dependent manner (Zargham et al., 2007). 
However, vSMC differentiation was not altered in vSMC of mice lacking the α8 integrin 
subunit (Marek et al., 2010). 
In summary several integrins are implicated to play a role in the vasculature. Differences 
between pharmacological and genetic approaches, as well as between physiological and 
pathological angiogenesis indicate that, although some integrins (e.g. α5β1) are essential for 
vascular development, others are dispensable but might have specific modulatory functions, 
which, under physiological conditions, can be compensated by alternative integrins and/or 
signaling pathways. Future studies are required to resolve these discrepancies and to define 
the signaling specificities of different integrins. The IPP complex and in particular the α-
Parvin is essential for vascular development by regulating actin cytoskeleton dynamics, 
migration and contractility of vSMC. Defining the signaling specificities of distinct IPP 
complexes will provide further insight into the underlying molecular mechanisms. 
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10) Development and architecture of the skin 
 
The skin is the largest organ of the body and serves as a barrier that prevents dehydration and 
protects the organism against a variety of external threats of physical, chemical and biological 
nature including ultraviolet radiation, extreme temperatures, trauma, toxic or harmful 
substances and infectious organisms. Skin is composed of an outer stratified squamous 
epithelium, the epidermis, which is separated from the underlying mesenchymal dermis by a 
BM. (Fuchs and Raghavan, 2002; Lippens et al., 2009). Underneath the dermis lies the 
adipose subcutis or hypodermis. Additional components of skin are epidermal appendages 
such as hair follicles (HFs) and sweat glands, which derive from the epidermis. 
 
10.1.1) Morphogenesis of the epidermis 
 
During embryogenesis, the epidermis develops from a single layer of ectoderm. Wnt-
signaling is required for the specification of the epidermis by repressing FGF signaling, which 
promotes a neural fate, and promoting BMP (bone morphogenetic proteins) signaling (Stern, 
2005). From E9.5 to E12.5, the developing epidermis consists of a monolayer of multipotent 
epithelial progenitor cells. Their differentiation results in the formation of the periderm, a 
protective layer which initially covers the epithelial cells but is shed into the amniotic fluid 
when a functional epidermis has formed towards the end of embryonic development 
(M'Boneko and Merker, 1988). Starting at E12.5, mesenchymal cues induce a differentiation 
program in epithelial cells, which first leads to the formation of a mitotically active 
intermediate layer (stratum intermedium). The stratification of the epidermis successively 
increases through further differentiation and by E17.5 the epidermis consists of several 
transcriptionally, functionally, and morphologically distinct layers of keratinocytes, which are 
in consecutive stages of differentiation (Blanpain and Fuchs, 2006; Koster and Roop, 2007) 
(Figure 6). 
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Figure 6: The epidermis is a stratified squamous epithelium 
Schematic representation of the epidermis. Proliferation is restricted to keratinocytes in the basal layer of the 
epidermis, which firmly adhere to the BM through hemidesmosomes. Delamination of basal keratinocytes and 
sequential differentiation gives rise to the suprabasal layers of the epidermis, which are morphologically and 
functionally distinct and express different markers as indicated on the right side. See text for details. Figure is 
modified from (Fuchs, 2008). 
 
Proliferation is confined to the basal layer of keratinocytes (basal keratinocytes), which are in 
direct contact with the underlying BM. The proliferating basal keratinocytes are characterized 
by the expression of keratin 5 and 14 as well as several integrins. Upon commitment to a 
terminal differentiation program, basal keratinocytes withdraw from the cell cycle, down 
regulate integrins, delaminate from the BM and translocate to the stratum spinosum, which is 
the first suprabasal layer. In contrast to basal keratinocytes, keratinocytes in the spinous layer 
are characterized by the expression of keratin 1 and 10 (Fuchs, 2008). Alternatively or 
additionally, asymmetric cell division, with a mitotic spindle oriented perpendicular to the 
BM, contributes to the formation of the spinous layer, at least during development (Lechler 
and Fuchs, 2005). However, in tail skin from adult mice, only 3% of dividing basal 
keratinocytes display spindle orientations perpendicular to the BM (Clayton et al., 2007). 
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Keratinocytes of the spinous layer further differentiate as they translocate to the stratum 
granulosum. Expression of loricrin is characteristic for keratinocytes in the granular layer. 
Finally, terminal differentiation of keratinocytes from the granular layer results in the 
formation of the stratum corneum, which consists of enucleated and dead keratinocytes, also 
referred to as corneocytes. Corneocytes are characterized by the presence of filaggrin and a 
cornified envelope of cross-linked lipids and proteins, which essentially contributes to the 
barrier function of the skin (Fuchs, 2008). During adult life, corneocytes are constantly shed 
off from the body surface in a process referred to as desquamation (Milstone, 2004). The shed 
corneocytes are replenished through the proliferation of basal keratinocytes and their 
successive terminal differentiation, which results in the continuous renewal of the epidermis 
throughout life. 
The homeostasis of the epidermis and its remarkable ability to regenerate after injury depends 
on stem cells residing in the interfollicular epidermis (IFE), the bulge region of HFs and in 
sebaceous glands (SC). Stem cells are infrequently dividing cells with a high potential of self-
renewal. In the epidermal proliferative unit (EPU) model, asymmetric lateral division of a 
single stem cell, positioned in the center of a discrete epidermal unit in the IFE, generates 
transit amplifying cells (TA), which in turn can undergo a limited number of divisions before 
being committed to terminally differentiate (Potten, 1981). Challenging the EPU model, a 
single progenitor model questions the existence of TAs. Instead, asymmetric lateral division 
of stem cells might directly result in the generation of post-mitotic cells committed for 
differentiation (Clayton et al., 2007). 
 
10.1.2) Morphogenesis and cycling of the HF 
 
Mammalian skin is characterized by the presence of hair, which physically protects the skin, 
contributes to thermoregulation, has sensory functions and plays an important role in social 
interactions (Botchkarev and Paus, 2003). Hair is formed by the HF, which together with the 
arrector pili muscle and the sebaceous gland is organized into a functional pilosebaceous unit 
(Schneider et al., 2009). In the HF, keratinocytes terminally differentiate into dead 
trichocytes, which condense into a fiber with high tensile strength, commonly known as hair, 
but more specifically referred to as the hair shaft (HS) (Schmidt-Ullrich and Paus, 2005). 
Morphogenesis of the HF is initiated during embryonic development and depends on the 
reciprocal interaction and signaling crosstalk between the epithelium and the underlying 
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mesenchyme. The involved signals include components of the Wnt, hedgehog, TGF-β/BMP, 
FGF and TNF signaling pathways (Schneider et al., 2009). 
Inductive cues from the mesenchyme are thought to promote the proliferation of epithelial 
cells, which subsequently extend locally into the mesenchyme to form the hair placode. The 
hair placode first becomes morphologically recognizable by E14. In turn, signals derived from 
the epithelial cells in the placode induce the clustering of underlying mesenchymal fibroblasts 
into a dermal condensate, which is the precursor of the dermal papilla. Inductive cues from 
the dermal papilla promote further proliferation and differentiation of keratinocytes, which 
subsequently extend deeper into the mesenchyme to eventually encapsulate the dermal papilla 
in a structure referred to as the hair bulb. In the hair bulb, melanocytes derived from neural 
crest cells, form the pigmentary unit of the hair follicle. Melanocytes produce melanin, the 
pigment of the HS. Melanin is stored in melanosomes and is transferred to terminally 
differentiating keratinocytes of the HS, which in the end results in the pigmentation of the HS 
(Botchkarev and Paus, 2003). Highly proliferative keratinocytes in the hair bulb are in close 
proximity to the dermal papilla and are known as hair matrix (HM) keratinocytes. 
Proliferation and differentiation of HM keratinocytes critically depends on regulatory signals 
from the dermal papilla and results in the formation of six concentric layers of the HS 
(Medulla, Cortex and Cuticle) and the inner root sheath (IRS) (Huxley’s layer, Henley’s layer 
and Companion layer). The inner root sheath separates the hair shaft from the outermost layer 
of the HF, known as the outer root sheath (ORS) (Botchkarev and Paus, 2003). Keratinocytes 
from the ORS are continuous with the basal layer of the IFE, and as such express Keratin 5 
and 14, and are in direct contact with the BM that surrounds the HF. HF development in mice 
is asynchronous. Vibrissa are induced at E12.5, whereas primary tylotrich guard hairs are 
initiated by E14.5, and secondary non-tylotrich intermediate (awl and auchene) and downy 
(zigzag) hairs start to develop between E17 and birth. By postnatal day 8 (P8), all HFs 
complete morphogenesis but HF elongation and maturation continues up to P14, by which 
time all HF bulbs reside deep in the subcutis and are in close vicinity to the panniculus 
carnosum muscle layer (Botchkarev and Paus, 2003; Schmidt-Ullrich and Paus, 2005). 
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Figure 7: Hair follicle morphogenesis and cycling 
Schematic representation of distinct stages of HF-morphogenesis and cycling. After HF-morphogenesis is 
completed, HF cycle between stages of apoptosis driven regression (catagen), relative quiescence (telogen) and 
active growth (anagen). See text for details. Figure taken from (Fuchs, 2007). 
 
After HF morphogenesis is completed, HFs cycle between alternating phases of growth 
(anagen), rapid regression (catagen), and relative quiescence (telogen) throughout adult life 
(Schneider et al., 2009) (Figure 7). By P17 the HF cycle is initiated by the first catagen, which 
lasts about two to three days. Apoptosis of HM, IRS and ORS keratinocytes results in the 
degeneration of the non-permanent part of the HF, which comprises the region below the stem 
cell-containing HF bulge. Importantly, retraction of the remaining epithelial strand brings the 
dermal papilla into close proximity to the HF bulge. Following a resting telogen phase of 
several days, inductive signals from the dermal papilla promote the proliferation of stem cells 
in the bulge and thereby initiate the first anagen phase, which eventually results in the 
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regeneration of a mature HF. During the anagen phase, TA keratinocytes, derived from stem 
cells in the bulge, migrate along the ORS-underlying BM towards the bulb region, where they 
differentiate into the distinct HF lineages of the mature HF. Although the old HS, known as 
club hair, might be retained for several hair cycles, it eventually will be shed in a process 
referred to as exogen. In mice, the initial hair cycles are synchronous. However, synchronous 
cycling becomes confined to regional domains in aging animals and telogen phases 
successively get prolonged, leading to an increased duration of the hair cycle. Signals that 
regulate cycling include anagen promoting components of the Wnt, BMP and Shh signaling 
pathways, whereas FGF5 promotes the induction of catagen (Botchkarev and Paus, 2003; 
Schneider et al., 2009). 
 
10.1.3) Integrins in the epidermis 
 
Tight adhesion of basal and ORS keratinocytes to the underlying BM is essential for 
epidermal homeostasis. Integrins are the key mediators of this adhesion and play an essential 
structural and functional role in epidermal homeostasis, HF development/maintenance and 
wound healing. Conversely, abnormal expression of integrins or altered integrin signaling is 
involved in the development and progression of skin carcinomas and a psoriasis-like disease 
(Watt, 2002). 
With the exception of αvβ8, which is expressed only in suprabasal layers, expression of the 
other epidermal integrins normally is confined to the basal layer of the epidermis and to 
keratinocytes of the ORS. Integrins constitutively expressed in the epidermis include the 
laminin receptors α3β1 and α6β4 as well as the collagen receptor α2β1 and the vitronectin 
receptor αvβ5 which is expressed at a low level. Additionally, the fibronectin receptor α5β1 
and the fibronectin and tenascin receptors αvβ6 and α9β1 are induced or upregulated in cell 
culture and during pathological conditions such as wounding or tumorigenesis (Watt, 2002). 
Unlike other integrins, the α6β4 integrin heterodimer facilitates the linkage to intracellular 
keratin filaments and is a major component of hemidesmosomes, which tightly anchor 
keratinocytes to the BM. While α6β4 localization is restricted to the basal membrane, other 
integrins also localize to lateral and apical surfaces of basal keratinocytes. In mice, genetic 
ablation of either the α6 or the β4 subunit impairs hemidesmosome-formation and results in 
neonatal lethality due to severe epidermal detachment from the BM (Dowling et al., 1996; 
Georges-Labouesse et al., 1996; van der Neut et al., 1996). However, differentiation of 
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keratinocytes is normal in regions of partial attachment to the BM, indicating that α6β4 is not 
essential for this process. Similar defects in humans are characteristic for the autosomal 
recessive disorder junctional epidermolysis bullosa, which is caused by mutations in the genes 
for the α6 or the β4 integrin subunits. 
The constitutive deletion of the α3 integrin subunit also results in epidermal detachment. 
However these defects are less pronounced than the absence of α6β4 and are accompanied by 
a defective organization and rupture of the BM (DiPersio et al., 1997). Lack of α3 also affects 
the organization of the glomerular BM, impairs lung and kidney development and results in 
death shortly after birth (Kreidberg et al., 1996). Conclusively, the BM defects indicate that 
the α3β1 integrin heterodimer is essential for the organization and integrity of BMs. Genetic 
deletion of both α6β4 and α3β1 does not result in a more severe phenotype than the individual 
deletion of either heterodimer. Furthermore, even in the simultaneous absence of both 
heterodimers, proliferation, stratification and epidermal morphogenesis before blister 
formation are normal, indicating that both heterodimers are dispensable for epidermal 
development but are critically required for the organization of and attachment to the BM 
(DiPersio et al., 2000). Interestingly, in adult skin α3β1 is required for HF morphogenesis and 
maintenance. Growth and differentiation of HFs is severely impaired in skin-grafts from α3 
deficient mice. Additionally, the BM of the IFE but not of the HF is disorganized in the α3-
deficient skin-grafts (Conti et al., 2003). 
Genetic ablations of the integrin subunits α2 (Chen et al., 2002; Holtkotter et al., 2002), α9 
(Huang et al., 2000b), and β5 (Huang et al., 2000a) have not been reported to result in a skin-
related phenotype, although migration is severely compromised in β5-deficient keratinocytes 
in vitro (Huang et al., 2000a) and α2β1 is critically required for the adhesion of keratinocytes 
to type I collagen (Zhang et al., 2006). 
 
10.1.4) The function of β1 integrins in the epidermis 
 
Conditional deletion of genes specifically in the epidermis and its appendages can be achieved 
by crossing mice in which the gene of interest has been modified by the insertion of two loxP-
recombination sequences, with mice expressing the Cre-recombinase transgene under the 
control of the keratin-5 (K5) or keratin-14 (K14) promotor. Cre-mediated recombination 
results in the excision of the DNA-sequence between the two loxP-sites, leading to the 
disruption of the gene of interest. When controlled by the K5 or K14 promotor, Cre-
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expression and Cre-mediated disruption of the gene of interest is restricted to basal and ORS 
keratinocytes, which are the progenitors for keratinocytes of the IRS, HS, and the suprabasal 
layers of the IFE. Consequently the gene of interest is disrupted in the progeny, resulting in 
conditional deletion in all keratinocytes of the epidermis and its appendages. 
The keratinocyte-restricted deletion of the β1 integrin subunit, which prevents the formation 
of all epidermal β1 integrin heterodimers, results in severe defects in epidermal homeostasis, 
wound healing and HF morphogenesis (Brakebusch et al., 2000; Grose et al., 2002; Lopez-
Rovira et al., 2005; Raghavan et al., 2000). Mice lacking β1 integrins in the epidermis and its 
appendages either die shortly after birth due to epidermal detachments and dehydration, when 
Cre-expression is driven by the K14-promotor (Raghavan et al., 2000), or within several 
weeks after birth, when Cre-expression is under the control of the K5-promotor (Brakebusch 
et al., 2000). This discrepancy can be explained by differences in the onset of Cre-transgene 
expression and its expression levels. In the absence of β1 integrins, assembly and organization 
of the IFE-underlying BM is severely impaired, whereas BM integrity around HFs is 
unaffected. BM defects are accompanied by reduced expression levels of the α6β4 integrin 
and a significant reduction/instability of hemidesmosomes leading to pronounced blister 
formation at the dermal-epidermal junction (DEJ). Although keratinocyte proliferation is 
reduced in the absence of β1 integrins, mutant epidermis eventually becomes hyperplastic due 
to a delay in terminal differentiation. However, differentiation per se is not impaired in the 
absence of β1 integrins, and basal keratinocytes lacking β1 integrins do not prematurely 
differentiate. This argues against β1 integrins being required to prevent premature 
differentiation of keratinocytes. HF morphogenesis is also distorted in the absence of β1 
integrins and due to a progressive loss of hair mutant animals develop severe alopecia four to 
six weeks after birth. Defects associated with mutant HFs include reduced proliferation of 
HM keratinocytes, ORS hyperplasticity, stunted and prematurely arrested HF growth, and 
severe morphological HF abnormalities. Furthermore, from P9, macrophages and 
granulocytes infiltrate and accumulate around miss-formed mutant HFs, accompanied by an 
upregulation of pro-inflammatory cytokines. Due to an abnormal deposition of ECM 
components, the dermis of mutant mice becomes fibrotic at later stages. In vitro, β1-deficient 
keratinocytes are compromised in their adhesion to and spreading on various ECM 
components, as well as in their migratory capacity. Although proliferation of mutant 
keratinocytes is reduced in vitro and under physiological conditions in vivo, expansion of 
keratinocytes that escaped Cre-mediated deletion partially compensates for the proliferation 
defects during wound healing in vivo (Piwko-Czuchra et al., 2009), indicating that defects in 
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wound healing are due to impaired keratinocyte adhesion and migration rather than to a 
reduced proliferation rate (Grose et al., 2002). 
 
10.1.5) The function of ILK in the epidermis 
 
Similar to the conditional deletion of β1 integrin in keratinocytes, conditional ablation of ILK 
in the epidermis also results in severe defects in epidermal homeostasis and HF 
morphogenesis. Mice lacking ILK in keratinocytes die around P4, when Cre-expression is 
driven by the K14-promotor (ILK-K14) (Nakrieko et al., 2008). In these mice, keratinocyte 
proliferation is reduced in HFs and also in vitro. In contrast, mice with a K5-Cre-mediated 
deletion of ILK in the epidermis survive to adulthood (ILK-K5) (Lorenz et al., 2007). These 
mice are characterized by ectopic hyper-proliferation of integrin expressing keratinocytes in 
suprabasal layers of the epidermis from P7 and by the accumulation of proliferative 
keratinocytes in the ORS. Additionally, proliferation of ILK-K5 keratinocytes is increased in 
vitro. Irrespective of whether deletion is mediated by K5-Cre or by K14-Cre, keratinocyte-
restricted deletion of ILK results in discontinuous distribution of the hemidesmosome integrin 
heterodimer α6β4, keratinocyte detachment from the BM and blister formation at the DEJ, 
disruption of the IFE-underlying BM, delayed terminal differentiation of keratinocytes and 
severe defects in hair follicle morphogenesis. These defects are highly reminiscent of the 
defects in mice lacking β1 integrin specifically in keratinocytes. Similarly, when ILK deletion 
in keratinocytes is mediated by K5-Cre, ORS and IFE become hyperplastic and macrophages 
infiltrate and accumulate around mutant HFs. Additionally, the morphology and polarity of 
ILK-deficient keratinocytes is severely compromised in vivo and in vitro. In vitro, adhesion, 
spreading and migration of ILK-deficient keratinocytes is severely compromised and 
directional migration and velocity is strongly reduced in these cells. Mutant keratinocytes fail 
to form stable lamellipodia and formation of FCs and FAs is reduced in vitro. Furthermore, 
actin cytoskeleton organization is severely distorted in ILK-deficient keratinocytes. While no 
change in Rac1 activity is detectable in ILK-K5 keratinocytes, activation of Rac1 is reduced 
and active Cdc42 distribution is altered in ILK-K14 keratinocytes (Lorenz et al., 2007; 
Nakrieko et al., 2008). 
The striking similarities between the phenotypes of mice lacking β1 integrins or ILK in the 
epidermis demonstrate an essential function of ILK downstream of β1 integrins in epithelial 
cells. K5-mediated deletion of PINCH-1 in keratinocytes also results in a similar phenotype 
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(Lorenz-Baath, unpublished data). However, defects in cell-cell contacts might be more 
pronounced in the PINCH-1-deficient epidermis, although similar defects have been reported 
in the epidermis of ILK-K14 mice (Nakrieko et al., 2008). Differences between ILK- and 
PINCH-1-deficient keratinocytes suggest an IPP complex-independent function for PINCH-1. 
However, it is currently not clear whether IPP constituents can function in an IPP complex-
independent manner in mammals. Alternatively, upon deletion of one IPP component, 
residual amounts of the remaining constituents could exert a dominant negative effect, which 
might result in additional cellular defects. Further studies are required to discern IPP-
dependent and independent functions of its constituents and to identify and characterize 
potential PINCH and Parvin isoform-specific functions. 
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Aim of the thesis 
 
The β1 integrins and members of the IPP complex are essential for mammalian development. 
Genetic ablation of either the β1 integrin subunit, or PINCH-1, or ILK results in embryonic 
lethality during the peri-implantation stage. The mammalian Parvin isoforms are essential 
components of the IPP complex. They connect the IPP complex to the actin cytoskeleton and 
are crucially involved in the regulation of actin cytoskeleton dynamics, cell adhesion, 
spreading, migration and survival. While β- and γ-Parvin are dispensable for mammalian 
development, the in vivo function of α-Parvin has not been analyzed. 
 
Aim 1 
 
 
Analysis of the in vivo consequences of the constitutive deletion of α-Parvin-gene in mice 
and characterization of the resulting alterations in vitro. 
 
 
Constitutive deletion of α-Parvin results in embryonic lethality between E11.5 and E14.5, 
preventing the functional analysis of α-Parvin in adult animals. Furthermore, global gene-
deletion complicates the discrimination between primary and secondary defects. The Cre-lox 
system enables gene disruption in a tissue specific and/or inducible manner and is a versatile 
tool to analyze the in vivo function of α-Parvin in various organs and cell types during 
development and in adult animals. 
 
Aim 2 
 
 
Generation of floxed α-Parvin mice by means of homologous recombination to enable the 
conditional deletion of α-Parvin-gene in specific cell types and organs. 
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Integrins are essential for skin homeostasis. They are involved in the deposition and 
organization of BM components, control keratinocyte adhesion, spreading and migration and 
influence proliferation, survival and differentiation of keratinocytes. How exactly integrins 
facilitate the spatiotemporal control of all this processes is unclear. Certainly it depends on 
the recruitment and assembly of signaling and adaptor molecules to the cytoplasmic tails of 
integrins. Among the numerous molecules recruited to the integrin cytoplasmic tails, the IPP 
complex has emerged to be a key component of integrin signaling. However, the underlying 
molecular mechanisms still remain largely elusive, necessitating the detailed functional 
analysis of its components in vivo and in vitro. 
 
Aim 3 
 
 
Analysis of the in vivo consequences of the K5-Cre mediated conditional deletion of α-Parvin 
in keratinocytes to identify the functional relevance of  α-Parvin in epidermal morphogenesis 
and homeostasis. 
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Short summaries of publications 
Publication 1: α-Parvin controls vascular mural cell 
recruitment to vessel wall by regulating RhoA/ROCK 
signalling 
 
Together with ILK and PINCH, α-Parvin forms a ternary complex (IPP complex) whose 
assembly precedes its recruitment to FAs. The IPP complex is essential for the integration of 
integrin signaling with actin cytoskeleton organization and dynamics. To analyze the function 
of α-Parvin in vivo, we used homologous recombination to constitutively delete the α-Parvin 
gene in mice. 
The constitutive deletion of α-Parvin-gene in mice resulted in embryonic lethality between 
E11.5 and E14.5 due to severe cardiovascular defects. Heart defects in α-Parvin-deficient 
embryos likely contributed to the early lethality and included a persistent single outflow tract 
due to defective septation of the truncus arteriosus, pericardial effusion, reduction of 
cardiomyofibrils and abnormal organization and shape of cardiomyocytes. 
The vasculature of α-Parvin-deficient embryos and yolk-sacs was poorly remodeled due to 
compromised recruitment of mural cells to blood vessels. Micro-aneurysms and insufficient 
investment of the vessel wall by mural cells resulted in the dilation and rupture of blood 
vessels, leading to edemas and severe bleedings in α-Parvin-deficient embryos. Defective 
mural cell recruitment and vessel coverage was due elevated RhoA/ROCK/MLC2 signaling 
resulting in the hypercontractility of α-Parvin-deficient vSMCs, which failed to polarize their 
cytoskeleton to form stable membrane protrusions and were severely impaired in their 
directional migration. 
Our studies demonstrate that α-Parvin is essential for vascular development in vivo by 
negatively regulating RhoA/ROCK/MLC2-mediated contractility in vSMCs. This function is 
specific for α-Parvin, since β-Parvin, although expressed in these cells, cannot compensate 
for the loss of α-Parvin. 
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Publication 2: α-Parvin controls epidermal homeostasis 
and hair follicle morphogenesis by regulating adhesion 
and migration of keratinocytes 
 
Epidermal homeostasis and HF morphogenesis critically depend on β1 integrins and the FA-
proteins ILK and PINCH-1, which together with α-Parvin form the IPP complex facilitating 
integrin signaling and linkage to the actin cytoskeleton. To analyze the in vivo function of  α-
Parvin in epidermal morphogenesis and homeostasis, we generated mice carrying a floxed α-
Parvin-gene, allowing the conditional deletion of α-Parvin in keratinocytes. 
In this manuscript we report that K5-Cre-mediated deletion of α-Parvin in keratinocytes 
severely impairs FA-formation, adhesion, spreading and migration of keratinocytes in vitro, 
resulting in local disruptions at the DEJ and severely compromised HF morphogenesis and 
cycling in vivo. Defects in integrin-dependent adhesion were accompanied by severe 
distortions in BM-integrity, compromised hemidesmosome formation, and displacement of 
proliferative basal keratinocytes into suprabasal layers of the epidermis. Ectopic 
hyperproliferation in suprabasal layers, suprabasal expression of integrins and delayed 
differentiation were observed in the mutant epidermis and likely contributed to the 
development of a severe epidermal hyperplasia, which clearly preceded the recruitment of 
inflammatory granulocytes and macrophages. In vitro, velocity and directionality of 
migration were severely impaired in α-Parvin-deficient keratinocytes due to defects in FA-
formation and compromised actin cytoskeleton organization, resulting in inefficient migration 
of keratinocytes toward the dermal papilla in vivo and the accumulation of proliferative 
keratinocytes in the ORS during HF morphogenesis. HF-growth during anagen was 
completely inhibited, resulting in progressive hair loss and persistent alopecia. 
We conclude that α-Parvin is crucially required for IPP-dependent integrin signaling and 
control of actin cytoskeletal dynamics in keratinocytes and thus is essential for epidermal 
homeostasis and hair follicle development in vivo. 
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a-parvin controls vascular mural cell recruitment
to vessel wall by regulating RhoA/ROCK signalling
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Department of Molecular Medicine, Max Planck Institute
of Biochemistry, Martinsried, Germany
During blood vessel development, vascular smooth muscle
cells (vSMCs) and pericytes (PCs) are recruited to nascent
vessels to stabilize them and to guide further vessel
remodelling. Here, we show that loss of the focal adhesion
(FA) protein a-parvin (a-pv) in mice leads to embryonic
lethality due to severe cardiovascular defects. The vascular
abnormalities are characterized by poor vessel remodel-
ling, impaired coverage of endothelial tubes with vSMC/
PCs and defective association of the recruited vSMC/PCs
with endothelial cells (ECs). a-pv-deficient vSMCs are
round and hypercontractile leading either to their accu-
mulation in the tissue or to local vessel constrictions.
Because of the high contractility, a-pv-deficient vSMCs
fail to polarize their cytoskeleton resulting in loss of
persistent and directed migration. Mechanistically, the
absence of a-pv leads to increased RhoA and Rho-kinase
(ROCK)-mediated signalling, activation of myosin II and
actomyosin hypercontraction in vSMCs. Our findings
show that a-pv represents an essential adhesion check-
point that controls RhoA/ROCK-mediated contractility
in vSMCs.
The EMBO Journal advance online publication, 1 October 2009;
doi:10.1038/emboj.2009.295
Subject Categories: cell & tissue architecture; development
Keywords: angiogenesis; contractility; integrin; migration/
parvin
Introduction
The cardiovascular system is the first functional organ that
develops in vertebrate embryos. Vascular development starts
with the differentiation and expansion of endothelial cell (EC)
precursors that coalesce into a primitive vascular network.
This vascular plexus is then extended and remodelled by a
process called angiogenesis, which involves sprouting,
branching and fusion (Risau, 1997). Once the ECs are
assembled into vascular tubes, they become surrounded by
mural cells (MCs) of the smooth muscle cell lineage, referred
to as pericytes (PCs) and vascular smooth muscle cells
(vSMCs). PCs are associated with capillaries, small venules
and immature blood vessels in which they are enclosed by a
single basement membrane (BM). In contrast, vSMCs are
associated with mature and large blood vessels in which
they form one or several sheets around the BM of ECs. The
vSMC/PCs are essential for blood vessel development, as
they provide mechanical support required to counterbalance
the increasing blood pressure, control ECs proliferation, limit
further sprouting and regulate the vascular tone with their
highly contractile actomyosin cytoskeleton (Adams and
Alitalo, 2007).
The vSMC/PCs differentiate from the mesenchyme and
migrate around the growing blood vessels. The migration to
and spreading on developing blood vessels are tightly regu-
lated by growth factors and extracellular matrix (ECM)
proteins, and their receptors such as integrins. Integrins are
heterodimeric cell adhesion molecules composed of a and b
subunits. When bound to the ECM they cluster and form focal
adhesions (FAs), through which they relay signals into cells
(Hynes, 2002; Legate et al, 2009). In vitro and in vivo studies
have shown that integrin adhesion has essential functions in
angiogenesis and vascular remodelling. For instance,
deletion of the b1 integrin gene in ECs impairs angiogenesis
(Carlson et al, 2008; Tanjore et al, 2008) and deletion in MCs
impairs their ability to spread, differentiate and support
vessel wall stability (Abraham et al, 2008). Conversely,
ablation of genes encoding for integrin ligands such as
fibronectin (FN), laminin a4 or collagen 4a1/2 has also a
fatal effect on blood vessel formation (George et al, 1993;
Thyboll et al, 2002; Pöschl et al, 2004). How integrins execute
these properties is less clear.
The cytoplasmic domains of integrins are short and lack
enzymatic activity, and therefore they trigger signalling by
recruiting kinases such as FAK and src, and adaptor proteins
such as integrin-linked kinase (ILK), PINCH and parvins.
Parvins are a family of adaptor proteins consisting of three
members; a-parvin/actopaxin/CH-ILKBP (a-pv), which is
ubiquitously expressed; b-parvin/affixin (b-pv), which is
enriched in heart and skeletal muscle; and g-parvin (g-pv)
whose expression is restricted to haematopoietic cells
(Nikolopoulos and Turner, 2000; Olski et al, 2001; Tu et al,
2001; Yamaji et al, 2001; Chu et al, 2006). Together with
ILK and PINCH they form a ternary protein complex (IPP
complex) that localizes to FAs. Parvins consist of an
N-terminal polypeptide stretch followed by a single actin-
binding domain (ABD) that consists of two in tandem
arranged calponin homology (CH) domains. The ABD
domain enables parvins to recruit F-actin to FAs and associate
with stress fibres. Additional parvin-binding partners are
actin binding and regulatory proteins including paxillin,
Hic5, a-actinin, CdGAP and a-PIX, which explains the pro-
minent functions of parvins in integrin-mediated adhesion
and actin-dependent processes such as cell shape regulation
and cell migration (Legate et al, 2006).
Vascular tone, which is regulated by the actomyosin-
mediated contractility of the vSMCs, controls the bloodReceived: 10 July 2009; accepted: 15 September 2009
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pressure and tissue perfusion. The contraction and relaxation
of smooth muscle actin (SMA) filaments in vSMCs are
controlled through phosphorylation of the myosin light
chain (MLC). The phosphorylation of MLC is mediated by
myosin light chain kinase (MLCK) and reversed by myosin
light chain phosphatase (MLCP). Vasodilators activate MLCP,
which causes MLC dephosphorylation and relaxation,
whereas vasoconstrictors induce phosphorylation and inhibi-
tion of MLCP activity, which in turn stabilizes MLC phos-
phorylation and leads to contraction (Karnam, 2006).
Vasoconstrictor agonists promote contractility of vSMCs
through RhoA-mediated activation of ROCK, which in turn
can either indirectly activate MLC through phosphorylation
and inactivation of MLCP, or by directly phosphorylating
MLC (Amano et al, 1996; Kimura et al, 1996). The parvin-
binding partner ILK has also been shown to directly phos-
phorylate MLC and thereby modulate vSMC contraction
(Wilson et al, 2005). A basal RhoA activity is required for
cardiovascular homeostasis, whereas a sustained hyperacti-
vation of RhoA is a common feature of several cardiovascular
pathologies. Furthermore, RhoA signalling is also critical for
cell polarity and directed cell migration (Danen et al, 2005) by
promoting the maturation of integrin adhesion sites, forma-
tion of stress fibres and cell contraction at the rear (Xu et al,
2003). Therefore, a tight regulation of RhoA in vSMCs
is crucial for the mature vascular system but may be equally
important during the recruitment of vSMCs to developing
vessels.
To directly address the function of a-pv in vivo, we
generated mice and cells lacking a-pv expression. Our find-
ings indicate that a-pv controls vSMC/PC recruitment to
developing vessels and vessel wall stability by regulating
RhoA/ROCK signalling in vSMCs.
Results
Loss of a-pv leads to severe cardiovascular defects
To explore the functions of a-pv in vivo, we disrupted the a-pv
gene by homologous recombination in embryonic stem
(ES) cells and generated a-pv mutant mice (Supplementary
Figure 1A and B). Mice heterozygous for the a-pv null mutation
(a-pvþ /) were viable and phenotypically normal (data not
shown). a-pvþ / intercrosses failed to yield newborn
a-pv homozygous mutant (a-pv/) mice. Timed mating of
a-pvþ / intercrosses showed that a-pv/mice were present at
the expected Mendelian ratio up to embryonic day (E) 11.5
(Supplementary Table 1). Lethality of a-pv/mice commenced
at around E10.5 and no alive a-pv/ mice were found later
than E14.5 (Supplementary Table 1). Western blot analysis of
E9.5 a-pv/ embryo and yolk sac (YS) lysates showed loss of
a-pv expression, unaltered or increased levels of b-pv and
slightly decreased levels of ILK and PINCH1 when compared
with wild-type (wt) lysates (Supplementary Figure 1C and D).
Development of a-pv/ embryos was normal until E9.5
(data not shown). Growth retardation was first evident in
E10.5 a-pv/ embryos (Figure 1A). a-pv/ embryos dis-
played different degrees of cardiovascular abnormalities in-
cluding aberrant vascular beds with dilated blood vessels and
pericardial effusion (Figure 1A and B; Supplementary Figure
2A). By E12.5, a-pv/ embryos showed whole-body edema
and severe bleedings due to vessel rupture (Figure 1A and B;
Supplementary Figure 2B).
Aberrant cardiac morphogenesis and disrupted
sarcomeric integrity in a-pv/ embryos
To examine the heart abnormalities, we performed histologi-
cal analysis of serial sections of wt and a-pv/ embryonic
hearts. Heart chambers developed normally in a-pv/
embryos (data not shown). However, although E12.5 wt
embryos showed septation of the truncus arteriosus resulting
in an ascending aorta and pulmonary trunk (Figure 1C),
a-pv/ embryos showed a defective septation of the truncus
arteriosus leading to a persistent single outflow tract (OFT)
(Figure 1C).
Cell-ECM adhesion mediated by integrins is required to
stabilize myofibrils (Fässler et al, 1996). Immunostaining of
a-actinin and desmin, important Z-disc proteins that cross-
link sarcomeric actin and connect Z-discs with adjacent
myofibrils, showed reduced numbers of cardiomyofribrils in
a-pv/ embryos compared with wt littermates (Figure 1D
and data not shown). Moreover, wt cardiomyocytes were
elongated and aligned in a parallel manner, while a-pv/
cardiomyocytes were round and distributed in a random
pattern (Figure 1D). In line with earlier reports (Chen et al,
2005), we found that a-pv is localized at FAs as well as at
Z-disc of the sarcomeres in normal cardiomyocytes (data not
shown). Together, these data indicate that a-pv is required for
the development of the OFT of the heart and for maintaining
the structure and stability of sarcomeres, but not for initiating
cardiomyofibrillogenesis. Because of the well-known func-
tions of integrins, ILK and parvins for cardiac muscle mor-
phogenesis and function (Fässler et al, 1996; Chen et al, 2005;
Bendig et al, 2006), we focused our further analysis on the
vascular defects.
Defective MC coverage in a-pv/ embryos
To study the vascular abnormalities of a-pv/ embryos in
more detail, we performed whole mount immunostaining of
wt and a-pv/ embryos and YSs using antibodies against
CD31, aSMA and anti-neuron glial 2 (NG2) to visualize ECs
and MCs, respectively. Immunostaining for CD31 revealed the
presence of a vascular plexus with microvessel and macro-
vessel containing blood cells in E10.5 and E11.5 a-pv/
embryos and YSs (Figure 2A; Supplementary Figure 2C). In
addition, isolated primary ECs from a-pv/ YSs did not
show differences in their ability to adhere and spread on
collagen I (Col I) and FN (Supplementary Figure 2D and E
and data not shown). Furthermore, ECs differentiated from
a-pv/ ES cells were able to migrate and form blood vessel-
like structures comparable to wt ECs (Supplementary Figure
2F), suggesting that the vascular defects do not arise from
defects in ECs.
However, a-pv/ vessels were frequently enlarged and
exhibited multiple microaneurysms, whereas in other areas
they were constricted (Figure 2A–C; Supplementary Figure
3A). Vessel enlargement was associated with reduced MC
coverage (Figure 2A; Supplementary Figure 3B). MCs directly
interact with ECs and regulate vessel sprouting. Consistently
with this function, the number of vascular sprouts was
significantly increased in the vascular plexus of a-pv/
embryos (Supplementary Figure 3C and D).
To assess the defect in MC coverage, we analysed the
hindbrain vasculature, which is particularly rich in these
cells (Abramsson et al, 2007). Quantitative analysis of EC
coverage by PCs revealed that in wt embryos, the PCs were
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tightly associated with ECs and the relative proportion of
endothelial staining (CD31) overlapping with PC staining
(NG2) per total vessel area was 58% (±9.6) (Figure 2D
and E). In contrast, the PCs of a-pv/ embryos frequently
stretched away from the endothelium, and covered only 23%
(±2.4) of the endothelial area (Figure 2D and E).
Furthermore, analysis of the distance from the growing
endothelial edge to the closest PCs revealed that in E10.5
wt embryos, the PCs arrived to the growing front of the
vascular plexus marked by the tip cells, whereas in a-pv/
littermates PCs failed to reach the growing vascular front
(Figure 2F). No differences could be detected in E11.5 em-
bryos, indicating that lack of a-pv is a result of a delay in PC
recruitment in vivo (Figure 2F). Poor MC coverage and
impaired MC/EC association were also observed in blood
vessels of a-pv/ YSs and placentas (Supplementary Figure
4A and B). Collectively, these results indicate that a-pv is
dispensable for vasculogenesis, but required for vascular
maturation and MC investment into vessel walls.
a-pv regulates spreading and polarity of MCs
Successful MC coverage of the vascular bed depends on a
number of factors including proliferation, survival, spreading
and migration (Beck and D’Amore, 1997). We found no
apparent defects in MC proliferation or increased apoptosis
of E9.5, E10.5, E11.5 and E12.5 a-pv/ embryos
(Supplementary Figure 5 and data not shown). However, in
contrast to wt vSMCs/PCs, which spread and showed strong
and often punctate aSMA staining at the plasma membrane
and thin filamentous staining in the cytoplasm (Figure 3A
and B), a-pv/ vSMC/PCs displayed a round shape and
showed thick aSMA-positive actin bundles traversing the
cytoplasm in a criss-cross manner (Figure 3A and B;
Supplementary Figure 6).
To analyse this defect in more detail, we isolated SMA-
positive cells from wt and a-pv/ YSs and tested their ability
to adhere and spread on ECM proteins. No difference in the
ability of wt and a-pv/ cells to adhere to laminin-111
(LN111), FN or Col I was observed (Figure 3C). In addition,
the cell surface expression pattern of integrins was also
unaltered (data not shown). However, despite their ability
to adhere to ECM substrates, a-pv/ cells remained round
even after an overnight culture and developed multiple
membrane protrusions, whereas wt cells spread within
60 min after plating (Figure 3D and E). Live video microscopy
showed that wt cells were able to extend lamellipodia and
spread to adopt a flattened shape. In contrast, a-pv/ cells
displayed continuous, highly dynamic and instable mem-
brane ruffling at the cell cortex, leading to the formation of
multiple retraction fibres (Supplementary Movies 1 and 2). To
further analyse the morphology of the cells, we performed
computational analysis of the cell shape (shape factor;
Figure 1 Embryonic lethality and cardiovascular defects in the absence of a-pv expression. (A) Gross examination of wt and a-pv/ embryos.
(B) a-pv/ embryos display bleedings (arrowhead), whole-body edema (asterisks) and enlarged vessels (arrows). (C) Hematoxylin and eosin
staining of frontal sections through the heart outflow tract (OFT) of E12.5 wt and a-pv/ embryos. Bar: 50 mm. (D) Confocal sections of E12.5-
13.5 hearts from wt and a-pv/ embryos. Cardiomyocytes were labelled with a-actinin. Bar: 10 mm. A, atrium; V, ventricle; Av, aortic valve; Pv,
pulmonary valve; RVOT, right ventricular OFT; LVOT, left ventricular OFT.
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described in detail in Materials and methods), of individual
cells plated for 3 h on FN. We found that 490% of the wt
cells reached a shape factor value between 0.25 and 0.75,
indicating that they contain a single broad lamella
(Figure 3F). In contrast, more than half of the a-pv/ cells
adopted a value below 0.25, which corresponds to an un-
polarized cell with either an elongated or a highly complex
outline of the plasma membrane (Figure 3F). Importantly, the
spreading and shape defects were rescued by re-expressing
a-pv-GFP in a-pv/ SMA-positive cells (Figure 3G–I).
Sustained cell contraction leads to retraction, followed
by cell rounding and formation of retraction fibres, which
are, unlike stress fibres, not associated with myosin (M)
(Cramer and Mitchison, 1995). To examine whether cell
spreading, shape and polarity defects of the a-pv/ cells
were a consequence of abnormal cell contraction, we per-
formed double immunostaining of wt and a-pv/ cells using
anti-aSMA and anti-M-II antibodies and found that the actin
protrusions of a-pv/ cells lacked M-II (Figure 4A). The
majority of the M-II signal was observed in the thick cortical
actin bundles of the a-pv/ cells, whereas stress fibres
were positive in wt cells (Figure 4A). These data further
indicate that the actin protrusions of a-pv/ cells are
retraction fibres.
a-pv controls RhoA/ROCK-mediated cell contraction
The morphological analysis suggested that the a-pv/ SMA-
positive cells were highly contractile. Sustained contraction
Figure 2 Reduced MC coverage and defective MC/EC association in the absence of a-pv/. (A) Whole mount immunostaining of the head
vasculature. ECs were labelled with CD31 (green) and vSMC with aSMA (red). Bar: 0.2 mm. (B) Quantification of the diameter of the
macrovessels (I) and microvessel (II, III, IV) from the head vasculature. Values are mean±s.e.m.; *P¼ 0.012 (I); *P¼ 0.039 (II); P¼ 0.091 (III);
*P¼ 0.01 (IV). (C) CD31 and aSMA whole mount immunostaining of the right subclavian artery. Note the defective vSMC coverage and the
presence of local constriction (red arrows) of a-pv/ vasculature. Bar: 50 mm. (D–F) Whole mount immunostaining of E10.5-115 hindbrain
endothelium CD31 (red) and associated PCs (green) from wt and a-pv/ embryos. Bar: 50mm (D) and 20mm (E, F). (D) Reduced MC coverage
in the peripheral region of the hindbrain of a-pv/ embryos. (E) Defective MC/EC association in a-pv/ vasculature (arrow). (F) Delayed PC
recruitment in a-pv/ embryos. The distance of the endothelial edge (line) to the closest PC (arrows) is labelled.
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of vSMCs can be mediated by the RhoA/ROCK/MLC2
signalling pathway (Karnam, 2006). To determine RhoA
activity in primary vSMCs, we measured Rho-GTP binding
to the Rhotekin-Rho binding domain and found a significant
increase in RhoA-GTP levels in primary a-pv/ cells
(Figure 4B). Consistent with the increased RhoA activity,
a-pv/ cells showed higher levels of phospho-MLC2 than wt
cells (Figure 4C). Increased levels of RhoA-GTP and elevated
levels of phospho-MLC2 were also observed in immortalized
SMA-positive cells derived from E9.5 a-pv/ embryos
(Figure 4D and E; Supplementary Figure 7A and B).
Re-expression of a-pv in the immortalized cells induced
normal cell spreading, accompanied by loss of retraction
fibres and reduced RhoA-GTP and phospho-MLC2 levels
(Figure 4D and E; Supplementary Figure 7A–D).
Importantly, immunostaining of tissue sections of YSs
also revealed elevated MLC2 phosphorylation in vSMC/PCs
in the vascular plexus of E13.5 a-pv/ embryos (Figure 4F),
indicating that activation of the RhoA/ROCK/MLC2 signalling
pathway is also elevated in vivo.
To test whether increased RhoA and MLC2 activity leads to
increased contractile properties of vSMCs, we seeded wt or
a-pv/ cells in 3D collagen gels and observed gel contrac-
tion over a time period of 48 h. Indeed, a-pv/ cells showed
a two-fold increase in gel contraction compared with wt cells
(Figure 5A and B).
Consistent with increased RhoA/ROCK signalling, addition
of Y-27632, an inhibitor of ROCK, to collagen gels normalized
the collagen gel contraction (Figure 5B). Interestingly, treat-
ment of a-pv/ cells with ML-9, an inhibitor of MLCK, did
not change the contractile properties of a-pv/ cells (data
not shown). Finally, when cells were cultured in the presence
of Y-27632, wt and a-pv/ cells displayed similar morpho-
logy (Figure 5C and D). Collectively, these results indicate
that a-pv controls vSMC contraction through negatively
regulating the RhoA/ROCK/MLC2 signalling pathway.
Figure 3 Impaired cell spreading and cell shape of MCs in the absence of a-pv/. (A) Whole mount immunostaining of vasculature of E13.5
YSs. ECs were labelled with CD31 and MCs with NG2. Bar: 20 mm. (B) Whole mount immunostaining of vasculature of E13.5 YSs. MCs were
labelled with aSMA. Bar: 10 mm. (C) Adhesion assay of isolated wt and a-pv/ SMA-positive cells on different ECM substrates. Values are
mean±s.e.m. (D) Brightfield images and immunofluorescence staining for aSMA (red) and a-pv (green) of wt and a-pv / SMA-positive cells
seeded of FN (10mg/ml). Bar: 50 and 10 mm, respectively. (E) Quantification of cell area and (F) shape factor of wt and a-pv/ SMA-positive
cells. Values are mean±s.e.m; ***P¼ 0.0001 (G–I) Re-expression of a-pv-GFP restores size and shape of a-pv/ SMA-positive cells. Green
represents the EGFP signal and the cytoskeleton is visualized with aSMA (red). Bar: 20mm. Values are mean±s.e.m; ***P¼ 0.0001.
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a-pv controls MC recruitment and directed cell
migration
MC recruitment to angiogenic vessels depends on platelet-
derived growth factor BB (PDGF-BB)-mediated directed
migration (Hellström et al, 1999; Abramsson et al, 2007). As we
observed defects in this process, we next determined whether
a-pv/ SMA-positive cells were able to respond to PDGF-BB.
To this end, we stimulated serum-starved primary wt and
a-pv/ cells with 100 ng/ml PDGF-BB and measured the
phosphorylation levels of downstream signalling molecules.
PDGF-BB treatment triggered a comparable increase in Erk
and Akt phosphorylation in wt and a-pv/ cells, indicating
that loss of a-pv did not impair PDGFR signalling per se
(Figure 6A and data not shown). To test whether a-pv/
cells were still capable of migrating towards a source of
PDGF-BB, we performed both chemokinesis and chemotaxis
assays using Transwell motility chambers and found that
a-pv/ cells exhibited accelerated rates of random chemo-
kinetic migration, but migrated less efficiently towards a
PDGF-BB gradient compared with wt cells (Figure 6B and
C). Similar results were observed in cells migrating to a
source of serum (data not shown). These data indicate that
a-pv is required for persistent directed migration.
Cell polarity is essential for directed migration. Live video
microscopy over a period of 12 h showed that wt cells
extended stable lamellipodia in the direction of the move-
ment, while a-pv/ cells continuously formed lamellipodia-
like protrusions that were highly instable and appeared
randomly at different parts of the cells, causing continuous
changes in the direction of cell movement (Supplementary
Movies 3 and 4). Similar migration behaviour was observed
in the immortalized cells, whereas re-expression of a-pv
restored normal cell motility (Supplementary Movies 5, 6
and 7). Tracking of individual cells combined with statistical
analysis confirmed that a-pv/ cells moved significantly less
persistently than wt cells (Figure 6D). In the presence of
Y-27632, a-pv/ cells formed stable lamellipodia, and the
persistence of cell motility was restored to the level of wt cells
(Figure 6D; Supplementary Movies 8 and 9).
Rac activity is essential for the establishment of lamellipo-
dia and directed cell migration. It has been shown that a-pv
can regulate Rac activity in HeLa and osteosarcoma cells by
controlling the activity of the Rac/Cdc42 GAP CdGAP
(LaLonde et al, 2006). To assess whether dysregulation of
Rac activity is also involved in the altered lamellipodial
dynamics of a-pv/ SMA-positive cells, we determined Rac
activity in immortalized cells during the first 90 min of
spreading on FN. Adhesion to FN induced a transient increase
in Rac-GTP levels that peaked after 10 min of spreading and
was comparable in wt and a-pv/ cells (Supplementary
Figure 4 Elevated RhoA activity in the absence of a-pv. (A) Immunofluorescence staining for aSMA (red) and M-II (green) of wt and a-pv/
SMA-positive cells. Note that actin protrusions of a-pv/ cells lack M-II staining. Bar: 25 mm. Freshly isolated a-pv/ SMA-positive cells show
increased RhoA activity. Values are mean þ / s.e.m.; **P¼ 0.0012 (B) and increased phosphorylation of MLC2 (C). Total MLC2 served as
loading control. Immortalized a-pv/ SMA-positive cells show increased RhoA activity (D) and increased phosphorylation of MLC2 (E). (F)
Immunofluorescence analysis of E13.5 YS sections with aSMA (red) and phospho-MLC2 (green) shows increased phosphorylation of MLC2
in vivo. Bar: 20 mm.
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Figure 7E and F). Although in wt cells Rac-GTP levels re-
mained stable for 30 min and gradually decreased to basal
levels after 90 min of spreading, a-pv/ cells showed a rapid
decrease in Rac-GTP levels to baseline levels already after
10 min (Supplementary Figure 7E and F). The early decrease of
Rac-GTP levels in a-pv/ cells correlated with a strong
increase in RhoA activity at this time point (Supplementary
Figure 7G and H). Moreover, Y-27632-mediated inhibition
of ROCK normalized Rac activity in a-pv/ cells
(Supplementary Figure 7I). These results indicate that Rac
activation occurs normally in a-pv/ cells, but its sustained
activation is suppressed through elevated RhoA/ROCK activity.
a-pv-mediated regulation of RhoA is specific to MCs
and is not compensated by b-pv
The interaction of parvins with ILK is necessary to target both
proteins to FAs and to prevent degradation of the IPP complex
(Legate et al, 2006). As the IPP complex is an important
regulator of cell shape and cell migration, we tested whether
loss of a-pv affects the stability and subcellular localization of
the other members of the complex. WB analysis revealed
normal levels of ILK and PINCH1 in a-pv/ SMA-positive
cells, whereas the levels of b-pv were increased when com-
pared with wt cells (Figure 7A). Immunostaining showed
normal ILK localization in FAs (Figure 7B). In addition,
immunoprecipitation experiments from wt and a-pv/
cells showed that ILK co-precipitated with b-pv both in the
presence and absence of a-pv (Figure 7C). Furthermore, in wt
cells both a- and b-pv associated with ILK, but not with each
other (Figure 7C).
To assess whether the function of a-pv in regulating cell
contractility is specific for vSMCs, we isolated and investi-
gated wt and a-pv/ fibroblasts (Supplementary Figure 8A).
Like ECs, fibroblast lacking a-pv did not show apparent
defects in spreading and actin cytoskeleton organization. In
addition, there was no apparent difference in the levels of
MLC2 phosphorylation in these cells (Supplementary Figure
8B and data not shown).
It has been suggested that ILK modulates vSMC contrac-
tility by directly phosphorylating MLC (Wilson et al, 2005).
To test whether loss of a-pv could lead to hyperphosphoryla-
tion of MLC through ILK, we depleted ILK in wt cells
using siRNA and found increased levels of MLC2 phosphor-
ylation and reduced levels of a-pv (Figure 7D). To further
confirm that the elevated RhoA/ROCK signalling was
due to the loss of a-pv and not due to an upregulation of
b-pv, we depleted b-pv in wt and a-pv/ cells. Depletion
of b-pv had no effect on MLC2 phosphorylation (Figure 7E),
whereas depletion of a-pv in wt cells increased
the levels of MLC2 phosphorylation (Figure 7F). Together,
these data suggest that (i) b-pv can stabilize ILK and PINCH1
protein levels and localize them into FAs in the absence of
a-pv, (ii) a- and b-pv exist in separate complexes containing
ILK, (iii) the spreading and shape defects are exclusively
due to the absence of a-pv and (iv) the ILK/a-pv
complex is a negative regulator of MLC2 phosphorylation in
these cells.
Figure 5 Increased collagen matrix contraction in the absence of a-pv. (A) Three-dimensional collagen gel containing wt and a-pv/ SMA-
positive cells. (B) Quantification of collagen gel area. a-pv/ SMA-positive cells display higher collagen matrix contraction capacity than wt
cells. Note that in the presence of ROCK inhibitor Y-27632 (1.5mM) wt and a-pv/ cells show similar contraction capacity. (C) Wt and a-pv/
SMA-positive cells seeded on FN for 15 min in the absence and presence of Y-27632 (1.5mM) and stained with aSMA (red) and phospho-MLC2
(green). Bar: 25 mm. (D) Quantification of shape factor of wt and a-pv/ SMA-positive cells in the absence and presence of Y-27632. Values are
mean±s.e.m.
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Discussion
The results of our study show that a-pv is a central regulator
of vascular maturation and blood vessel stability. Disruption
of the a-pv gene in mice results in embryonic lethality due to
severe cardiovascular defects. In the absence of a-pv, vascu-
lar beds are aberrantly organized and abnormally covered by
MCs. a-pv/ vSMCs display defects in cell spreading, polar-
ity and directed migration. These cellular defects are caused
by increased RhoA/ROCK activity that leads to elevated
MLC2 phosphorylation and aberrant cell contractility.
The pump function of the heart has a critical role in
embryonic development, growth and survival by transporting
oxygen and nutrients through the vascular network and by
promoting organogenesis such as vascular remodelling and
formation of haematopoietic stem cells (Lucitti et al, 2007;
Adamo et al, 2009; North et al, 2009). Therefore, severely
impaired heart function caused either by defects during heart
morphogenesis or by abnormal cardiomyocyte organization
and sarcomere assembly can lead to embryonic lethality as
early as E10.5-12.5 (Huang et al, 2003). Integrin-mediated cell
adhesion has an essential function during cardiac develop-
ment (Sengbusch et al, 2002). In this study, we report that
a-pv is required for the remodelling of the OFTand formation
and/or stability of cardiomyofribrils, which likely contributes
to the early embryonic lethality of the a-pv/ mice. These
observations are in line with earlier studies reporting that b1
integrins, ILK and parvins have an essential function in heart
development, cardiomyocyte contraction and integrity in
different model organisms (Fässler et al, 1996; Chen et al,
2005; Bendig et al, 2006).
Deletion of a-pv also leads to severe vascular defects,
including impaired vascular remodelling, vessel dilatation,
formation of microaneurysms and vessel rupture. As cell
type-specific ablation of the ILK gene in mice revealed an
important function for ILK in vascular development and EC
survival (Friedrich et al, 2004), it was important to determine
whether a-pv would act in co-operation with ILK to regulate
the endothelium. Interestingly, we found no increase in
apoptosis of a-pv/ ECs. Furthermore, a-pv/ ECs adhere,
spread and are able to migrate and form vascular networks
comparable to wt ECs. This suggests that the defects in the
vascular endothelium of a-pv/ embryos are likely cell non-
autonomous and arise from cells that regulate vascular
remodelling and stability. In line with this hypothesis, we
observed vascular abnormalities already in E10.5 embryos, a
developmental stage when flow-dependent remodelling de-
fects are still of minor importance. Although this observation
indicates that vascular abnormalities develop independent of
the heart defect, we need to determine the contribution of the
defective heart function on the abnormal vascular remodel-
ling (Lucitti et al, 2007) at later developmental stages by
deleting the a-pv gene exclusively in cardiomyocytes using
the Cre/loxP system. To this end, we have generated a-pv
floxed mice.
Functional blood vessels consist of endothelial tubes
surrounded by tightly associated and organized vSMC/PCs
that provide stability to vessels. Dysfunction of vSMC/PCs is
Figure 6 Normal PDGF-BB signalling but impaired directed cell migration of a-pv/ SMA-positive cells. (A) Wt and a-pv/ SMA-positive
cells stimulated for 15 min with 100 ng/ml PDGF-BB show similar phosphorylation of Erk. Total Erk served as loading control.
(B) Quantification of chemokinetic migration. Note that a-pv/ cells display higher rates of random migration compared with wt cells.
(C) Quantification of chemotactic migration using 20 ng/ml PDGF-BB as chemoattractant (24 h). Control medium without PDGF-BB was used
to assess baseline migration. Note that although all cells migrated towards PDGF-BB, the ratio of stimulated/unstimulated migration is reduced
in a-pv/ cells. (D) Quantification of persistent motility of wt and a-pv/ vSMCs (12 h) seeded on FN. Note that a-pv/ cells move less
persistently than wt cells, whereas in the presence of Y-27632 (0.5mM), wt and cells display similar persistent motility. Values are mean±s.e.m;
***P¼ 0.0001; NS, not significant.
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associated with dilated vessels, formation of microaneurysms
and vessel wall disruption (Hellström et al, 2001; Boucher
et al, 2003). The same defects were also observed in a-pv/
embryos. Consistently, the endothelial tubes of a-pv/
embryos are poorly covered with vSMC/PCs, and the few
recruited cells fail to properly spread around the endothelial
tube. To surround and stabilize the vascular endothelium,
MCs have to proliferate and migrate to vessels. Integrin-
mediated adhesion has an important function in both of
these functions. This was shown by deleting the b1 integrin
gene in MCs, which leads to aberrant proliferation of these
cells and deficient vessel wall stability (Abraham et al, 2008),
and by ablating the a4 integrin subunit, which impairs
migration of vSMCs/PCs to developing blood vessels
(Grazioli et al, 2006). We found no requirement of a-pv for
proliferation or survival of vSMC/PCs indicating that the poor
vSMC/PCs investment is not caused by a deficiency of vSMC/
PCs. This finding also suggests that b1 integrin function is not
completely compromised in the absence of a-pv, a notion
further supported by the findings that a-pv/ cells adhere
normally to various ECM substrates and that ILK is normally
recruited to integrin adhesion sites. Moreover, the restricted
phenotype of the a-pv/ mice to the cardiovascular system
indicates that a-pv is indispensable for only a specific subset
of signals downstream of b1 integrin.
Cell migration is directed by gradients of chemoattractants
and/or repulsive molecules as well as by ECM molecules that
serve as haptotactic tracks. During vascular development,
MCs are attracted by a gradient of PDGF-BB produced by ECs
to migrate directionally towards newly formed vessels
(Hellström et al, 1999; Abramsson et al, 2007). Our results
show that a-pv/ MCs are improperly recruited to the
vascular endothelium and that a-pv/ vSMC-like cells dis-
play accelerated random motility but migrate less efficiently
towards PDGF-BB or towards a serum source. Interestingly,
a-pv/ vSMCs are still capable of responding to PDGF-BB
stimulation by activating mitogenic signalling pathways.
These findings suggest that a-pv does not control recruitment
Figure 7 ILK/a-pv complex is a negative regulator of MC contractility. (A) Western blot analysis of IPP proteins in wt and a-pv/ SMA-
positive cells. Note that a-pv/ cells show similar protein levels of ILK and PINCH1, and increased protein levels of b-pv compared with wt.
(B) Immunofluorescence staining for paxillin (green) and F-actin (red) (a, b) and ILK (green) and aSMA (red) (c, d) of wt and a-pv/ SMA-
positive cells seeded of FN. Bar: 25 mm. (C) Immunoprecipitation experiments from wt and a-pv/ SMA-positive cells. Note that both a- and
b-pv co-immunoprecipitate with ILK but not with each other. (D) ILK depletion by two siRNA duplexes in wt cells induces increased MLC2
phosphorylation accompanied by reduced levels of a-pv. (E) b-pv depletion by two siRNA duplexes in wt and a-pv/ cells does not change the
levels of MLC2 phosphorylation. (F) a-pv depletion by two siRNA duplexes in wt cells induces increased MLC2 phosphorylation.
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of MCs through regulating PDGFR signalling per se, but rather
by regulating the molecular machinery required for efficient
directional motility of MCs.
In response to a pro-migratory stimulus, cells polarize in
the direction of the chemotactic gradient by extending a
lamellipodium at the leading edge. Integrin-mediated
adhesions then form directly behind the lamellipodium to
stabilize the lamella and to exert a force between the ECM
and the cytoskeleton required for the advance of the leading
edge. To move the cell body forward, adhesions are
subsequently disassembled at the cell rear, which is then
pulled in the direction of motility by the contractile machin-
ery of the actomyosin network (Ridley et al, 2003). Integrins
and Rac establish a positive feedback loop within the leading
edge that forms and maintains the lamella, whereas RhoA is
necessary for the generation of contractile forces and tail
retraction (Burridge and Wennerberg, 2004). Our results
show that a-pv/ vSMC fail to spread due to enhanced
RhoA/ROCK activity leading to elevated MLC2 phosphoryla-
tion and increased cell contractility. This finding is consistent
with earlier observations showing that cell spreading requires
a transient downregulation of RhoA activity (Ren et al, 1999).
Suppression of RhoA activity is necessary to promote lamel-
lipodial protrusion during migration (Arthur et al, 2000;
Arthur and Burridge, 2001). This is partly achieved
by negative regulation of RhoA activity by Rac, which is
transiently activated on cell adhesion to induce lamellipodia
formation (Sander et al, 1999; del Pozo et al, 2000).
On the other hand, RhoA activation restricts lamellae forma-
tion by inhibiting Rac activity (Tsuji et al, 2002; Worthylake
and Burridge, 2003). We could also show that a-pv is not
required for Rac activation induced by cell adhesion in vSMC-
like cells. However, Rac activity is rapidly suppressed during
the spreading of a-pv/ SMA-positive cells. This down-
regulation occurs concomitantly with a robust upregulation
of RhoA activity. These observations together with the
finding that defects in cell spreading and in directional
motility can be rescued with ROCK inhibitors and that the
ROCK-inhibited cells are able to establish lamellipodia and
normalize their Rac activity strongly suggests that the aber-
rant RhoA activity is the primary defect in a-pv/ SMA-
positive cells. ROCK-mediated activation of MLC2, which is
located both at the leading edge and at the rear of the cell,
leads to a global contraction of the cells and loss of cell
polarity (Matsumura and Hartsthorne, 2008). Thus, as a
consequence of the elevated RhoA activity and the subse-
quent suppression of Rac activity, a-pv/ vSMC are not able
to properly establish a stable leading edge and a cell
rear, resulting in highly inefficient and non-directional cell
motility.
The mechanisms by which integrin adhesion regulates
RhoA activity are complex, and it seems that distinct integrin
heterodimers use different strategies to regulate this activity,
even in response to the same extracellular ligand (Danen
et al, 2005). The parvin-binding partner ILK has been shown
to negatively regulate RhoA activity (Yamazaki et al, 2009),
but also to positively regulate vSMC contraction through
direct phosphorylation of MLC2 (Wilson et al, 2005). The
interaction of parvins with ILK is necessary to target both
proteins to FAs and to prevent degradation of the IPP complex
(Legate et al, 2006). However, ILK levels and localization to
FAs are apparently not altered in a-pv/ vSMCs. In addition,
b-pv levels are upregulated in these cells, and b-pv, which
also localizes to FAs, binds ILK also in the absence of a-pv.
These results suggest that the b-pv upregulation acts to
stabilize the IPP complex in the absence of a-pv, and is
sufficient to localize this complex to FAs. However, we also
show that a- and b-pv exist in separate complexes, and that
the b-pv/ILK complex is unable to compensate for the loss of
a-pv as a negative regulator of vSMC contractility.
Furthermore, we found that depletion of ILK in wt SMA-
positive cells triggers MLC2 phosphorylation accompanied by
a dramatic reduction in a-pv levels, whereas the depletion of
b-pv has no effect on MLC2 phosphorylation. Moreover, it
has been observed that a vSMC/PCs specific-deletion of ILK
leads to MCs dysfunction also associated with a RhoA-de-
pendent hypercontractility phenotype (Kogata et al, 2009).
This clearly indicates that ILK does not contribute to the
hyperphosphorylation of MLC2 through directly phosphory-
lating MLC2 in a-pv/ cells and that the recruitment of
a-pv and ILK form a mechanosensory complex at FAs of
contractile cell types such as vSMCs. This complex has an
essential function in downregulating RhoA-dependent con-
tractility to allow efficient cell spreading and migration.
Consistent with our observations, a similar mechanism for
ILK has been recently observed in the nervous system
(Pereira et al, 2009). How the ILK/a-pv complex downregu-
lates RhoA is not known. This might occur through a-pv-
dependent recruitment of negative regulator(s) of the RhoA/
ROCK/MLC2 signalling pathway to this complex. As we
observed the RhoA downregulation only in certain
cell types, the negative regulators recruited by the ILK/a-pv
complex are likely to be expressed in a cell type-specific
manner.
Materials and methods
Generation of a-parvin-deficient mice
A 400 bp a-parvin cDNA fragment derived from ESTclone AI006605
was used to screen a 129/Sv mouse P1-derived artificial chromo-
some library. Five positive PAC clones were identified and used to
generate the a-parvin targeting construct. To abolish a-parvin gene
function, an IRES-b-galactosidase cassette and a neomycin resis-
tance gene was inserted into exon 2. Genotyping of wt and
recombinant alleles was performed by Southern blot using an
external probe after PstI digestion of genomic DNA. Wt and mutant
mice were genotyped by PCR using a three-primer system; forward
1 (F1) 50-GGAATGAACGCCATCAACCT-30, F2 50-GATTAGATAAATGC
CTGCTC-30, reverse (R) 50-TTGCGTGAGTTTGGATCGAC-30.
Antibodies
The following antibodies were used: rabbit antibody against
a-parvin (Chu et al, 2006); rabbit antibody against b-parvin (Chu
et al, 2006); rat antibody against CD31 (PharMingen); rabbit
antibody against desmin (Oldberg); Cy3-conjugated mouse anti-
body against aSMA (Sigma); rabbit antibody against anti-NG2
(Chemicon); mouse antibody against GAPDH (Calbiochem); rabbit
antibody against ILK (Cell Signalling Technology); rabbit antibody
against myosin light chain (MLC2) (Santa Cruz); rabbit antibody
against phospho-MLC2 (Cell Signaling); mouse antibody against
paxillin (Transduction Laboratories); Cy3-and FITC-conjugated
antibodies specific for mouse IgG, rabbit IgG and rat IgG (Jackson
Immunochemicals Laboratories Inc.; West Grove, PA, USA) were
used as secondary antibodies. TRITC-conjugated phalloidin was
used to detect F-actin (Molecular Probes; Eugene, OR, USA).
Isolation of SMA-positive cells
Embryos and YSs were harvested and washed in PBS. For each
embryo, the tail was removed and used for genotyping. YSs were
treated with Type I collagenase (2 mg/ml) (Invitrogen) in PBS at
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371C for 45 min. The tissue was then passed through a fine-tip
Pasteur pipette with a 2-mm diameter. Cells were plated on tissue
culture plates coated with 10 mg/ml FN and cultured in DMEM
medium containing 10% fetal bovine serum and antibiotics. After
60 min of culture, the SMA-positive cells had attached to dish, and
the medium containing visceral endoderm cells and ECs was
carefully aspirated. After 2 days in culture, SMA-positive cells were
used for experiments.
The same protocol was used to isolate SMA-positive cells from
E9.5 embryos, which were subsequently immortalized using the
SV40 T-large oncogene. SMA-positive cells were isolated and
characterized by western blot and immunofluorescence analyses.
To avoid changes in the contractile properties of the cells,
experiments were performed with low (8–10) cell passages.
Transient expression of a-pv
a-pv-GFP was generated by cloning the murine a-pv cDNA (gift
from Dr A Noegel, University of Cologne) into the pEGFP-C1 vector
(Clontech). Primary cells were transiently transfected with Lipo-
fectamine 2000 transfection reagent (Invitrogen) according to the
manufacturer’s protocol.
Adhesion assay
Cells (1105 cells/well) were plated onto 96-well plates coated with
FN, LN or collagen I. After 45 min incubation, cells were lysed in a
substrate buffer (7.5 mM NPAG (Sigma), 0.1 M Na citrate pH 5,
0.5% Triton X-100) over night at 371C. The reaction was stopped by
adding 50 mM Glycine pH 10.4, 5 mM EDTA after which OD 405 was
measured.
Immunoprecipitation
Cells were lysed in lysis buffer (in 150 mM NaCl, 50 mM Tris pH 8,
10 mM EDTA, 1% Triton X-100, 0,05% sodium deoxycholate
supplemented with protein inhibitors (Roche) and phosphatase
inhibitors (Sigma)) and 0.5 mg of cell lysate was incubated with
anti-a-parvin rabbit polyclonal or anti-b-parvin rabbit polyclonal
antibodies for 30 min on ice. Immunocomplexes were then bound to
protein G-beads (Sigma) for 1 h, washed in lysis buffer, resuspended
in SDS sample buffer (Invitrogen) and analysed by SDS–PAGE.
RhoA activation assay and affinity precipitation of cellular
GTP-Rho and Rac
Freshly isolated cells from the YSs were seeded on FN (10mg/ml) for
10 min and a quantitative assay for RhoA activity was performed
using G-LISA RhoA Activation Assay Biochem Kit following the
manufacturer’s instructions (Cytoskeleton, Inc., CO).
For affinity precipitation of GTP-Rho and Rac, immortalized cells
were lysed in lysis buffer (50 mM Tris, pH 7.4, 1% Triton X-100,
0.1% SDS, 500 mM NaCl, 10 mM MgCl2, supplemented with
protease inhibitors (Roche)). Cell lysates were clarified by
centrifugation at 900 r.p.m. at 41C for 10 min, and equal volumes
of lysates were incubated with GST–Rhotekin (Rho) beads or GST-
PAK-CRIB beads at 41C for 60 min. The beads were washed four
times with buffer B (50 mM Tris, pH 7.4, 1% Triton X-100, 150 mM
NaCl, 10 mM MgCl2, supplemented with protease inhibitors
(Roche)). Bound Rho and Rac proteins were detected by western
blotting using monoclonal antibodies against RhoA and Rac1 (Santa
Cruz Biotechnology).
siRNA-mediated ILK and parvin depletions
siRNA duplexes for ILK, a-parvin, b-parvin and scrambled control
were purchased from Sigma. Two siRNA duplexes (50-CAGUGUAAU
CGAUCGAUGAATT-30 and 50-CCAUAUGGAUCUCUCUACATT-30 for
ILK; 50-CGACAAUGGUCGAUCCAAA-30 and 50-GAACAAGCAUCUGA
AUAAA-30 for a-parvin; 50-CAAACACCUGAAUAAGCUA-30 and 50-CC
UGACUCCUGACAGCUUU-30 for b-parvin) were transfected into
SMA-positive cells using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s protocol. Experiments were carried out 48 h
after transfection.
SDS–PAGE and immunoblotting
Cells were lysed in lysis buffer (150 mM NaCl, 50 mM Tris pH 7,4,
1 mM EDTA, 1% Triton X-100 supplemented with protease
inhibitors (Roche) and phosphatase inhibitors (Sigma)), homo-
genized in Laemmli sample buffer and boiled for 5 min. Cell lysates
were resolved by SDS–PAGE gels. Proteins were then electrophor-
etically transferred from gels onto nitrocellulose membranes,
followed by incubation with antibodies. Bound antibodies were
detected using enhanced chemiluminescence (Millipore Corpora-
tion, Billerica, USA).
Whole embryo immunohistochemistry
Staged embryos were dissected in PBS and genotyped by PCR. YSs
and embryos were fixed overnight in fixation buffer (80%
methanol, 20% DMSO). Samples were rehydrated in 0.1% Tween-
20 in PBS, incubated in blocking buffer (10% goat serum, 5% BSA
in PBS) for 2 h, and exposed to primary antibody overnight at 41C.
After 5–7 h wash with 0.1% Tween-20 in PBS, samples were
incubated with secondary antibodies overnight at 41C.
Histology of tissue sections, immunostaining and
morphological analysis
Immunohistochemistry and immunofluorescence studies of em-
bryos, YSs and cells were performed as described earlier in
Montanez et al (2008). Analysis of vessel diameter was performed
as described by Grazioli et al (2006). Three embryos of each genotype
were analysed. The area and the shape factor (4parea/perimeter2) of
cells were analysed using the MetaMorph software. The data
represent three independent assays (150 cells/experiment).
Migration assay
Chemotactic and chemokinetic migration assays were performed in
3-mm pore size chamber inserts (BD Falcon). For chemotaxis assays,
4104 cells were plated into the chamber and transferred into 24-
well plates containing serum-free medium with or without 20 ng/ml
PDGF-BB. For chemokinesis assays, 4104 cells in serum-free
medium with or without 20 ng/ml PDGF-BB were plated into the
chamber and transferred into 24-well plates containing serum-free
medium.
After overnight incubation, the cells in the bottom part of the
chamber were stained with a crystal violet solution and counted.
Five microscopic fields per chamber were analysed. Data are
represented as percentage of total cell number/field±s.d. The assay
was performed in triplicate in three independent assays.
Collagen matrix contraction assay
Cells were suspended in a collagen mixture (1.6 mg/ml collagen I
(INAMED), 7.5% NaHCO3 in cell culture medium (MEM)) with a
final concentration of 4105 cells/ml. A measure of 100ml of the
collagen-cell mixture was placed in a 24-well suspension culture
plate (Greiner) and incubated for 1 h under standard cell culture
conditions causing the polymerization of the collagen. Finally, 2 ml
of cell culture medium (DMEMþ 10% serum) was applied on top of
the gel. The area of the collagen lattices was calculated after 24 and
48 h of culture. The assay was performed in triplicate in three
independent assays.
Statistical analysis
The statistical analysis was performed using the Mann–Whitney
test. The values are presented as meanþ s.e.m. At least three
independent experiments were performed.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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Abstract 
 
The focal adhesion (FA) protein α-Parvin (αPv) has been shown to regulate integrin signaling 
and integrin-actin linkage. Here we report that the conditional deletion of the αPv gene in 
keratinocytes leads to impaired hair follicle (HF) morphogenesis, epidermal hyperplasia and 
micro-blistering. Expression of integrin α6 was reduced on αPv-deficient keratinocytes, 
leading to defects in hemidesmosome (HD) formation and integrin-dependent adhesion 
associated with rupture of the basement membrane and the presence of proliferating 
keratinocytes in suprabasal layers of the epidermis. Suprabasal expression of integrins was 
accompanied by disturbed and delayed terminal differentiation of αPv-deficient 
keratinocytes. The defects in FA formation/maturation and actin cytoskeleton organization 
resulted in impaired migration of primary αPv-deficient keratinocytes which is likely the 
cause for the impaired HF morphogenesis and cycling and progressive loss of hair. Our data 
demonstrate that αPv is required for epidermal homeostasis and HF development by 
facilitating integrin signaling and actin cytoskeleton organization in keratinocytes. 
 
Introduction 
 
Skin constitutes the interface to the external environment. It prevents dehydration and 
protects against environmental threads of physical, chemical and biological nature. These 
vital functions depend on the establishment and maintenance of a tight barrier, which is 
formed by the outermost compartment of skin, the epidermis. The epidermis is a stratified 
squamous epithelium, consisting of multiple layers of keratinocytes that are separated from 
the mesenchyme-derived dermis by a basement membrane (BM). Proliferation is restricted to 
the basal layer, where keratinocytes adhere to the BM. Once basal keratinocytes commit to a 
program of terminal differentiation, they exit the cell cycle, detach from the BM and 
translocate sequentially from the basal layer to the spinous layers, to the granular layers and 
finally to the cornified layers of the epidermis. Keratinocyte transition is accompanied by the 
successive differentiation of basal keratinocytes into terminally differentiated corneocytes, 
which are shed from the skin surface (Fuchs and Raghavan, 2002). Throughout life the 
epidermis is continuously renewed by the proliferation and differentiation of basal 
keratinocytes, which are replenished by stem cells that reside in the basal layer of the 
epidermis, the sebaceous gland and the HF bulge (Fuchs, 2008). The HF and sebaceous gland 
are epidermal appendages that form a pilosebaceous unit. Its major function is the production 
of the hair shaft (HS), which is enveloped by the inner-root-sheath (IRS) and the outer-root-
sheath (ORS) of the HF. The ORS is contiguous with the basal layer of the interfollicular 
epidermis (IFE) and is surrounded by the BM. HF morphogenesis is initiated during 
embryogenesis by epithelial progenitors in response to inductive cues from the underlying 
mesenchyme and is completed by postnatal day 14 (P14). Thereafter, HFs cycle between 
phases of apoptosis-dependent regression (catagen), quiescence (telogen), and growth 
(anagen) (Paus and Cotsarelis, 1999). During HF growth, bulge-derived keratinocytes of the 
ORS migrate along the BM towards the distal HF bulb, where they come in close proximity 
with the dermal papilla (DP), a specialized mesenchymal compartment enclosed by the hair 
bulb. In the hair bulb, ORS keratinocytes differentiate into highly proliferative hair matrix 
(HM) keratinocytes. Terminal differentiation of HM keratinocytes results in the specification 
of the distinct HF linages of the IRS and the HS. Keratinocyte differentiation as well as HF 
morphogenesis and cycling critically depend on epithelial-mesenchymal signaling crosstalk. 
Epidermal homeostasis, keratinocyte differentiation, and HF morphogenesis depend on the 
ability of keratinocytes to adhere to and migrate along the extracellular matrix (ECM). This is 
to a large extent facilitated by integrins. They are cell-ECM receptors composed of an α- and 
a β-subunit. Integrins switch from an inactive conformation with low ligand affinity to an 
active conformation with high ligand affinity. Integrin “activation” is regulated by 
cytoplasmic proteins such as talin and kindlin in a process referred to as inside-out signaling 
(Moser et al., 2009). Basal and ORS keratinocytes express the α2β1, α3β1 and α6β4 integrins 
(Commo and Bernard, 1997; Watt, 2002). Additionally, basal keratinocytes express αvβ5 and 
upregulate α5β1, α9β1 and αvβ6 under pathological conditions such as wound healing and in 
cell culture (Watt, 2002). Adhesion to the BM is mediated by the laminin (Ln) binding α6β4 
integrin heterodimer, which is a central component of HDs and connects the BM to keratin 
intermediate filaments. The β1 integrins also contribute to the adhesion of basal keratinocytes 
to the BM and are required for deposition and integrity of the BM, keratinocyte proliferation 
and differentiation, HF morphogenesis and cycling and wound healing (Brakebusch et al., 
2000; Grose et al., 2002; Raghavan et al., 2000). 
The short cytoplasmic tails of integrins lack intrinsic enzymatic activity. Instead integrins 
depend on the recruitment of signaling and adaptor molecules to accomplish downstream 
signaling events (outside-in signaling) and to enforce the linkage to the actin cytoskeleton. 
The integrin linked kinase (ILK), which directly binds to β1-integrin cytoplasmic tails, has 
been identified as a key component required for integrin functions. Through its N-terminal 
ankyrin repeats ILK binds to the LIM-only proteins PINCH-1 and PINCH-2, and through its 
C-terminal kinase-like domain ILK binds to the CH (calponin homology) domain-containing 
proteins α-, β-, or γ-Parvin (αPv, βPv and γPv). Together ILK, PINCH and Parvin form a 
ternary complex (IPP-complex), whose assembly in the cytosol precedes its recruitment to 
integrin adhesions. Assembly of the ternary IPP-complex is required for the stability of its 
constituents and genetic ablation of one component results in a proteasome dependent 
downregulation of the remaining constituents (Fukuda et al., 2003; Grashoff et al., 2004; 
Legate et al., 2006). 
Genetic ablation of ILK in the epidermis and its appendages alters BM integrity, epidermal 
homeostasis and HF development/maintenance and results in epidermal detachments from the 
BM and the progressive loss of hair (Lorenz et al., 2007; Nakrieko et al., 2008). 
Parvins regulate cell adhesion, spreading, migration and survival by controlling actin 
cytoskeleton dynamics via direct binding to actin and modulating the activity of actin 
regulators (Legate et al., 2006). αPv is widely expressed, βPv expression is enriched in heart 
and skeletal muscle and γPv expression is restricted to the hematopoietic system (Chu et al., 
2006; Nikolopoulos and Turner, 2000; Olski et al., 2001; Tu et al., 2001; Yamaji et al., 2001). 
Deletion of αPv in mice leads to embryonic lethality due to cardiovascular defects (Montanez 
et al., 2009). The functions of αPv in epidermal homeostasis, however, are not known. 
To analyze the function of αPv in epidermal homeostasis we conditionally deleted αPv gene 
in the epidermis. Here we show that αPv is required for epidermal homeostasis and HF 
morphogenesis and maintenance. Mice lacking αPv in the epidermis progressively loose hair 
and develop a persistent alopecia. This is accompanied by epidermal detachments from the 
BM and hyperplasticity of the epidermis and the ORS due to the accumulation of ectopically 
proliferating keratinocytes in suprabasal layers of the epidermis and in the ORS. Surface 
expression of integrin α6 is reduced on αPv-deficient keratinocytes, which display 
disorganized actin cytoskeleton organization and impaired cell adhesion, spreading, 
migration and differentiation. Our data indicate that αPv regulates HF morphogenesis and 
epidermal homeostasis by controlling keratinocyte adhesion and migration. 
Results 
 
Keratinocyte restricted deletion of αPv leads to progressive hair loss 
 
To analyze the function of αPv in the epidermis and its appendages we deleted the αPv gene 
in basal keratinocytes by generating αPv-floxed mice (αPvfl/fl) (Sup. Fig. 1) and intercrossing 
them with mice expressing Cre recombinase under the control of the K5 promotor (K5-Cre) 
(Ramirez et al., 2004). K5-Cre-expressing αPvfl/+ K5Cre control (αPv Ctrl) and αPvfl/fl K5Cre 
mutant mice (αPv K5) were born at the expected Mendelian ratio. No macroscopic 
differences were observed until skin pigmentation set in at around postnatal day (P) 3 to 4. 
From P4 on, αPv K5 mice showed irregular skin pigmentation. By P7, control mice 
developed a homogenous hair coat, whereas αPv K5 mice displayed a patchy hair coat. 
Sparse hair with partial alopecia persisted for about 4 weeks (Sup. Fig. 2A). Thereafter αPv 
K5 gradually lost hair, resulting in complete and persistent alopecia at around 8 weeks of age 
(Fig. 1A). Western-blot (WB) analysis of protein lysates of keratinocytes isolated from one 
week old mice showed loss of αPv protein and reduced ILK and Pinch protein levels in αPv 
K5 mice compared to control mice (Fig. 1B). We did not detected βPv expression in 
keratinocyte lysates. 
To characterize the expression of αPv in skin, we performed immunostaining using an 
antibody specific for αPv (Chu et al., 2006) on back-skin sections from 2-week-old mice and 
tail-skin from 2-month-old mice. In the skin of control mice, αPv was found highly expressed 
in basal keratinocytes of interfollicular epidermis (IFE) and outer-root-sheath (ORS) (Fig. 
1C). αPv was evenly distributed around the cortex of basal keratinocytes in control IFE (Fig. 
1D). No αPv-specific signal was detected in the epidermis of αPv K5 mice, except for some 
locally restricted areas adjacent to intense integrin α6 staining and in a few suprabasal cells 
(Fig. 1C). ILK expression was absent in IFE of αPv K5 mice while clearly present in IFE of 
control mice (Fig. 1E). Taken together, these data showed that the efficient deletion of αPv in 
keratinocytes destabilizes the IPP-complex and results in gradual hair loss followed by 
persistent alopecia. 
 
 
 
 
Deletion of αPv impairs HF development and epidermal homeostasis 
 
To morphologically characterize the consequences of keratinocyte-restricted αPv-deletion, 
we performed hematoxylin and eosin (H&E) staining on back-skin sections of control and 
αPv K5 mice. No differences in epidermal morphology were found between control and αPv 
K5 mice before P3. At later stages, in contrast to control skin, progressive epidermal 
hyperplasia and locally confined epidermal detachments at the dermal-epidermal junction 
(DEJ) were observed in the skin of αPv K5 mice (Fig. 2C, E, F and 3A). From P3 on, αPv K5 
mice also displayed impaired HF morphogenesis (Fig. 2A-F and 3A, B). At P14, HFs of 
control mice reached an average length of 1100µm. In contrast, 68% of HFs of αPv K5 mice 
were shorter than 400µm with an average length of 270µm and thus entirely remaining in the 
dermal compartment (Fig. 2B, C and 3A, B). HS and dermal papilla were either severely 
distorted or completely absent in those prematurely growth arrested HFs (Fig. 3A) and only 
32% of HFs of αPv K5 mice reached into the subcutaneous fat layer (Fig. 2B, C and 3A, B). 
At P23, HFs of both control and αPv K5 mice were in telogen, indicating that HF regression 
was not impaired in the absence of αPv (Fig. 2D). HF of control mice elongated during the 
following anagen phase and by P28 reached into the subcutis. In contrast, HFs of αPv K5 
mice remained confined to the dermis (Fig. 2E). By P56, complete resorption of HFs resulted 
in aberrant melanin depositions in the dermis of αPv K5 mice (Fig. 2F). These results showed 
that αPv is required for HF morphogenesis and epidermal homeostasis. 
 
Deletion of αPv results in decreased surface expression of integrin α6 
 
The IPP complex is a major mediator of integrin signaling (Legate et al., 2009). Next, we 
analyzed surface expression of integrins on control and αPv-null keratinocytes by FACS 
analysis using antibodies against several integrin subunits. Surface levels of integrins β1, β4, 
α2, αv and α5 were not altered in αPv-null keratinocytes compared to control cells (Fig. 4A, 
C). However, surface expression of integrin α6 on αPv-null keratinocytes was significantly 
reduced compared to control cells (Fig. 4A, C). To investigate whether integrin localization 
was affected upon deletion of αPv, immunohistochemistry using antibodies against β1, β4 
and α6 integrins was performed on back-skin sections from 2-week-old mice. While in the 
epidermis of control mice integrin β1 expression was restricted to basal keratinocytes, in the 
epidermis of αPv K5 mice β1 integrin expressing cells were also found in suprabasal cell-
clusters (Fig. 5A). In control mice, basal keratinocytes showed a continuous integrin β4 and 
α6 staining that was restricted to the basal membrane (Fig. 1C and Fig. 5A, B). In contrast, 
basal keratinocytes of αPv K5 mice showed a discontinuous integrin β4 and α6 staining (Fig. 
1C and Fig. 5A, B) and suprabasal cells expressing β4 integrin on their entire surface were 
observed in areas where the BM was disrupted (Fig. 5B). These data showed that deletion of 
αPv results in decreased surface expression of integrin α6 and ectopic expression of β1 and 
β4 integrins in suprabasal layers of the epidermis. 
 
Abnormal cell-polarity, impaired HD formation and compromised adhesion to and 
organization of the BM in the absence of αPv 
 
Discontinuous integrin α6 and β4 staining and reduced integrin α6 surface expression 
suggested defective HD formation. To investigate, whether HD formation was compromised 
in the absence of αPv, electron microscopy (EM) was performed on back-skin sections from 
2-week-old control and αPv K5 littermates. Ultrastructural analyzes showed the absence of 
HDs in areas where basal keratinocytes had detached from the BM in the skin of αPv K5 
mice (Fig. 5C, D and Sup. Fig. 5). In the skin of control mice the BM was continuous and 
was located between the epidermis and the dermis. In contrast, in the skin of αPv K5 mice the 
BM was frequently disrupted or displaced into the dermis. (Fig. 5D and Sup. Fig 5). EM 
analyzes also revealed a complete lack of caveolae in αPv-deficient BM-detached basal 
keratinocytes (Fig. 5D). Additionally, edemas and lose cell-cell contacts were observed in the 
epidermis of αPv K5 mice (Sup. Fig. 5). 
Cell adhesion, shape and polarity as well as cell-cell contacts depend on the correct 
organization of the actin cytoskeleton. In the epidermis of control mice, actin localized at the 
apical and lateral side of basal keratinocytes. In contrast, in the epidermis of αPv K5 mice 
actin was frequently localized at the basal side of basal keratinocytes and actin cables were 
observed between loosely connected adjacent cells (Fig. 5E). Furthermore, in contrast to 
control mice, in αPv K5 mice β-catenin (Fig. 5F) as well as E-cadherin (Fig. 5G) were found 
at the basal side of basal keratinocytes that were detached from the BM. Together, these data 
indicated that αPv is required for adhesion and polarization of keratinocytes. 
 
 
Deletion of αPv compromises adhesion and impairs recruitment of the IPP complex and 
paxillin into FAs of keratinocytes 
 
To analyze actin organization and subcellular distribution of the IPP complex in vitro, 
phalloidin-staining to visualize filamentous actin and immunostaining using antibodies 
against αPv, ILK, Pinch and paxillin were performed on primary keratinocytes isolated from 
control and αPv K5 mice. While αPv, ILK, Pinch and paxillin were colocalizing at FAs in 
control keratinocytes, in αPv-null keratinocytes paxillin-containing FAs were either missing 
or strongly reduced in size without detectable αPv, ILK and Pinch signals (Fig. 6B-D, Sup. 
Fig. 4B-D). αPv-null keratinocytes displayed a roundish or spiky cell morphology and were 
less spread than control keratinocytes (Fig. 6A-D and Sup. Fig. 4A-D). αPv was localizing to 
the tip of actin stress-fibers in control keratinocytes. In contrast, formation of stress-fibers 
was impaired in αPv-null keratinocytes (Fig. 6A and Sup. Fig. 4A). 
To analyze whether the in vivo detachment of keratinocytes primarily resulted from abnormal 
BM organization or defective integrin-mediated adhesion to the BM, adhesion of primary 
keratinocytes to ECM components was analyzed in vitro. While integrin-independent binding 
to poly-L-Lysine was not affected by the deletion of αPv, integrin-dependent binding of αPv-
null keratinocytes to fibronectin (FN), collagen type-I (Col-I) and laminin 332 (Ln332) was 
significantly reduced compared to control cells (Fig. 6E). 
 
Ectopic hyperproliferation upon loss of αPv 
 
To investigate whether the hyperplastic epidermis and ORS observed in αPv K5 mice were a 
consequence of increased proliferation, immunostaining using the proliferation markers Ki67 
and phospho-Histone 3 was performed on skin sections from 2-week-old animals. In HFs of 
control mice, proliferation was mainly observed in HM-keratinocytes surrounding the DP 
(Fig. 7A). In contrast, in HFs of αPv K5 mice, proliferative cells accumulated in the ORS and 
partially were absent from the hair bulb (Fig. 7A). In the epidermis of control mice, 
proliferative cells were found in the basal layer of the epidermis (Fig. 7B-D). In contrast in 
the epidermis of αPv K5 mice, about 30% of Ki67-positive keratinocytes were observed in 
suprabasal layers (Fig.7 B, C). However, the percentage of proliferating cells in the basal 
layer of the epidermis was not different between control and αPv K5 mice (Fig. 7B-D). These 
data suggested that hyperplasia in αPv-deficient epidermis and ORS is due, at least in part to 
ectopic proliferation of keratinocytes in suprabasal layers of the epidermis and in the ORS. 
 
Deletion of αPv results in delayed keratinocyte-differentiation 
 
Ectopic proliferation and expression of integrin β1 and β4 by suprabasal cells could be a 
consequence of delayed differentiation and/or abnormal translocation of undifferentiated 
basal keratinocytes to suprabasal layers. To assess whether αPv regulates keratinocyte 
differentiation, immunohistochemistry using epidermal differentiation markers was 
performed on back skin sections of 2-week-old mice. In the epidermis of control mice, 
expression of K5 was restricted to the basal layer (Fig. 8A), K10 was found to be expressed 
in the first suprabasal cell-layer (spinous layer) (Fig. 8B) and loricrin expression was 
confined to the stratum granulosum (Fig. 8C). In contrast, in the epidermis of αPv K5 mice 
expression of K5 was detected in the basal layer and additionally in up to five suprabasal 
layers (Fig. 8A) and K10 (Fig. 8B) and loricrin (Fig. 8C) were expressed in all suprabasal 
layers. Together these data suggested that αPv controls differentiation of keratinocytes. 
Wound-healing responses and recruitment of inflammatory cells upon blister-formation at the 
DEJ could additionally contribute to the hyperproliferation. To analyze whether loss of αPv 
in the epidermis results in the recruitment of inflammatory cells, we performed 
immunostaining on back-skin sections of control and αPv K5 mice using markers for 
granulocytes (gr1) and macrophages (mac1). At P14, both granulocyte and macrophage 
infiltrates were found in areas with disrupted or displaced BM and around distorted HFs in 
the skin of αPv K5 mice, whereas no signs of inflammation could be observed in the skin of 
control mice (Fig. 8D, E). Although epidermal hyperplasia, abnormal polarity of 
keratinocytes and defects in BM-integrity were already obvious in skin of αPv K5 mice at P7 
(Sup. Fig. 3A-D), no signs of inflammation were detected in back-skin sections from 1-week-
old control and αPv K5 animals (Sup. Fig. 3E). These data provided evidence that 
hyperproliferation precedes the inflammatory response rather than being its consequence. 
 
Impaired directional migration upon αPv deletion 
 
The accumulation of proliferative cells in the ORS and their partial absence in the hair bulb 
indicate compromised downward migration of keratinocytes from the bulge region. To 
analyze whether αPv regulates migration of keratinocytes, we performed in vitro wound-
healing migration assays with primary keratinocytes isolated from control and αPv K5 
animals. Control keratinocytes closed the wound within 24h, whereas αPv-null keratinocytes 
failed to efficiently migrate into the wound (Fig. 9A). Single-cell tracking revealed two 
reasons for the impaired wound closure (Fig. 9B). First, whereas control keratinocytes 
migrated with an average speed of 0.56 ±0.19 µm/min, αPv-null keratinocytes were 
significantly slower, only migrating with an average speed of 0.34 ±0.16 µm/min. Therefore 
the accumulated distance migrated by αPv-null keratinocytes (481.92 ± 227.85 µm) was 
significantly shorter than that of control keratinocytes (808.52 ± 275.12 µm). Second, αPv-
null keratinocytes were impaired in their directionality. The directionality index determined 
for control keratinocytes was 0.34 ± 0.14, whereas it was only 0.14 ± 0.09 for αPv-null 
keratinocytes. Both defects together resulted in a significantly reduced euclidean migration 
distance of αPv-null (62.59 ± 40.76 µm) compared to control (262.23 ± 107.13 µm) 
keratinocytes and thus in the impaired wound-closure. 
Discussion 
 
In the present manuscript, we reported that αPv is essential for epidermal homeostasis and HF 
morphogenesis and cycling. Conditional deletion of the αPv gene in keratinocytes in mice 
resulted in locally confined epidermal detachments at the DEJ, abnormal BM organization, 
epidermal hyperplasia and progressive and persistent alopecia due to impaired HF 
development and maintenance. Loss of αPv also resulted in delayed keratinocyte-
differentiation and accumulation of proliferating keratinocytes in suprabasal layers of the 
epidermis and in the ORS of HFs. We reported that loss of αPv is required for the proper 
expression and distribution of integrins, actin cytoskeleton organization and polarity of 
keratinocytes 
Epidermal detachments from the BM upon keratinocyte-restricted deletion of αPv indicate 
that αPv is essential for the adhesion of keratinocytes to the BM. The adhesion of basal 
keratinocytes to the BM largely is mediated by the hemidesmosomal integrin α6β4 (Watt, 
2002). Here we show that in the absence of αPv the surface levels of the α6 integrin subunit 
are reduced. Moreover, our analyses showed absence of HDs in αPv K5 mice, indicating that 
αPv is required for HD formation/maintenance. Additionally, deletion of αPv in keratinocytes 
resulted in splitting of the interfollicular BM and its displacement into the dermis, indicating 
that αPv is required for BM-integrity. These results are in line with previous data showing 
that β1 integrins and ILK are required for HD formation/maintenance and BM-integrity 
(Brakebusch et al., 2000; Lorenz et al., 2007; Nakrieko et al., 2008; Raghavan et al., 2000). A 
direct interaction of the IPP-complex with the α6β4 integrin heterodimer has not been 
reported, suggesting that loss of αPv might indirectly affect HD assembly/stability. One 
possibility is that defects in BM integrity compromise the assembly/stability of HDs (Litjens 
et al., 2006). Additionally, the integrin heterodimer α3β1 has been suggested to be involved 
in the nucleation of HDs (Litjens et al., 2006; Sterk et al., 2000). However, although BM 
integrity is severely compromised in α3β1-deficient mice, HDs are not affected (DiPersio et 
al., 1997). This might be due to a compensatory function of other β1 integrins and suggests 
that impaired BM integrity is not the primary cause for the defective HD 
assembly/maintenance in αPv-deficient epidermis, that αPv facilitates BM integrity 
downstream of integrin α3β1 and that αPv is required to facilitate β1 integrin-dependent HD 
assembly/stability, possibly by affecting surface expression and/or localization of the integrin 
α6 subunit. 
Integrin-dependent adhesion of αPv-deficient keratinocytes to ECM-components was also 
severely compromised in vitro, suggesting that epidermal detachments are due to impaired 
integrin-mediated adhesion. Although reduced surface expression of the integrin α6 subunit 
in αPv-deficient keratinocytes likely contributes to the compromised adhesion to Ln332, it 
cannot explain the defects in the adhesion to Col-I and FN. This indicates, that αPv 
additionally facilitates adhesion through β1 integrins such as the collagen receptor α2β1, the 
fibronectin receptor α5β1 and the laminin receptor α3β1. 
Adhesion to the ECM depends on the clustering of integrins into adhesive structures such as 
FAs. Maturation and strengthening of FAs in turn requires the linkage of integrins to the actin 
cytoskeleton. The IPP-complex facilitates the linkage of integrins to the actin cytoskeleton 
through Parvins. Although small paxillin-containing FAs could form in the absence of αPv, 
ILK and Pinch were absent from FAs and αPv-deficient keratinocytes displayed a poorly 
organized actin cytoskeleton with an almost complete lack of actin stress fibers. This 
indicates that actin cytoskeleton organization and recruitment of ILK and Pinch-1 to FAs 
critically depend on αPv and suggests that the adhesion defects of αPv-deficient keratinocytes 
are due to a combination of reduced surface expression of integrin α6, defective organization 
of the actin cytoskeleton and compromised FA formation/maturation. 
Rho GTPases are major regulators of actin cytoskeleton dynamics and although Rac1 
activation was normal during spreading on Ln332 in the absence of ILK (Lorenz et al., 2007), 
Rac1 activation was reduced during in vitro wound healing assays in ILK-deficient 
keratinocytes (Nakrieko et al., 2008), indicating a critical function of the IPP complex in the 
regulation of Rho GTPases during keratinocyte migration. Additionally, αPv negatively 
regulates RhoA activity in vascular smooth muscle cells (Montanez et al., 2009), suggesting 
that αPv might regulate keratinocyte-migration by controlling the organization of the actin 
cytoskeleton via Rho GTPase signaling. Whether αPv regulates Rho GTPases in 
keratinocytes remains to be elucidated. 
In addition to the adhesion defects, filamentous (f)-actin, β-catenin and E-cadherin localized 
to the basal membrane of αPv-deficient basal keratinocytes in vivo, indicating that αPv is 
required to maintain cell-polarity. E-cadherin and β-catenin are core components of adherens 
junctions, which facilitate cell-cell adhesion and are linked to the actin cytoskeleton 
(Yonemura, 2011). Loosely connected cells and edemas (Sup. Fig. 5) in the epidermis of 
αPv-deficient animals suggest that αPv facilitates formation or stabilization of cell-cell 
contacts. Cell polarity and adherens junctions depend on the correct organization of the actin 
cytoskeleton, suggesting that αPv might indirectly affect polarity and cell-cell adhesion by 
controlling the organization of the actin cytoskeleton. Defects in cell-cell adhesion also have 
been reported in embryoid bodies in the absence of Pinch-1 but not in the absence of ILK and 
it has been suggested that these differences could be due to an IPP complex-independent 
functions of Pinch-1 in cell-cell adhesion (Li et al., 2005). However, how Pinch-1 and αPv 
can control cell-cell adhesion in an IPP-independent manner currently is not known and 
needs to be elucidated. 
Keratinocyte-restricted deletion of ILK results in suprabasal expression of integrins, 
inflammation, delayed terminal differentiation, ectopic proliferation in suprabasal layers of 
the epidermis and epidermal hyperplasia (Lorenz et al., 2007). In line with these findings, we 
observed strikingly similar defects in the epidermis of αPv-deficient mice. It has been 
suggested that inflammation is required to trigger the epidermal hyperproliferation in mice 
expressing integrins in suprabasal layers (Romero et al., 1999). However, hyperthickening of 
αPv-deficient epidermis clearly preceded the accumulation of inflammatory granulocytes and 
macrophages, indicating that inflammation is not the primary cause for hyperproliferation in 
αPv-deficient epidermis but rather results from disturbed epidermal homeostasis in the 
absence of αPv. 
Loss of αPv resulted in severely compromised HF morphogenesis and progressive loss of 
hair. About one-third of the HFs in αPv K5 mice completed morphogenesis by P14, whereas 
the remaining two-thirds were severely distorted and prematurely growth-arrested. 
Asynchronous initiation and morphogenesis of distinct types of HFs together with a perinatal 
loss of αPv-protein can explain the development of both prematurely growth arrested and 
mature HFs in αPv K5 mice (Paus et al., 1999; Schmidt-Ullrich and Paus, 2005). Thus, in 
prematurely growth arrested HFs αPv had been deleted in early phases of HF-morphogenesis, 
leading to their premature growth arrest, whereas mature HFs had lost αPv in late stages of 
morphogenesis. However, also mature HFs displayed several morphological abnormalities, 
including a markedly reduced length, a hyperplastic ORS, interrupted HSs and a distorted 
DP. Although catagen and telogen appeared to proceed normal in HFs of αPv K5 mice, all 
HFs failed outgrowth during the following anagen phase. HF growth depends on the 
proliferation and directional migration of stem cell-derived keratinocytes from the HF bulge 
region towards the HF bulb, where they differentiate into HM keratinocytes. Directed 
migration is impaired in αPv-deficient keratinocytes, suggesting that these migration defects 
account for the accumulation of proliferative keratinocytes in the ORS of mature αPv-K5 
HFs, the impaired development of prematurely growth arrested αPv-K5 HFs and the impaired 
HF outgrowth during anagen in the absence of αPv. 
Materials and methods 
 
Generation of floxed αPv mice and intercrossing with K5-Cre mice 
 
A 129/Sv mouse P1-derived artificial chromosome (PAC) library was screened with cDNA-
probes to identify PAC-clones containing αPv-genomic DNA. Positive PAC clones were 
used to generate the αPv targeting construct, encompassing a 2.7 kb 5’-homology arm and a 
5.9 kb 3’-homology arm, targeting a region from intron 1 to intron 4 of the αPv gene. A 
neomycin-resistance cassette flanked by two frt-recognition sequences was inserted into 
intron 2 to allow the selection of neomycin-resistant ES cell clones. The first loxP sequences 
was introduced 5’ of the neomycin cassette into intron 2, the second loxP sequences was 
introduced into intron 3, thus flanking exon 3 of the αPv gene. Genotyping of wt and 
recombinant alleles was performed by Southern blot using an external probe after EcoRI 
digestion of genomic DNA. The neomycin-resistance cassette was removed by intercrossing 
αPv-floxed mice with FLP recombinase-expressing mice (Farley et al., 2000). Efficient 
removal of the neomycin-resistance cassette was confirmed by PCR. Homozygous αPv-
floxed mice lacking the neomycin-resistance cassette were viable and phenotypically normal. 
For the genotyping of αPv-floxed mice, a PCR with the three primers APE2f (forward) 5'-
GAAGGAATGAACGCCATCAAC-3', APloxPf (forward) 5'-
CTGAGTGACATGGAGTTTGAG-3' and APloxPr (reverse) 5'-
GGACTTGTGGACTAGTTAG AC-3' was used, allowing the discrimination of wt (1.1kb 
and 186bp), floxed (240bp) and Cre-mediated-recombined (595bp) alleles. For the 
keratinocyte-restricted deletion of the floxed αPv-gene, homozygous floxed αPv-females 
were mated with heterozygous floxed αPv-males, expressing the Cre-recombinase under the 
control of the keratin 5 promotor (Ramirez et al., 2004). Presence of the K5-Cre transgene in 
littermates was determined by PCR using the primers CreF (forward) 5'-
AACATGCTTCATCGTCGG-3' and CreR (reverse) 5'-TTCGGATCAGCTACACC-3'. 
 
Isolation and culture of primary keratinocytes 
 
Primary keratinocytes were isolated and cultured as previously described (Montanez et al., 
2007). Keratinocyte growth medium (KGM) was prepared from Minimal Essential Medium 
(Spinner Modification; Sigma-Aldrich), complemented with 8% chelated FCS, 45µM CaCl2, 
5mg/ml insulin (Sigma-Aldrich), 10ng/ml EGF (Sigma-Aldrich), 10mg/ml transferrin 
(Sigma-Aldrich), 10mM phosphorylethanolamine (Sigma-Aldrich), 10mM ethanolamine 
(Sigma-Aldrich), 0.36mg/ml hydrocortisone (Calbiochem), 2mM L-Glutamine (Invitrogen) 
and 1x Penicillin/Streptomycin (PAA). Keratinocytes were cultured on tissue-culture dishes 
coated with 10µg/ml Col-I (INAMED) and 10µg/ml FN (Merck). 
 
Adhesion assay 
 
Primary keratinocytes (1*105 cells/well) were plated onto 96-well plates coated with poly-L-
lysine (Sigma-Aldrich), Col-I (INAMED), FN (Merck) or Ln332 (Dr. Monique Aumailley, 
University of Cologne, Germany). After 30 min incubation, cells were lysed in substrate 
buffer (7.5mM NPAG (Sigma-Aldrich), 0.1M Na citrate pH 5, 0.5% Triton X-100) over night 
at 37°C. The reaction was stopped by adding 50mM Glycine pH 10.4, 5mM EDTA, and the 
OD 405 was measured. 
 
In vitro wound healing assay 
 
After 4h incubation in KGM supplemented with 4µg/ml Mitomycin C (Sigma-Aldrich), 
keratinocyte monolayers were gently scratched with the tip of a cell-scraper. Subsequently, 
images were captured every 10 min for 24h at 37°C and 5% CO2 using a Zeiss Axiovert 
microscope equipped with 10× NA 0.3, 20× NA 0.4, 40× NA 0.6, and 100× NA 1.3 
objectives, a motorized scanning table (Märzhäuser), a stage incubator (EMBL Precision 
Engineering) and a CCD camera (Roper Scientific MicroMAX). MetaMorph (Universal 
Imaging Corp.) software was used for microscope control and data acquisition. For single-
cell tracking and data analyzes, the ImageJ software-plugins “Manual Tracking” (Fabrice P. 
Cordelières) and “Chemotaxis and Migration Tool” (ibidi) were used. At least three 
independent experiments were performed and more than 20 individual cells were tracked for 
each experiment. 
 
FACS analyses 
 
FACS analyses were performed as previously described (Montanez et al., 2007). Primary 
keratinocytes were cultured three to four days prior to FACS analyses, to exclude suprabasal 
keratinocytes from the analyses. Antibodies used for FACS analyzes were biotinylated 
hamster antibody against integrin β1; rat antibody against integrin β4; FITC-conjugated rat 
antibody against integrin α6; biotinylated rat antibody against integrin αv; biotinylated rat 
antibody against integrin α5 (all from PharMingen, San Diego, CA); FITC-conjugated 
hamster antibody against integrin α2 (BD Biosciences); Cy5-conjugated Streptavidin 
(Jackson Immunochemicals Laboratories Inc.; West Grove, PA, USA); Anti-Rat-Alexa488 
(Invitrogen); FITC-conjugated IgG2a,k (rat) (NatuTec); biotinylated IgG2a,k (rat) 
(eBioscience); FITC-conjugated IgG2 (hamster) (PharMingen, San Diego, CA); biotinylated 
IgM (hamster) (BioLegend); biotinylated IgG2a,k (rat) (eBioscience). 
 
Epidermal lysates and cell lysates 
 
Primary keratinocytes, either directly after isolation or after cultivation for up to five days, 
were lysed in lysis buffer (50mM Tris pH 7.4, 150mM NaCl, 1mM EDTA, 1% NP40, 1% 
SDS, 1% Na-deoxycholate) supplemented with protease inhibitor cocktail tablets (Complete 
Mini, EDTA-free; Roche). Proteins were separated by SDS-PAGE and blotted onto PVDF-
membranes. For subsequent immuno-detection, the following antibodies were used: rabbit 
antibody against αPv (Chu et al., 2006); rabbit antibody against βPv (Chu et al., 2006); rabbit 
antibody against ILK (Cell Signaling Technology); mouse antibody against Pinch (BD 
Biosciences); mouse antibody against GAPDH (Calbiochem); goat anti–mouse HRP; and 
goat anti–rabbit HRP (Bio-Rad Laboratories). 
 
Histology and immunohistochemistry 
 
Histology and immunohistochemistry on skin sections was performed as previously described 
(Montanez et al., 2007). Back-skin was fixed overnight at 4°C in 4% PFA in PBS, dehydrated 
in a graded alcohol series and embedded in paraffin (Paraplast X-tra; Sigma-Aldrich) using a 
embedding machine (Shandon). For cryo-sections, unfixed back-skin was embedded in OCT 
(Shandon Cryomatrix, Thermo) and rapidly frozen. Prior to staining, cryo-sections were fixed 
with PFA, methanol or Zn-fixative (40mM ZnCl2, 3mM Calcium acetate monohydrate, 
10mM Zinc trifluoroacetate hydrate, 100mM Tris pH 6.8). For immunostaining, primary 
keratinocytes were plated overnight onto glass-coverslips coated with 10µg/ml FN and 
10µg/ml Col-I. Cells were fixed in 3% PFA, permeabilized with 0.1% Triton-X100 and 
blocked with 3% BSA (all in PBS). The following antibodies were used for 
immunohistochemistry: rabbit antibody against αPv (Chu et al., 2006); mouse antibody 
against ILK, Pinch and Paxillin (all BD Biosciences); TRITC-conjugated phalloidin and 
rabbit antibody against β-catenin (all Sigma-Aldrich); rat antibody against β4-Integrin, FITC-
conjugated rat antibody against α6-Integrin, Biotin-conjugated rat antibody against Mac-1 
(integrin αM), and PE-conjugated rat antibody against Gr1 (all PharMingen, San Diego, CA); 
Alexa488-conjugated goat antibody against rabbit, Alexa546-conjugated goat antibody 
against rabbit (Invitrogen) and Alexa546-conjugated goat antibody against mouse (all 
Invitrogen); Cy3-conjugated goat antibody against rat and Cy3-conjugated streptavidin (all 
Jackson Immunochemicals Laboratories Inc.; West Grove, PA, USA); rat antibody against β1 
integrin (Chemicon); rat antibody against E-cadherin (zymed); rabbit antibody against Ln332 
(Dr. Monique Aumailley, University of Cologne, Germany); rat antibody against Ki67 (Tec3) 
(DakoCytomation); biotin-conjugated rabbit antibody against phospho-Histone H3 (Ser10) 
(Upstate); rabbit antibodies against keratin 5 and 10 and loricrin (all Covance). Confocal 
images were acquired with a Leica TCS SP5 microscope (Leica Microsystems CMS, 
Mannheim, Germany), equipped with 20.0x NA 0.70, 40x NA 1.25, 63x NA 1.4 and 63x NA 
1.2 objectives, using Leica Application Suite Advanced Fluorescence (LAS AF) software 
version 1.6.2. build 1110. 
 
Epidermal whole mounts 
 
Whole mounts from tail-skin were prepared as previously described (Braun et al., 2003). 
Small pieces of tail-skin were incubated in 5mM EDTA in PBS at 37°C for four hours. 
Subsequently, the epidermis was carefully peeled from the dermis and fixed in Zn-fixative 
(40mM ZnCl2, 3mM Calcium acetate monohydrate, 10mM Zinc trifluoroacetate hydrate, 
100mM Tris pH 6.8) at 4°C overnight. For immunohistochemistry, rabbit antibody against 
αPv (Chu et al., 2006), mouse antibody against ILK (BD Biosciences) and FITC-conjugated 
rat antibody against α6-Integrin (PharMingen, San Diego, CA) were used. 
 
Electron microscopy 
 
Samples from back-skin were processed as described (Hess et al., 2010) by using immersion 
fixation with glutaraldehyde and OsO4, followed by epoxy resin embedding. 
Statistical analysis 
 
Statistical analyses were performed using a two-tailed T-test. Values are presented as mean 
plus standard error of the mean. P-values lower than 0.05 (*), 0.01 (**) or 0.001 (***) were 
regarded as significant. 
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filamentous actin; FCS: fetal calf serum; FN fibronectin h: hour; HD: hemidesmosome; 
H&E: hematoxylin and eosin; HF, hair follicle; HM: hair matrix; HRP: horse radish 
peroxidase; HS hair shaft; IFE: interfollicular epidermis; IL-1α: interleukin-1α; ILK: integrin 
linked kinase; IPP-complex: ILK-Pinch-Parvin-complex; IRS: inner-root-sheath; K: keratin; 
kb: kilobase; KGM: keratinocyte growth medium; LIM: Lin11, Isl1, Mec3; Ln332: Laminin 
5, Laminin 332; min: minute; µm: micrometer; ORS: outer-root-sheath; P: postnatal day; 
PAC: P1-derived artificial chromosome; PC: panniculus carnosum; PFA: paraformaldehyde; 
Pinch: particularly interesting Cys-His-rich protein; SC: subcutis; SDS-PAGE: sodium 
dodecyl sulfate polyacrylamide gel electrophoresis; WB: Western-blot. 
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Figure Legends 
 
Figure 1: Keratinocyte-restricted deletion of αPv results in complete and persistent 
alopecia 
(A) αPv Ctrl and αPv K5 mice at four month of age. (B) αPv, βPv, Pinch and ILK protein 
levels in αPv-null kidney-derived fibroblasts (αPv -/-) and primary keratinocytes from one-
week-old Ctrl and αPv K5 mice. (C) Immunostaining of αPv (red) and integrin α6 (green) on 
back-skin sections from Ctrl and αPv K5 mice at P14. Arrows indicate residual cells in αPv 
K5 skin that escaped Cre-mediated deletion. Scale bar: 20µm. (D) Whole mount staining of 
αPv (red) and integrin α6 (green) of tail-skin from two-month-old Ctrl and αPv K5 mice. 
Scale bar: 40µm. A higher magnification of the αPv-staining (white) of the boxed region is 
shown below. αPv localizes to the cell cortex of basal keratinocytes of the IFE. Scale bar: 
20µm. (E) Whole mount staining of ILK (red) and integrin α6 (green) of tail-skin from two-
month-old Ctrl and αPv K5 mice. Scale bar: 40µm. A higher magnification of the ILK-
staining (white) of the boxed region is shown below. Scale bar: 20µm. 
 
Figure 2: Keratinocyte-restricted deletion of αPv affects HF morphogenesis and results 
in epidermal hyperplasia and regional detachments from the DEJ 
H&E staining of back-skin from Ctrl and αPv K5 mice at (A) P3, (B) P7, (C) P14, (D) P23, 
(E) P28 and (F) P56. Arrows indicate areas of epidermal detachments at the DEJ; arrowheads 
indicate abnormal melanin-deposits, triangles (▲) indicate short and prematurely growth-
arrested HFs and rectangles (■) indicate long HFs. E: epidermis; D: dermis; SC: subcutis; 
PC: panniculus carnosum. Scale bar: 200µm. 
 
Figure 3: Impaired HF-cycling, epidermal hyperplasia and local detachments at the 
DEJ upon keratinocyte-restricted deletion of αPv 
H&E staining of back-skin from Ctrl and αPv K5 mice at P14. (A) Epidermis of Ctrl and αPv 
K5 mice. Asterisks indicates epidermal hyperplasia; arrows indicate epidermal detachments 
at the DEJ; triangles (▲) indicate short and prematurely growth-arrested HFs. Scale bar: 
100µm. (B) HFs of Ctrl and αPv K5 mice. Star indicates hyper-thickened ORS; rectangle (■) 
indicates long HF. Note the interrupted HS and the abnormal dermal papilla in the mutant 
HF. Scale bar: 50µm. (C) Histogram of HF length distributions at distinct stages of the HF-
cycle. The length of a minimum of 100 HFs was measured on H&E stained back-skin from 
Ctrl and αPv K5 mice. 
 
Figure 4: Reduced surface expression of α6 integrin on αPv-deficient primary 
keratinocytes 
(A) Integrin-profile of primary keratinocytes isolated from Ctrl (blue) and αPv K5 (red) mice. 
The isotype-control is shown in grey. (B) Quantification of at least three FACS integrin-
profile experiments of αPv Ctrl (blue) and αPv K5 (red) primary keratinocytes. Values of 
integrin-expression on αPv K5 were normalized to the respective integrin-expression on αPv 
Ctrl cells. 
 
Figure 5: Keratinocyte-restricted deletion of αPv impairs BM-integrity, disturbs 
keratinocyte-polarity and results in the translocation of integrin-expressing cells to 
suprabasal layers 
(A) Immunostaining of Ln332 (green) and β1 integrin (red) of back skin from Ctrl and αPv 
K5 mice at P14. Arrow indicates β1 integrin expressing suprabasal cells. Scale bar: 20µm. 
(B) Immunostaining of Ln332 (green) and β4 integrin (red) of back skin from P14 Ctrl and 
αPv K5 mice. Arrow indicates β4 integrin expressing suprabasal cells. Scale bar: 20µm. (C 
and D) EM analysis of back skin from Ctrl and αPv K5 mice at P14. Long arrows indicate 
HDs. Short arrows indicate the presence of the BM. Arrowheads indicate the presence of 
caveoli in basal keratinocytes. Scale bar: 500 nm. (E) Immunostaining of Ln332 (green) and 
f-actin (red) of back-skin from Ctrl and αPv K5 mice at P14. Arrow indicates basal f-actin 
localization in basal keratinocytes. Asterisks indicate intercellular spaces and spiky 
protrusions of f-actin. Scale bar: 10µm. (F) Immunostaining of Ln332 (green) and β-Catenin 
(red) of back-skin from Ctrl and αPv K5 mice at P14. Arrow indicates basal localization of β-
Catenin in basal keratinocytes. Asterisks indicate intercellular spaces. Scale bar: 10µm. (G) 
Immunostaining of Ln332 (green) and E-Cadherin (red) of from back-skin from Ctrl and αPv 
K5 mice at P14. Arrow indicates basal localization of E-Cadherin in basal keratinocytes. 
Asterisks indicate intercellular spaces and disruption of the BM. Scale bar: 10µm. 
 
 
 
Figure 6: Compromised FA-formation, abnormal organization of the actin-cytoskeleton 
and reduced spreading and adhesion of αPv-deficient primary keratinocytes 
Immunostaining of (A) f-actin (red) and αPv (green) (B) ILK (red) and αPv (green) (C) Pinch 
(red) and αPv (green) (D) Paxillin (red) and αPv (green) of primary keratinocytes isolated 
from Ctrl and αPv K5 mice. Scale bars: 20µm. (E) Quantification of adhesion to PLL, Ln332, 
Col-I and FN of αPv Ctrl and αPv K5 primary keratinocytes. Mean values of the percentage 
of adhering cells plus standard error of the mean are represented. At least three independent 
adhesion assays were performed. 
 
Figure 7: Keratinocyte-restricted deletion of αPv results in the accumulation of 
ectopically proliferating cells in suprabasal layers of the epidermis and in the ORS 
Immunostaining of (A and B) Ki67 (brown) (C) integrin α6 (green) and phospho-histone 3 
(red) of back-skin from Ctrl and αPv K5 mice at P14. (A) Ki67-positive cells are located in 
the bulb of αPv Ctrl HFs, whereas they accumulate in the ORS of αPv K5 HFs and fail to 
replenish proliferating cells in the bulb. Arrow indicates proliferative cells in the ORS of αPv 
K5 HFs. Asterisks indicate a region in the αPv K5 HF-bulb that is devoid of proliferative 
cells. Scale bar: 50µm. (B) Ectopic proliferation in suprabasal layers of αPv K5 epidermis. 
Arrows indicate Ki67-positive cells in suprabasal layers of αPv K5 epidermis. Scale bar: 
50µm. (C) Ectopic proliferation in suprabasal layers of αPv K5 epidermis. Arrows indicate 
phospho-histone 3-positive cells in suprabasal layers of αPv K5 epidermis. Scale bar: 20µm. 
(D) Quantification of Ki67-positive cells in basal and suprabasal layers of αPv Ctrl and αPv 
K5 epidermis. The percentage of proliferative to total cells in the basal layer of αPv Ctrl and 
αPv K5 is not significantly different, whereas proliferative cells in suprabasal layers are 
almost exclusively observed in αPv K5 epidermis, comprising approximately 30% of Ki67-
positive cells in αPv K5 epidermis. Depicted are the mean values plus standard error of the 
mean. 
 
Figure 8: Keratinocyte-restricted deletion of αPv results in delayed differentiation and 
the recruitment of inflammatory cells. 
Immunostaining of (A) integrin α6 (green) and K5 (red); (B) integrin α6 (green) and K10 
(red); (C) Ln332 (green) and loricrin (red); (D) Ln332 (green) and Mac1 (red); (E) Ln332 
(green) and Gr1 (red) of back-skin from Ctrl and αPv K5 mice at P14. Scale bars: 20µm. (A) 
Expression of keratin 5 is restricted to the basal layer of αPv Ctrl epidermis, whereas keratin 
5 additionally is expressed in suprabasal layers in αPv K5 epidermis. (B) Expression of 
keratin 10 is restricted to the first suprabasal layer of αPv Ctrl epidermis, whereas keratin 10 
is expressed in additional suprabasal layers of αPv K5 epidermis but not in the basal layer. 
(C) Expression of loricrin is restricted to the stratum granulosum in αPv Ctrl epidermis, 
whereas loricrin is expressed in all suprabasal layers of αPv K5 epidermis but not in the basal 
layer. (D) Macrophages are recruited to αPv K5 dermis in areas where the BM is disrupted, 
whereas no signs of inflammation can be recognized in αPv Ctrl dermis. Arrow indicates 
Mac1-positive macrophages in αPv K5 dermis. Star indicates the splitting and disruption of 
the BM in αPv K5 skin. (E) Granulocytes are recruited to αPv K5 dermis in areas where the 
BM is disrupted and to distorted αPv K5 HFs, whereas no signs of inflammation can be 
recognized in αPv Ctrl epidermis and around αPv Ctrl HFs. Arrows indicates Gr1-positive 
granulocytes in αPv K5 dermis and adjacent to αPv K5 HFs. Asterisk indicates the splitting 
and disruption of the BM in αPv K5 epidermis. 
 
Figure 9: Reduced migration-velocity and directionality of αPv-deficient primary 
keratinocytes 
(A) In vitro wound healing assay with αPv Ctrl and αPv K5 primary keratinocytes. While 
αPv Ctrl keratinocytes close the artificial wound within 24 hours, αPv K5 keratinocytes are 
unable to migrate efficiently into the wounded area. Colored lines represent the migration-
tracks of individual keratinocytes. (B) Quantification of the migration-parameters of αPv Ctrl 
and αPv K5 primary keratinocytes during in vitro wound healing assays. Migration-velocity 
and directionality of αPv keratinocytes are significantly reduced compared to αPv Ctrl 
keratinocytes, resulting in a severe reduction in the accumulated distance (Acc. D.) and in the 
Euclidean distance (Euc. D.) of αPv keratinocytes. Mean values plus standard error of the 
mean are represented. At least three independent scratch assay experiments were performed 
and more than 20 individual cells were tracked in randomly chosen regions in each 
experiment. 
 
Supplementary figure 1: Targeting strategy for the generation of αPv floxed animals 
The wild type (WT) αPv locus was targeted with a construct containing homology arms of 
2.7 kb and 5.9 kb (indicated by grey lines). A neomycin-resistance cassette (Neo; grey box) 
flanked by two frt-sites (grey triangles) was introduced into intron 2. The first loxP-site 
(black triangle) was inserted into intron 2 and the second loxP-site was inserted into intron 3, 
thus flanking exon 3 of the αPv gene. Binding sites for the primers a: APE2f, b: APloxPf and 
c: APloxPr are indicated by bent arrows, pointing into the direction of polymerization. The 
resulting PCR-products are indicated by black lines and their respective product size above. 
Southern blot was used to identify ES-cell clones after homologous recombination. EcoRI-
restriction-sites are indicated by grey lines and the position of the 3’ external probe is 
indicated by a black line. The genomic-fragment resulting from EcoRI digestion is indicated 
by a black line and its expected size is below. The neomycin-resistance cassette was removed 
by crossing heterozygous floxed αPv mice (fl n+) with FLP-recombinase-expressing mice 
(Farley et al., 2000), resulting in αPv floxed mice without neomycin-resistance cassette (fl n-
). Cre-recombinase mediated recombination results in the excision of exon 3 and deletion of 
the αPv gene (fl-). 
 
Supplementary figure 2: Keratinocyte-restricted deletion of αPv results in progressive 
loss of hair 
(A) αPv Ctrl and αPv K5 mice at the age of one week, two weeks, four weeks and four month 
(as in Fig.1A). Reduction of hair can be clearly recognized one week after birth and αPv K5 
mice are characterized by a complete and persistent alopecia by two month of age. (B) 
Southern-blot of ES-cell-clones after homologous recombination. Genomic DNA from ES-
cell-clones in lane 3, 8 and 10 indicates successful homologous recombination of the 
targeting vector and the αPv-gene. (C) PCR with DNA from a litter of αPv homozygous 
floxed female mated to an αPv heterozygous male, expressing the Cre-recombinase under the 
control of the K5-promotor. LoxP: PCR to distinguish the wild type (WT), floxed (fl) and 
recombined (fl-) αPv gene. CRE: PCR to determine the presence of the K5-Cre transgene. 
The first two mice (lanes 1-4) are αPv homozygous floxed and carry the K5-Cre transgene 
(fl/fl K5+). Mice of this genotype are referred to as αPv K5 in this study. The third mouse 
(lanes 5-6) is αPv homozygous floxed but does not carry the K5-Cre transgene (fl/fl K5-). 
The fourth mouse (lanes 7-8) is αPv heterozygous floxed and also does not carry the K5-Cre 
transgene (fl/+ K5-). The fifth mouse (lanes 9-10) is αPv heterozygous floxed and carries the 
K5-Cre transgene (fl/+ K5+). Mice of this genotype are referred to as αPv Ctrl and served as 
control animals in this study. 
 
 
Supplementary figure 3: Defects in HF morphogenesis and epidermal homeostasis 
precede the inflammatory response 
Cryo-section from back-skin of P7 αPv Ctrl and αPv K5 mice stained for: (A) Ln332 (green) 
and β1 integrin (red). Arrow indicates suprabasal αPv K5 keratinocytes expressing β1 
integrin. Asterisk indicates intercellular spaces in αPv K5 epidermis. Note disruption and 
displacement of the BM in αPv K5 skin. Scale bar: 20µm. (B) Ln332 (green) and β4 integrin 
(red). Asterisk indicates splitting of the BM in αPv K5 skin. Scale bar: 20µm. (C) Integrin α6 
(green) and f-actin (red). Arrow indicates localization of f-actin to the basal side of basal 
keratinocytes and discontinuous integrin α6 staining in αPv K5 epidermis. Scale bar: 20µm. 
(D) Ln332 (green) and E-Cadherin (red). Arrow indicates localization of E-Cadherin to the 
basal side of basal keratinocytes and splitting of the BM in αPv K5 epidermis. Scale bar: 
20µm. (E) Ln332 (green) and Gr1 (red). Gr1-positive granulocytes are absent from αPv K5 
skin at P7. Scale bar: 20µm. 
 
Supplementary figure 4: Compromised FA formation, abnormal organization of the 
actin cytoskeleton and reduced spreading of αPv-deficient primary keratinocytes 
Separate channels from the immunostaining of αPv Ctrl and αPv K5 primary keratinocytes in 
Fig.6: (A) f-actin (white) and below αPv (white); (B) ILK (white) and below αPv (white); (C) 
Pinch (white) and below αPv (white); (D) Paxillin (white) and below αPv (white). Scale bars: 
20µm. Note the presence of spiky and poorly spread αPv K5 cells in (B) (C) and (D). 
Paxillin-positive FA are present in spread αPv K5 keratinocytes, however their number and 
size is reduced compared to αPv Ctrl keratinocytes. FA-recruitment of ILK and Pinch is 
impaired in αPv K5 keratinocytes. 
 
Supplementary figure 5: Edemas and poor interdigitation of keratinocytes upon loss of 
αPv 
Overview of the EM-pictures from back-skin of P14 αPv Ctrl and αPv K5 mice shown in Fig. 
4C and D. Arrows indicate edemas in αPv K5 epidermis (asterisk) accompanied with poor 
interdigitation of αPv-deficient keratinocytes. Scale bar: 5µm. Note the displacement of the 
BM into the collagen-fibrils of the dermis (cross) in αPv K5 skin as highlighted with a black 
frame and the local dermal-epidermal detachment. Areas with black or white frame are 
enlarged in Fig. 4C and D. 
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